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SUMMARY 
RNA-binding proteins (RBPs) are essential elements to fine-tune gene 
expression at the post-transcriptional level. They are numerous and, in a 
general manner, can be grouped in ribosomal proteins, ribonucleases and 
RNA chaperones, which comprise diverse protein domains. Cold shock 
proteins (CSPs) are a group of RNA chaperones belonging to the cold-
shock domain (CSD) family that is present in every kingdom of life. CSPs 
have been extensively studied but the specific RNA targets and the 
biological functions remain elusive for most of them. The name CSP 
comes from the first identified protein, whose expression was inducible by 
cold. However, most of the members of this family are not cold-inducible. 
In addition, one genome may encode several CSPs that are suspected to 
be functionally redundant due to their high sequence identity.  
In this Thesis, we have explored the regulon, specificity, biological role 
and regulatory mechanisms of the RNA chaperone CspA using 
Staphylococcus aureus as a model. S. aureus is a notorious pathogen that 
produces a wide range of diseases and, with the emergence of multidrug-
resistant strains, has raised awareness towards generating new 
antimicrobial strategies. Its genome encodes three CSP genes with a 
sequence identity higher than 70% between them, suggesting a possible 
functional overlap. To address this matter, we selected a cspA mutant 
strain, which presented reduced staphyloxanthin (STX) production, as an 
in vivo functional reporter for complementation studies. If CSP paralogs 
were functionally redundant, STX levels would be restored by expressing 
any of S. aureus CSPs. Expression of CSPs under the control of a 
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heterologous promoter showed that only CspA restored STX production. 
However, Western blots revealed different CSPs levels, indicating the 
existence of differential post-transcriptional regulatory processes, which 
possibly prevented the expression of appropriate CSP amounts to 
complement STX production. In an attempt to avoid such post-
transcriptional regulation bias, we genetically modified the cspA mRNA to 
encode CspB or CspC. Thanks to these mutated genes, CspB and CspC 
proteins were produced in comparable levels to those of CspA. 
Nevertheless, they were still unable to restore the wild type level of STX, 
suggesting individual functionalities for each of S. aureus CSP. To define 
the protein motifs responsible for CspA target specificity, we created CSP 
chimeric constructs by interchanging CspB and CspC motifs with their 
corresponding ones in CspA. We found that the amino acid differences in 
the carboxi-half of the protein, away from the RNA-binding motifs, were 
responsible for functional singularity.  
Seeing that S. aureus CSPs were not interchangeable, we focused on 
deciphering the specific biological role of CspA by elucidating its regulon. 
For this purpose, we combined genome-wide proteomics with in vivo RIP-
CHIP and found that CspA behaved as a global regulator of gene 
expression, modulating genes required for carbohydrate and 
ribonucleotide metabolism, stress response and virulence. Consequently, 
deletion of cspA deregulated biofilm formation and impeded bacterial 
survival in the presence of oxidative agents. This highlighted the 
importance of CspA for S. aureus to cope more efficiently with 
environmental stresses. 
5 
We noticed that CspA-binding could either promote or reduce protein 
expression. The latter was an unexpected trait since CSPs are widely 
regarded as enhancers of translation by unfolding RNA structures that 
impair ribosome progression on the mRNAs. Nevertheless, we observed 
that the repression exerted by CspA could occur by at least two different 
mechanisms. In the first case, CspA bound the 5’UTR of the cspC mRNA 
and decreased its translation without changing the mRNA levels. In the 
second case, CspA repressed its own expression by interfering with 
endoribonuclease III (RNase III) activity. RNase III is required for 
promoting CspA translation through processing of an RNA hairpin located 
in the 5’UTR of the cspA mRNA. CspA interacts with a U-rich motif from 
the right arm of such hairpin. As a consequence, it melts the double-
stranded structure avoiding RNase III cleavage and thus reducing CspA 
expression. The mechanism behind this auto-regulation depicted CspA as 
a putative antagonist of RNase III activity. 
This Thesis shows how RNA chaperones, like S. aureus CspA, can 
specifically interact with RNA structures targeted by other RBPs and offers 
new ways of understanding CSP-mediated regulation. At the same time, it 
highlights the importance of intrinsic mRNA regulatory elements and 
proposes the interaction between them and RBPs as the key factor 
determining proper protein levels and, ultimately, allowing the correct 
development of organisms. 
Sections of this Doctoral Thesis have been published in: 
Nucleic Acids Research, 2018. DOI: 10.1093/nar/gkx1284 
The regulon of the RNA chaperone CspA and its auto-regulation in Staphylococcus 
aureus. C. J. Caballero, P. Menendez-Gil, A. Catalan-Moreno, M. Vergara-Irigaray, B. 
García, V. Segura, N. Irurzun, M. Villanueva, I. Ruiz de los Mozos, C. Solano, I. Lasa and 
A. Toledo-Arana.
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RESUMEN 
Las proteínas de unión a RNA (RBPs) son elementos esenciales para 
regular la expresión génica a nivel post-transcripcional. Los genomas 
codifican numerosas RBPs que incluyen diversos dominios proteicos. De 
forma general, estas pueden agruparse en proteínas ribosomales, 
ribonucleasas y chaperonas de RNA. Las cold shock proteins (CSPs) son 
un grupo de chaperonas de RNA, que poseen un dominio cold shock 
(CSD), y que se encuentran distribuidas en todos los seres vivos. A pesar 
de haber sido ampliamente estudiadas, aún se desconocen las dianas y la 
función biológica de la mayoría de ellas. El nombre de estas chaperonas 
se debe a que la expresión de la primera en ser identificada se inducía al 
bajar la temperatura de crecimiento. Sin embargo, el estrés por frío no 
actúa como activador en otros miembros de esta familia. Un solo genoma 
puede codificar varias CSPs que, al tener una elevada similitud de 
secuencia, ha llevado a plantear la existencia de una posible redundancia 
funcional entre ellas. 
En esta Tesis hemos identificado y caracterizado el regulón, la 
especificidad, la función biológica y los mecanismos de regulación de la 
chaperona CspA utilizando Staphylococcus aureus como modelo. S. 
aureus es un patógeno de gran importancia clínica capaz de provocar una 
gran variedad de enfermedades y que, además, se ha convertido en un 
grave problema sanitario por la aparición de cepas multi-resistentes a los 
antibióticos. En el genoma de S. aureus existen tres variantes de CSPs 
con una identidad de secuencia superior al 70%. Para determinar si 
Resumen 
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existía una redundancia funcional entre las mismas, generamos un 
mutante en el gen cspA, que presentaba niveles reducidos de 
estafiloxantina (STX), el pigmento antioxidante que confiere el color 
característico a las colonias de S. aureus. Si los parálogos de CspA 
tuviesen la misma función, la producción de STX debería reestablecerse 
al expresar cualquiera de las tres variantes en dicha cepa. Sin embargo, 
los experimentos de complementación con un promotor heterólogo, 
revelaron que tan solo CspA restauraba la producción de STX. No 
obstante, a pesar de estar expresadas bajo el mismo promotor, 
observamos que los niveles de las proteínas CspB y CspC eran inferiores 
a los de CspA. Esto indicaba que las CSPs sufrían procesos de 
regulación post-transcripcional diferentes, lo que resultaba en 
concentraciones no comparables de las mismas. Con el fin de evitar esta 
limitación, modificamos genéticamente el mRNA de cspA para que 
codificase CspB o CspC. Estas mutaciones nos permitieron obtener una 
concentración similar para todas las CSPs. A pesar de ello, la producción 
de STX seguía siendo restaurada tan solo por CspA, lo que sugería una 
especialización funcional para cada una de las CSPs. Para determinar 
cuáles eran los motivos proteicos responsables de la especificidad, 
generamos construcciones quiméricas que intercambiaban regiones de 
CspB y CspC con CspA. De esta forma, descubrimos que las diferencias 
en los aminoácidos localizados en la mitad carboxi-terminal, y alejadas del 
dominio de unión a RNA, serían las responsables de la especificidad 
funcional de las CSPs.  
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Teniendo en cuenta que las CSPs de S. aureus resultaron no ser 
intercambiables entre sí, nos centramos en estudiar la función biológica 
específica de CspA. Para ello, combinando abordajes globales de 
proteómica cuantitativa e inmuno-precipitación de los complejos CspA-
RNA, determinamos su regulón. Pudimos observar que CspA se 
comportaba como un regulador global en S. aureus, modulando la 
expresión de genes relacionados con el metabolismo de carbohidratos y 
ribonucleótidos, así como con la respuesta al estrés y virulencia. Como 
consecuencia, la deleción de cspA producía cambios fenotípicos 
evidentes como la desregulación en la formación del biofilm o la 
disminución de la resistencia a agentes oxidantes. Todo ello destacaba la 
importancia de CspA en la adaptación de S. aureus a condiciones de 
estrés. 
El regulón mostraba que la unión de CspA a sus dianas podía afectar a la 
expresión proteica tanto positiva como negativamente. Generalmente, se 
asume que las CSPs son potenciadoras de la traducción al deshacer 
estructuras que dificultan el progreso de los ribosomas en los mRNAs. Por 
ello, la existencia de una regulación negativa fue una característica 
inesperada que nos llevó a estudiarla más en detalle. Descubrimos que la 
unión de CspA podía inhibir la expresión proteica mediante, al menos, dos 
mecanismos distintos. En el primer caso, CspA se unía a la 5’UTR del 
mRNA de cspC, disminuyendo la expresión de CspC. Esta unión no 
afectaba a los niveles del mRNA, por lo que cabía suponer que podía 
interferir con la traducción, probablemente dificultando el acceso del 
ribosoma. Los experimentos de traducción confirmaron que la sola 
Resumen 
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presencia de CspA era suficiente para inhibir la traducción de CspC in 
vitro. En el segundo caso, CspA reprimía su propia expresión al interferir 
con la acción de la endoribonucleasa III (RNase III). RNAse III potencia la 
traducción de CspA al procesar una horquilla de RNA localizada en la 
5’UTR de su propio mRNA. CspA interaccionaba con dicha horquilla a 
través de un motivo rico en uridinas, provocando una desorganización de 
su estructura y evitando así el procesamiento por RNase III. Como 
consecuencia, la traducción de CspA se veía inhibida. Este mecanismo de 
autorregulación propone a CspA como un posible antagonista de la 
actividad de RNase III.  
En esta Tesis, se pone de manifiesto que las chaperonas de RNA, como 
CspA, pueden interactuar de manera específica con estructuras de RNA, 
que a su vez pueden ser reconocidas por otras RBPs. Esto contribuye a 
un mejor entendimiento de la regulación mediada por este grupo de 
chaperonas de RNA. Además, se destaca la importancia de los elementos 
reguladores intrínsecos, presentes en cada mRNA, y se propone que la 
interacción de dichos elementos con distintas RBPs es un factor clave 
para la correcta expresión proteica que, en última instancia, permite el 
adecuado desarrollo de todos los seres vivos.  
 
Secciones de esta Tesis Doctoral han sido publicadas en: 
 
Nucleic Acids Research, 2018. DOI: 10.1093/nar/gkx1284 
The regulon of the RNA chaperone CspA and its auto-regulation in Staphylococcus 
aureus 
C. J. Caballero, P. Menendez-Gil, A. Catalan-Moreno, M. Vergara-Irigaray, B. García, V. 
Segura, N. Irurzun, M. Villanueva, I. Ruiz de los Mozos, C. Solano, I. Lasa and A. Toledo-
Arana 
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INTRODUCTION 
 
Post-transcriptional regulation in bacteria 
 
Control of gene expression is essential for bacteria as it economizes 
resources and adjusts the production of functional molecules to adapt to 
ever-changing environments. The central dogma of molecular biology 
states that a DNA molecule is transcribed into mRNA, which is then 
translated into protein. It was believed for many years that the levels of 
mRNA were a direct indicator of the amount of protein that would be 
produced (Crick, 1970). However, in the last decade different research 
groups have carried out investigations on regulation of gene expression 
that have come to question the role and importance of the mRNA within 
the genetic flow of information. 
After transcription occurs, the amount of protein production is determined 
by different elements that modulate mRNA levels and ribosome 
accessibility. Most of these elements can positively or negatively modulate 
the expression of their mRNA targets. Such is the case of small RNAs 
(sRNAs), which are transcripts of about 50-300 nt long that act through 
base pairing with their mRNA targets (Waters and Storz, 2009; Storz et al., 
2011). In a similar manner, antisense RNAs (asRNA) base pair with 
perfect complementarity with mRNAs that are generated in the opposite 
Introduction 
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strand (Lasa et al., 2012; Lasa and Villanueva, 2014). In addition, other 
RNA regulatory elements may be found within the mRNAs themselves. On 
the one hand, the 5’ untranslated region (UTR) often contains regulatory 
structures like hairpins or riboswitches that can dictate the fate of gene 
expression (Kortmann and Narberhaus, 2012; Serganov and Nudler, 
2013). On the other hand, the 3’ UTRs that apart from containing the 
transcription terminator signal, also harbour regulatory elements capable 
of influencing gene expression by different mechanisms. Some of these 
include circularization of mRNA that blocks RBS, altering mRNA decay 
and/or binding proteins (Ruiz de Los Mozos et al., 2013; López-Garrido et 
al., 2014; Zhu et al., 2015). 
Finally, complex networks of RNA-protein interactions regulate gene 
expression at the post-transcriptional level. Eukaryotic cells encode 
hundreds of RNA binding proteins (RBPs) that play critical roles affecting 
RNA structures, interactions, biogenesis, modifications, turnover, 
localization, export and translation of mRNAs (Glisovic et al., 2008). In 
bacteria, RBPs are numerous and contain diverse protein domains that 
recognize, bind, process or modify certain sequences and/or structures. 
As a consequence, bacterial RBPs could play diverse post-transcriptional 
roles, but elucidation of their precise molecular mechanisms require 
further investigations (Van Assche et al., 2015). Regarding their functions, 
they can be classified into three generic groups: ribosomal proteins, 
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ribonucleases and RNA chaperones. In the following sections, the most 
relevant roles of these RBP groups are described.  
 
 
Ribonucleases 
 
Ribonucleases (RNases) are a group of enzymes that recognize and 
process RNA in function of their sequence and/or structure. Many RNases 
exist, each recognizing particular RNA patterns and displaying specific 
processing mechanisms. 
RNase E is one of the most studied RNases, playing an essential role in 
Gram-negatives and processing the majority of its mRNAs (Ow and 
Kushner, 2002; Stead et al., 2011; Hammarlöf et al., 2015). It was first 
identified in Escherichia coli and found necessary for processing the 5S 
rRNA (Apirion and Lassar, 1978). The structure of RNase E involves two 
RNA binding domains that are important for target recognition, typically 
single stranded RNAs containing AU-rich regions instead of a particular 
nucleotide sequence (McDowall et al., 1994). Despite being an 
endonuclease, its catalytic domain shows predilection for RNAs lacking 
the triphosphate cap at the 5’-end (Mackie, 1998). One of the major 
aspects of RNase E is that it is considered the scaffolding protein of the 
degradosome in Gram-negative bacteria, a protein complex that mediates 
bacterial RNA degradation. In addition to RNase E, it includes the 
Introduction 
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exonuclease PNPase, RNA helicase RhlB and a glycolytic enzyme known 
as enolase (Vanzo et al., 1998; Carpousis, 2007). In Gram-positives, there 
are no RNase E homologs. However, they count with other RNases that 
somehow make up for it. Such is the case of RNase Y, an essential 
ribonuclease, which also targets single stranded AU-rich RNA regions. It 
has a preference for monophosphate 5’-ends and that affects a large 
amount of the mRNAs transcribed in Bacillus subtilis (Shahbabian et al., 
2009; Lehnik-Habrink et al., 2011). 
PNPase is a dual enzyme that combines the processing nature of an 
RNase with the synthetic capacity of an RNA polymerase. On the one 
hand, it degrades single stranded 3’-ends of at least 10-12 nt until it meets 
a stable secondary structure (Xu and Cohen, 1995; Coburn and Mackie, 
1998). On the other hand, it generates A-tails in the same extremity, if the 
concentration of available NDPs is sufficient, which will ultimately affect 
the susceptibility of the entire RNA molecule to single stranded processing 
RNases like itself (Xu and Cohen, 1995; Mohanty and Kushner, 2000; 
Mohanty and Kushner, 2011). The importance of PNPase in bacterial 
systems resides in its central role in the degradosome. This is true for both 
Gram-negatives and Gram-positives. In the former, it associates itself with 
RNase E, helicase RhlB and enolase, while in the latter RNase Y, helicase 
CshA and a phosphofructokinase are its partners (Carpousis, 2007; Cho, 
2017). 
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The 3’-exorribonuclease activity of PNPase is matched by that of RNase R 
and RNase II, two hydrolytic exonucleases that are also specialized in 
degrading single stranded 3’-ends (Nossal and Singer, 1968; Spickler and 
Mackie, 2000). RNase II initially seemed as functionally redundant with 
PNPase because, in addition to behaving as a 3’-exorribonuclease, it 
could not process double stranded structures of RNA and its deletion, 
alongside with that of PNPase, was unviable in E. coli (Donovan and 
Kushner, 1986; Spickler and Mackie, 2000). However, later studies 
reflected that both enzymes affected total RNA levels in the bacteria 
differently (Mohanty and Kushner, 2003). RNase R shows an additional 
role as it can manage through double stranded regions of RNA thanks to 
its unwinding capacity. Nevertheless, it needs the existence of a single 
stranded nucleotide stretch, like a poly-A tail, to recognize the substrate 
and initiate its activity (Cheng and Deutscher, 2005; Awano et al., 2010). 
The 5’-terminus of RNAs can also suffer processing from RNases. 
Homologs RNase J1 and RNase J2 were initially described as functional 
RNase E homologs in B. subtilis (Even et al., 2005). Today, they are 
known for also degrading RNA molecules in a 5’-3’ manner. RNase J1 
seems to have a preference for 5’-monophosphorylated transcripts, which 
result from the activity of an RppH homologous in B. subtilis. (Mathy et al., 
2007; Richards et al., 2011). RNase J1 and RNase J2, are encoded by 
rnjA and rnjB genes, respectively. Mutating both RNases to limit the 
expression of the former and delete the latter has a significant impact on 
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global gene expression. Although the number of transcripts whose levels 
are affecteds in RNase J1 and RNase J2 single mutants is very low, 
compared to a double mutant, RNAse J1 has a wider spectrum of targets 
than RNase J2. This is in agreement with the idea of RNase J1 having a 
more prominent exonuclease activity than RNase J2, in addition to being 
essential for cell viability (Mäder et al., 2008; Mathy et al., 2010).  
RNase III plays an important role processing double stranded RNA 
configurations in bacteria. As showed by Lasa and colleagues, the impact 
of RNase III on the transcriptome of Gram-positive bacteria is vast (Lasa 
et al., 2011). Up to three fourths of the annotated genome is affected by 
antisense transcription in Staphylococcus aureus, leading to the formation 
of overlapping transcripts. The repercussions of such double stranded 
RNA arrangements are the accumulation of short RNAs that result from 
the processing by this RNase (Lasa et al., 2011). A later study, showed 
that a significant percentage of the annotated RNAs were 
immunoprecipitated alongside RNase III in S. aureus, confirming the broad 
influence of this ribonuclease (Lioliou et al., 2012).  Likewise, it was 
proposed that E. coli produces many antisense transcripts that generate 
double stranded RNA structures upon hybridizing with RNAs from the 
opposite strand. These double stranded RNA formations were isolated 
and found enriched in RNase III deficient mutants, indicating a processing 
by such RNase in a wild type strain (Lybecker et al., 2014). These findings 
suggest that RNase III acts as a global regulator of antisense transcription, 
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processing overlapping coding sequences (CDSs), operons and UTRs 
(Lasa et al., 2012). It also acts on hairpins that are formed as a result of 
internal base pairing in different RNA species. This can affect the 
translation of the resulting processed mRNA, as observed for the major 
cold shock protein A (CspA), the stability of the sRNA rsaA or the 
maturation of ribosomal RNA 16S in S. aureus (Lioliou et al., 2012). 
Typically, these hairpins are 22 bp long, however, in vitro studies support 
that a minimum of 11 bp of double stranded RNA is required for efficient 
cleavage (Lamontagne and Elela, 2004; Gan et al., 2006; Pertzev, 2006; 
Court et al., 2013). Although no consensus sequence has been described 
for RNase III targets, certain nucleotides in the cleavage region are known 
to favour such processing more than others (Pertzev, 2006). 
 
 
Ribosomal proteins 
 
Ribosomal proteins are structural components of the ribosomes capable of 
binding RNA as well as interacting with each other. Since they are part of 
the ribonucleoprotein complex, they participate in translation of mRNAs.  
The 30S or small subunit of the ribosome, which is responsible for 
recognizing and binding the mRNA throughout the translation process, 
contains 20 different proteins in addition to the 16S rRNA. The 50S or 
large ribosome subunit, is in charge of enabling the polymerization of the 
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new peptide during translation and contains around 30 proteins alongside 
the 23S and 5S rRNAs. In this case, its proteins do not interact with the 
translated mRNA. However, many of them are considered RNA binding 
proteins since they often bind rRNAs and/or act as feed-back negative 
regulators of their translation by interacting with their own mRNA leaders 
(Nashimoto and Nomura, 1970; Nomura, 1970).  
Within the 30S, S1 protein is essential in a wide variety of bacteria with the 
exception of low GC content Gram-positives. It is composed of six S1 
motifs (stretches of 72-75 amino acids), which are also present in many 
other RBPs and their role is to bind RNA (Bycroft et al., 1997; Sorensen et 
al., 1998; Salah et al., 2009). S1 facilitates mRNA binding of the 30S 
about 11 nucleotides from the RBS (Sengupta et al., 2001). For this 
reason, S1 plays a major role during the early stages of translation 
(Sorensen et al., 1998; Delvillani et al., 2011). Other than enabling 
ribosome binding to the mRNA, it holds an unwinding capacity, working as 
a chaperone that allows the ribosome to access the RBS of structured 
5’UTRs of mRNAs. S1 would first bind to single stranded nucleotide 
stretches in close proximity to secondary structures and then melt them 
through a multistep process (Qu et al., 2012; Mélodie Duval et al., 2013).  
The rest of the proteins are highly conserved among different bacterial 
species. Such is the case of S2, an essential protein that interacts with the 
mRNA during the formation of the Shine-Dalgarno (SD)-anti-SD duplex in 
early translation and recruits S1 into the ribosome by direct protein-protein 
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interaction (Yusupova et al., 2006; Byrgazov et al., 2012). S3 and S4 play 
a role in unwinding secondary structures of the mRNA substrate and 
promote ribosome progression, which in the case of S4 is linked to its anti-
terminator properties (Torres et al., 2001; Takyar et al., 2005). S4 is also 
crucial during the initial steps of the 30S subunit assembly since it 
constitutes the first ribosomal protein that binds the 5’ region of the 16S 
rRNA and thus forms a complex into which the remaining proteins are 
subsequently integrated (Kim et al., 2014; Abeysirigunawardena et al., 
2017). S7 and S8 constitute two additional ribosomal proteins with RNA 
binding properties that interact with rRNA 16S (Saito and Nomura, 1994; 
Robert and Brakier-Gingras, 2001). S15 binds the 16S rRNA and serves 
as a bridge between the small and large ribosomal subunits (Culver et al., 
1999).  
The 50S or large ribosomal subunit is a key player in the generation of the 
new polypeptide by accommodating amino acid loaded transport RNAs 
(tRNAs) within its structure. However, unlike the 30S, it does not bind the 
mRNA and, since it is a bigger complex, its composition is of about 30 
proteins and two ribosomal RNAs, 23S and 5S. 
L1, which is known for binding the 23S rRNA and forming a structure that 
is often referred as the “stalk” of the 50S, is involved in the translocation of 
tRNAs from the P (peptidyl) to the E (exit) site within the ribosome (Mikel 
Valle et al., 2003). L4 also binds the 23S rRNA, contributing to its proper 
folding during ribosome assembly. Two additional elements of the 50S 
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subunit, L10 and L7/L12, form a complex of a pair of L7/L12 dimers that 
bind the C-terminal domain of L10 (Griaznova and Traut, 2000). Such 
complex recognizes the 23S rRNA, through L10, and recruits important 
translation factors (Wieden et al., 2001; Iben and Draper, 2008). Lastly, 
L20 also binds the 23S rRNA thanks to its C-terminal domain (Raibaud et 
al., 2003). 
Most of the ribosomal proteins with RNA binding properties are known for 
their ability to down-regulate their own translation upon binding their 
mRNA. In many cases, they behave like RNA chaperones by blocking the 
RBS or the start codon but they can also act through other mechanisms. 
However, the mode of action for some of them still remains unknown 
(Sorensen et al., 1998; Delvillani et al., 2011).  
 
 
RNA chaperones 
 
RNA chaperones are proteins that bind RNA and have the ability to 
rearrange or fix their structure, affecting their stability, RNA accessibility 
and translation. RBPs that facilitate the base-pairing between sRNAs and 
their mRNA targets are also included in this group. In general, Hfq and 
CsrA are the most known RNA chaperones and, therefore, offer great 
examples of how this type of RBPs regulate gene expression of their 
targets. 
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Host factor Q, Hfq 
 
Host factor Q, Hfq, was first described as a protein required for replication 
of phage QB in E. coli (Franze de Fernandez et al., 1968). Hfq is widely 
known for acting as an RNA chaperone that facilitates and stabilizes 
interactions between sRNAs and mRNAs that do not necessarily present a 
complete base pairing complementation. The RNA chaperone activity is 
carried out by a ring-shaped complex from the union of six identical Hfq 
monomers, each comprising five antiparallel beta sheets and an alpha 
helix at the N-terminal. The first three beta sheets conform the Sm1 motif, 
while sheets 4 and 5 correspond to the Sm2 motif. Sm motifs are present 
in proteins of the Sm and LSm families, which are known for binding RNA 
(Schumacher et al., 2002; Sauter et al., 2003). The doughnut-shaped 
structure of Hfq can be divided in different RNA binding faces, each with a 
different preference for specific nucleotide sequences: the proximal face, 
the distal face and the rim (Updegrove et al., 2016). The proximal face 
specializes in binding U-rich RNA motifs, like Rho-independent 
terminators. Removing the U-stretch from terminators of sRNAs may result 
in a deficient binding to Hfq. This was the case for SgrS sRNA that lost its 
ability to interact with Hfq and thus repress the expression of target mRNA 
ptsG, which encodes the major glucose transporter in E. coli (Otaka et al., 
2011; Ishikawa et al., 2012). From a structural point of view, such U-rich 
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motifs are kept into pockets placed between contiguous monomers of the 
protein (Schumacher et al., 2002; Sauer and Weichenrieder, 2011). Unlike 
the proximal face, the distal face recognizes sequences with high 
abundance of adenines (Link et al., 2009; C Lorenz et al., 2010). The 
position of the A-rich motif in the sRNAs and mRNAs seems of importance 
for Hfq activity. A good example to illustrate this is the mRNA that encodes 
the alternative sigma factor, rpoS, which in E. coli is targeted and 
positively regulated by sRNAs DsrA, RprA and ArcZ. These sRNAs 
interact with a hairpin present in the mRNA leader of rpoS that sequesters 
the RBS, releasing it and thus increasing translation. However, an A-rich 
motif located immediately upstream of the sRNAs binding site is required 
in the mRNA for Hfq to efficiently participate in the annealing and 
subsequent regulation of rpoS expression in vivo (Panja and Woodson, 
2012; Peng, Soper, et al., 2014).  
The rim of Hfq contains a patch or arginines that is important for ensuring 
an optimal binding of Hfq to RNA targets. Removing these amino acids 
from the protein causes a significant decrease in Hfq binding efficiency. It 
is suggested that the rim is in some cases required as an additional 
binding site for the interaction with RNA targets. This is true for the rpoS 
mRNA, which binds the distal face and the rim of Hfq (Sauer et al., 2012; 
Panja et al., 2013; Peng, Curtis, et al., 2014; Schu et al., 2015). 
In summary, the principal role of Hfq is to enhance RNA interactions. It 
acts as a platform where two different RNA molecules binding to different 
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faces of the protein meet. The interaction of two different RNAs with Hfq 
may involve structural rearrangements in which their complementary 
sequences are exposed and fall in close proximity to one another. As a 
consequence, gene expression and/or RNA stability are altered (Soper 
and Woodson, 2008; Beisel et al., 2012; Panja and Woodson, 2012; 
Wagner, 2013). 
 
 
Carbon storage regulator A, CsrA 
 
Carbon storage regulator A (CsrA) is known as the regulator of the central 
carbon storage metabolism for its role in enhancing glycolysis and 
suppressing gluconeogenesis (Sabnis et al., 1995). However, more recent 
studies highlight the global regulatory nature of this protein (Romeo et al., 
2013; Holmqvist et al., 2016; Potts et al., 2017). CsrA functions as a 
dimer, the interaction of two monomers leads to the formation of a b-barrel 
of 10 antiparallel b-sheets, which contain an RNA binding motif in each 
extreme, and two a-helixes hanging from each side of the protein 
(Gutiérrez et al., 2005; Mercante et al., 2006). It targets GGA motifs, 
typically found in the single stranded loops of short hairpins. These motifs 
are often found at the RBS (Dubey et al., 2005; Holmqvist et al., 2016). 
CsrA works as a post-transcriptional regulator of mRNAs at the level of 
translation. Most of the times it behaves as a repressor, occluding the SD 
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sequence and leading to early degradation of targeted mRNAs. Good 
examples of this are the glgC and cstA genes, responsible for glycogen 
synthesis and transport under carbon starvation in E. coli, respectively 
(Baker et al., 2002; Dubey et al., 2003). However, negative regulation 
does not always occur through the same mechanism. In the case of sdiA 
mRNA, the N-acylhomoserine-L-lactone receptor of E. coli, CsrA binds to 
the AUG codon preventing translation to initiate (Helen Yakhnin, Baker, et 
al., 2011). In a more recent study, CsrA was found to repress the 
translation of IraD, a protein that prevents RpoS proteolysis. This was 
achieved by CsrA binding to the SD of the upstream ORF, located in the 
same operon (Park et al., 2017).  
In some cases, CsrA can enhance translation by stabilizing the mRNA or 
making it less susceptible to RNase processing. The mRNA of flhDC, the 
master regulator of flagellum synthesis, is protected from RNase E thanks 
to CsrA binding (Alexander V Yakhnin et al., 2013). 
The activity of CsrA is controlled by the interaction with CsrB and CsrC 
sRNAs. These sRNAs contain several CsrA-recognition motifs in their 
sequences. As a result, CsrB and CsrC act as sequestering factors, 
restraining the protein and preventing its action (Mu Ya Liu et al., 1997; 
Weilbacher et al., 2003; Babitzke and Romeo, 2007). 
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Cold shock proteins 
 
Cold shock proteins (CSPs) are a group of RNA chaperones belonging to 
the cold shock domain (CSD) protein family which, as reflected in SMART 
database, is present in every kingdom of life (http://smart.embl.de/) 
(Letunic et al., 2015). Besides being very widespread, a variable number 
of CSPs can be found within a single bacterial genome depending on the 
species (Graumann and Marahiel, 1998). For example, the Gram-negative 
E. coli and the Gram-positive B. subtilis that have been widely used as 
bacterial models to study CSPs, contain nine and three Csp-paralogs, 
respectively. The fact that CSPs present a high identity between them 
(above than 45%), that four of E. coli CSPs (CspA, CspB, CspG and CspI) 
are cold inducible and suggests a possible overlapping role (Nakashima et 
al., 1996; Wang et al., 1999; Xia et al., 2001). A recent study in Salmonella 
has also shown that CspC and CspE have functional redundancy, 
supporting this notion (Michaux et al., 2017). However, although certain 
CSPs may make up for the absence of others, complementation in some 
cases is non-existent, indicating specific roles for some CSPs (Graumann 
et al., 1997; Xia et al., 2001). 
In conflict with their given name, several members of the CSP family are 
non-cold induced and their expression is either constitutive or activated 
upon different stresses other than cold. For this reason, it is thought that 
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CSPs might be required for bacterial adaptation to different environmental 
stresses. Thus, mutation of a specific CSP might prevent bacteria from 
adapting to cold, oxidative and osmotic stresses, as well as affect the 
intracellular lifestyle or stationary-growing phase (Willimsky et al., 1992; 
Yamanaka et al., 1998; Graumann and Marahiel, 1999; Schmid et al., 
2009; Brea D Duval et al., 2010; Loepfe et al., 2010; Czapski and Trun, 
2014; Derman et al., 2015). In B. subtilis, the presence of at least one csp 
gene is essential for viability (Graumann et al., 1997). However, in other 
bacteria such as Listeria monocytogenes, none of its three CSPs are 
required for survival in non-stress growth conditions (Schmid et al., 2009).  
Throughout decades of research, different activities have been attributed 
to CSPs. Presently, it is believed that most of them act by melting RNA 
secondary structures in a low binding affinity manner, allowing ribosome 
progression and thus improving translation (Phadtare, 2004; Phadtare and 
Severinov, 2005; Phadtare and Severinov, 2010). Such unwinding 
capacity has also been proven to be a mechanism for transcription anti-
termination of certain genes. This occurs in the metY-rpsO operon of E. 
coli, from which larger transcripts are generated upon CspE and CspC 
overexpression (Bae et al., 2000; Phadtare, Tyagi, et al., 2002; Phadtare 
et al., 2003).  
CSPs interact with RNA targets through hydrophobic interactions thanks to 
their CSD, which is about 7.4 kDa and consists of five anti-parallel β-
sheets that form a β-barrel (Newkirk et al., 1994; Schindelin et al., 1994). 
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Two RNA binding motifs, RNAP1 and RNAP2, are located in β-sheets 2 
and 3 respectively and are important for nucleic acid binding (Newkirk et 
al., 1994), (Lee et al., 2013). In E. coli and B. subtilis, mutations of 
residues from the aromatic cluster of CspA and CspB respectively, 
impaired nucleic acid binding (Schröder et al., 1995; Hillier et al., 1998). 
Several works on the structural features of this protein domain showed the 
key amino acids involved in the protein-nucleic acid interaction. The RNA 
binding and RNA melting activities are carried out by different amino acids. 
Thus, protein mutants in Phe17, Phe30, and His32 amino acids are unable to 
unwind RNA structures in vitro but retain the RNA binding capacity 
(Schröder et al., 1995; Phadtare, Tyagi, et al., 2002; Zeeb et al., 2006; 
Sachs et al., 2012). It is surprising that such a small protein domain carries 
out these functions in an ATP-independent manner, unlike the DEAD box 
helicases, which require ATP to rearrange RNA secondary structures 
(Redder et al., 2015).  
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Auto-regulatory mechanisms of RNA-binding proteins. 
 
Several RBPs have the ability to regulate their own expression. This 
suggests a generalized regulatory mechanism that makes it consistent to 
examine if the same kind of auto-regulation is true for the rest of the 
RBPs. Some examples of such mechanism are described below. 
RNase III, can regulate its own expression through a negative feedback 
loop. Its mRNA secondary structure contains three double stranded loops 
that are located in the UTRs. The second hairpin, found in the 5’UTR, can 
be targeted and processed by RNase III itself and lead to the 
destabilization of the mRNA, ultimately affecting its translation (Matsunaga 
et al., 1996). 
Ribosomal protein S1 controls its own expression by binding the leader of 
its mRNA (Skouv et al., 1990; Boni et al., 2001). In addition, S1 may 
cooperate with S2 in down-regulating the translation of the latter and that 
of the elongation factor Ts. This is accomplished by interaction of S2 with 
the 5’UTR of its operon, rspB-tsf, in which genes rspB and tsf are 
translated into S2 and Ts proteins, respectively (Aseev et al., 2008). S15, 
is able to bind its own mRNA and block its translation by stabilizing a 
pseudoknot secondary structure in the 5’UTR that, despite allowing 30S 
binding, avoids formation of an active ternary complex (Philippe et al., 
1993). Strikingly, such mechanism does not seem conserved, as indicated 
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in later observations in Thermus thermophilus. In this bacterium, S15 
facilitates the formation of a secondary structure in its mRNA that masks 
the RBS, thus preventing ribosome recognition and translation (Serganov 
et al., 2003). 
Ribosomal proteins S4, S7, S8, L1 and L4 have a similar way of exercising 
their auto-regulation capacity. They bind either the mRNA leader or the 
start codon of the first gene of their own operon and repress, not only their 
own translation, but also that of proteins encoded in the same polycistronic 
transcript. This usually includes polymerase subunits, elongation factors 
and other ribosomal proteins (Jinks-Robertson and Nomura, 1982; 
Thomas et al., 1987; Saito and Nomura, 1994; Robert and Brakier-
Gingras, 2001; Mattheakis and Nomura, 1988; Stelzl et al., 2003; Zengel 
et al., 2003; Nevskaya et al., 2005). 
Hfq, recognizes two sequences present in its 5’UTR, one of them in the 
RBS. Binding both sites is necessary to prevent the initiation of the 
translational complex and inhibit its own expression (Većerek et al., 2005).  
The 5’UTR of csrA mRNA is structured in the form of four different hairpins 
that contain binding sites for CsrA in their loops. One of these target 
regions overlaps with the RBS, causing the chaperone to compete with the 
ribosome. When in sufficient amount, CsrA can prevent the ribosome from 
binding its mRNA and thus disrupt translation (Helen Yakhnin, Yakhnin, et 
al., 2011). 
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In the case of CspA from E. coli, some evidences point out that it may be 
able to negatively regulate its protein expression by affecting mRNA 
stability. This concept emerged from the comparison of the expression and 
stability of the 5’UTR of CspA in a WT strain to those in ∆cspA (Bae et al., 
1997). In addition, a posterior study suggests that the existence of intrinsic 
regulatory elements in the 5’UTR could hinder translation of CspA 
{Yamanaka:1999vd}. Nonetheless, a more recent work pointed out that 
the whole cspA mRNA molecule secondary structure may behave as a 
regulator, transitioning between different forms in function of the 
temperature. The overall secondary structure at 4ºC would be less 
susceptible to RNases and more easily translated (Giuliodori et al., 2010).  
 
 
The RNA chaperone CspA in S. aureus as a working model 
 
In this Thesis, we have focused on the identification and characterization 
of the biological function of the CSPs from S. aureus, a Gram-positive, 
ubiquitous, facultative anaerobic bacterium of major clinical importance. It 
can cause different kinds of diseases, from mild skin abscesses or 
impetigo to more serious endocarditis, pneumonia or bone infections 
(Tong et al., 2015). Moreover, interest in studying this pathogen has 
increased with the emergence of strains capable of overcoming antibiotic 
treatment, also known as methicillin resistant S. aureus (MRSA) (Knox et 
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al., 2015; Tang et al., 2017). For this reason, and the need to develop new 
antimicrobial strategies, it has been widely used as a model organism in 
molecular genetics. Research on the post-transcriptional regulation of 
gene expression in this bacterium has made noteworthy advancements in 
the past years. S. aureus produces the first described sRNA to have an 
effect on virulence, RNAIII (Novick et al., 1993). Since then, many studies 
have been conducted, demonstrating the post-transcriptional implications 
of this sRNA in regulating expression of proteins that favour bacterial 
adhesion, cell wall remodelling, biofilm, capsule formation or genes related 
to toxin production (Bronesky et al., 2016). S. aureus is also one of the 
first model organisms where pervasive antisense transcription was found, 
with RNase III playing a major role in processing the double-stranded 
structures that resulted from such overlapping transcription. The majority 
of the transcriptome appeared affected by this phenomena, revealing the 
presence of a genome-wide post-transcriptional regulatory mechanism 
(Lasa et al., 2011; Lasa et al., 2012). Likewise, the importance of 3’UTRs 
in bacterial gene regulation has been highlighted in S. aureus. This 
untranslated region has remained disregarded in bacteria, from a 
regulatory point of view, until recent times. However, it is widely accepted 
that 3’UTRs are essential elements controlling expression in eukaryotic 
cells by contributing to circularization of mRNAs. S. aureus holds the first 
described interaction between the 5’ and 3’-UTRs of an mRNA in 
prokaryotes, which results in repression of its translation. It also serves as 
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one of the few examples in which the 3’UTR behaves as regulatory 
element by itself in bacteria (Ruiz de Los Mozos et al., 2013). Although 
new examples of important regulatory RNAs are constantly being 
discovered in S. aureus, many remain to be characterized (Fechter et al., 
2014; Tomasini et al., 2014; Bronsard et al., 2017).  
RNA-mediated regulatory mechanisms often require the participation of 
RBPs. However, this type of post-transcriptional regulators, such as RNA 
chaperones and their biological implications, remain uncharacterized in S. 
aureus. Here, we have concentrated our efforts in understanding the 
importance and mode of action of CspA, one of the three S. aureus CSPs, 
in regulating gene expression. CspA is one of the most abundant proteins 
present in the bacterial cytoplasm (Cordwell et al., 2002), making it a 
common immunodominant antigen that appears during S. aureus human 
sepsis (Lorenz et al., 2000). There is not much information available about 
this RBP but it has been suggested that the cspA gene could be slightly 
induced by cold stress (Katzif et al., 2003). However, more recent results 
contradicted this possibility and highlighted cspB as the cold-shock 
inducible gene in S. aureus (Anderson et al., 2006; Brea D Duval et al., 
2010; Lioliou et al., 2012). A global protein interaction network study 
performed in this bacterium revealed that CspA would interact with at least 
65 other proteins (Cherkasov et al., 2011). Interestingly, a large portion of 
these interactions involved elements of the translation machinery, such as 
proteins from both ribosomal subunits and translation elongation factors. 
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This suggests a possible involvement of CspA in regulating translation 
(Cherkasov et al., 2011). Up to date, the only known phenotype related to 
CspA is the production of staphyloxanthin (STX), the primary carotenoid 
pigment responsible for the characteristic golden yellow colour of S. 
aureus colonies (Katzif et al., 2005).  
The complex chromosomic organization surrounding cspA suggests that 
its expression is tightly regulated. It has been shown that its mRNA is 
synthetized from at least two different transcription start sites. The most 
active promoter is located in the intergenic region between cspA and the 
upstream gene SAOUHSC_01405 (also known as msaA), while the other 
is found immediately upstream of msaA. Consequently, cspA CDS could 
be translated from either a monocistronic or bicistronic transcript. An 
additional element in the genomic architecture surrounding cspA is an 
antisense transcript (as-cspA), complementary to the 5’UTR of the cspA 
monocistronic mRNA (Lioliou et al., 2012; Sahukhal and Elasri, 2014; 
Koch et al., 2014). Although the antisense mRNA is significantly less 
transcribed, the base pairing between both transcripts generates a double 
stranded RNA that can be processed by RNaseIII and could contribute to 
modulating the expression of CspA in vivo (Lioliou et al., 2012). RNase III 
can also process a hairpin that is formed at the 5’ UTR of the 
monocistronic cspA mRNA and generate a shorter version of the same 
mRNA. While both mRNA lengths can be translated, stability and toe-print 
experiments indicate that the generation of the short cspA mRNA makes 
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the transcript more stable and the RBS more accessible to the ribosome, 
respectively. Therefore, such mRNA length would likely be translated at a 
higher rate (Lioliou et al., 2012). 
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OBJECTIVES 
 
Despite cold-shock proteins (CSPs) being important for the correct 
functioning of bacterial systems, little is known about their biological role. 
Details relative to CSPs-mediated regulatory mechanisms as well as the 
identification of CSPs RNA targets would provide an accurate 
understanding of their cellular function. Consequently, this Thesis was 
aimed at the functional characterization of the RNA chaperone CspA as a 
modulator of gene expression, using S. aureus as a model. The general 
objective of this work was divided into the following milestones:  
 
1. Determine if the CSP paralogs have the same biological function in 
Staphylococcus aureus.  
2. Identify the in vivo targetome map and the regulon of the RNA 
chaperone CspA. 
3. Characterize the molecular mechanisms of the CspA-mediated 
regulatory pathways controlling gene expression. 
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MATERIALS AND METHODS 
 
Strains, plasmids, oligonucleotides and growth conditions 
 
The bacterial strains, plasmids and oligonucleotides used in this study are 
listed in Tables 1, 2 and 3, respectively (these tables can be found at the 
end of this section). S. aureus strains were grown in Trypticase Soy Broth 
(Pronadisa) supplemented with 0.25% glucose (TSBg) or Mueller Hinton 
Broth (MH) (Sigma-Aldrich). E. coli was grown in LB broth (Pronadisa). B2 
and SuperBroth media were used to prepare S. aureus and E. coli 
competent cells, respectively. For selective growth, media were 
supplemented with the appropriate antibiotics at the following 
concentrations: Erythromycin (Erm), 1.5 µg ml-1 or 10 µg ml-1; Ampicillin 
(Amp), 100 µg ml-1. In addition, 1.5 μM of cadmium was added when 
activation of the Pcad promoter was required. 
 
 
Generation of mutant strains by homologous recombination 
 
All mutant strains that were generated for the purpose of this study were 
obtained by marker-less homologous recombination, using the pMAD 
plasmid system (Arnaud et al., 2004). Briefly, the CspA3xFLAG, GdpP3xFLAG 
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and ∆cspA strains were generated by a two-step procedure that replaces 
a chromosomic region by the corresponding mutant allele, contained in the 
pMAD plasmid (Jaione Valle et al., 2003). The resulting modified strains 
were verified by PCR using the corresponding oligonucleotides, E and F 
(Table 3), and Sanger sequencing.  
 
 
Total protein extraction  
 
Preinocula were grown in 5 ml TSBg at 37ºC and 200 rpm overnight (ON). 
Bacterial concentrations were estimated by measuring their optical density 
(OD600). Normalized bacterial aliquots were diluted 1:50 in 250 ml 
Erlenmeyer flasks containing 50 ml of TSBg. Cultures were incubated at 
37ºC and 200 rpm and samples extracted at the experiment given time 
points. Samples were centrifuged for 3 min at 4,400 g and 4ºC. The 
resulting pellets were frozen in liquid nitrogen and stored at -80ºC until 
required. Pellets were thawed, washed once with PBS 1X and 
resuspended in 1ml of buffer containing 7 M Urea, 2 M Thiourea, 2% 
CHAPS and 50 mM Dithiothreitol (DTT) or 1 ml of phosphate buffered 
saline 1X (PBS) for LC-MS-based proteomics or Western blot 
experiments, respectively. Resuspended bacteria were transferred to Fast 
Prep tubes containing acid-washed 100 μm glass beads (Sigma) and 
mechanically lysed in a FastPrep-24 instrument (MP Biomedicals) for 45 s 
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and speed 6 twice. Tubes were centrifuged for 10 min at 21,000 g and 
4ºC. Supernatants, containing total protein extracts, were quantified using 
Bradford protein assay kit (Bio-Rad) and samples prepared at the desired 
concentration in Laemmli buffer.  
 
 
LC-MS-based comparative proteomics 
 
Total protein samples (10 μg) were loaded and 1D SDS-PAGE was 
performed. Gels were fixed (50% methanol / 10% acetic acid), stained with 
Coomassie (Simply Blue Safe Stain, Invitrogen) and washed to reveal a 
unique band. The band was distained twice with 100 μl of Acetonitrile 
(AcN) at 40ºC for 5 minutes. In-gel tryptic digestion was performed using a 
1:20 protein to trypsin ratio (Sequencing grade modified Trypsin-Promega) 
in 50 mM ammonium bicarbonate at 37ºC for 16 h, after a denaturation 
step with 10 mM DTT at 40ºC for 30 min, and an alkylation step with 25 
mM Iodoacetamide at room temperature (RT) for 30 min. The resulting 
peptides were extracted with 1% formic acid (FA), 50% AcN. Peptide 
desalting, concentration and purification were performed using Pierce C18 
Spint Tips, according to the manufacturer’s instructions, and evaporated to 
dryness in a SpeedVac. Peptides were resuspended in 2% AcN and 0.1% 
FA prior to LC-MSMS analysis.  
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Peptide mixtures (1 μg) were separated by reverse phase chromatography 
using an Eksigent nanoLC ultra 2D pump fitted with a 75 μm ID column 
(Eksigent 0.075 × 250). Samples were first loaded for desalting and 
concentrating into a 0.5 cm length 100 μm ID precolumn packed with the 
same chemistry as the separating column. Mobile phases were 100% 
water 0.1% FA (buffer A) and 100% AcN 0.1% FA (buffer B). The column 
gradient was developed in a 240 min two step gradient from 5% buffer B 
to 25% buffer B in 210 min and 25% buffer B to 40% buffer B in 30 min. 
The column was equilibrated with 95% buffer B for 9 min and 5% buffer B 
for 14 min. During the whole process, the precolumn was in line with the 
column and the flow maintained all along the gradient at 300 nl min-1. 
Eluted peptides from the column were analysed using a Sciex 5600 Triple-
TOF system. Data was acquired upon a survey scan performed with the 
mass range set at 350–1250 m/z in a scan time of 250 ms. The top 35 
peaks were selected for fragmentation. Minimum accumulation time for 
MS/MS was set to 100 ms, giving a total cycle time of 3.8 s.  
MS/MS data acquisition was performed using Analyst 1.5.2 (Sciex) and 
spectra files were processed through Protein PilotTM Software (v 5.0 
Sciex); using ParagonTM Algorithm (Shilov et al., 2007) for database 
search, ProgroupTM for data grouping, and searched against the S. aureus 
NCTC 8325 proteome obtained from PATRIC (https://www.patricbrc.org/) 
(Wattam et al., 2017). False discovery rate was performed using a non-
lineal fitting method and a “result.group” file was created reporting only 
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results with 1% Global false discovery rate or better. Peptide quantification 
was performed using Progenesis LC–MS software (Nonlinear Dynamics). 
With the accurate mass measurements from full survey scans in the TOF 
detector and the observed retention times, runs were automatically aligned 
to compensate for between-run variations, and the quality of these 
alignments was manually supervised. Peptide identifications were 
exported from Protein Pilot to Progenesis LC–MS, where they were 
matched to the respective features. For quantification, only unique 
peptides were included, and the total cumulative abundance was 
calculated by adding up the individual abundance of all peptides assigned 
to each protein. One-way ANOVA was used to calculate the P-value 
based on the transformed values.  
 
 
Gene functional analysis 
 
Gene classification was performed following the SEED online database 
(http://pseed.theseed.org/) (Overbeek et al., 2005). GO term enrichment 
analysis was performed by PANTHER Overrepresentation Test (release 
20170413) using default parameters, which hierarchically sorted the 
results based on GO Ontology database released on 2017-06-26 
(http://pantherdb.org) (Mi et al., 2017). 
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Plasmid constructions 
 
In general, plasmids used in this study were engineered by subcloning 
PCR fragments that were amplified from chromosomic DNA with 
DreamTaq DNA polymerase or Phusion High-Fidelity DNA Polymerase 
(Thermo Scientific) and the corresponding oligonucleotides (Table 3). The 
resulting PCR products were purified from agarose gels using 
NucleoSpin® Gel and PCR Clean-up Macherey-Nagel kit, ligated into the 
pJET 1.2 vector (Thermo Scientific) and cloned in E. coli XL1-Blue 
(Stratagene). Plasmids were purified from ON cultures with the 
NucleoSpin® Plasmid Macherey-Nagel kit and DNA fragments excised 
with FastDigest restriction enzymes (Thermo Scientific). The resulting 
DNA fragments were purified from agarose gels as described above and 
ligated, using the Rapid Ligation Kit (Thermo Scientific), into pCN51, 
pCN40 (Charpentier et al., 2004) or pMAD (Arnaud et al., 2004) plasmids. 
After verification by Sanger sequencing, the final constructs were 
introduced into S. aureus RN4220 by electroporation (Lee, 1995). 
Afterwards, the plasmids were purified from RN4220 strains and 
introduced into 15981 wild type and derivative strains by electroporation. 
Specifically, pMAD plasmids, required for chromosomal deletion of cspA 
gene and 3xFLAG tagging of cspA and gdpP (Table 2), were generated by 
amplifying 400-500 nt of the corresponding flanking regions with 
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oligonucleotides AB and CD, respectively (Table 3). The resulting PCR 
fragments were cloned as described above.  
pCspA3xFLAG (Table 2) was constructed by amplifying a PCR product with 
the corresponding +1 and term oligonucleotides (Table 3) using 
chromosomic DNA from the 15981 cspA3xFLAG strain (Table 1) as a 
template. DNA fragments were cloned into pCN51 using BamHI and 
EcoRI as described above. 
pCspB3xFLAG (Table 2) was generated by overlapping PCRs using 
oligonucleotides CspB +1 BamHI, 3xFcspB_B, 3xFcspB_C and CspC ter 
EcoRI (Table 3). The amplified product was ligated into pCN51. 
pCspC3xFLAG (Table 2) was generated by overlapping PCRs using 
oligonucleotides CspC +1 BamHI, 3xFcspC_B, 3xFcspC_C and CspC ter 
KpnI (Table 3). The amplified product was ligated into pCN51. 
pCspA3xFLAGDUTRs, pCspB3xFLAGDUTRs and pCspC3xFLAGDUTRs (Table 2) 
were constructed by amplifying PCR products with the forward 
CspA_D5UTR_BamHI, CspB_D5UTR_BamHI and CspC_D5UTR_BamHI 
oligonucleotides, respectively. CspX_D3UTR_KpnI was used as the 
reverse oligonucleotide (Table 3). The amplified products were ligated into 
pCN51. 
Plasmids pCspA_orfB3xFLAG, pCspA_orfC3xFLAG, pCspA_MLB, 
pCspA_MLC, pCspAB3xFLAG, pCspAC3xFLAG (Table 2) were generated by 
subcloning synthetic DNA fragments into pCN51 from plasmids pMA-
T_CspA_orfB3xFLAG, pMA-T_CspA_orfC3xFLAG, pMA-T_MLB, pMA-T_MLC, 
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pMA-T_CspAB3xFLAG and pMA-T_CspAC3xFLAG, respectively (Table 2). The 
latter were previously generated by GeneArt (Invitrogen, ThermoFisher 
Scientific) using BamHI and EcoRI sites. 
pSigB3xFLAG (Table 2) was constructed by amplifying two PCR products: (I) 
from pCN51 with oligonucleotides SpeI 3xF TT pCN51 and NarI 3xF TT 
pCN51, (II) from the chromosome with oligonucleotides SpeI SigB and 
EcoRI SigB (Table 3), which were cloned simultaneously in pCN40. 
pCspA, pCspB and pCspC were generated by PCR with the 
corresponding +1 and term oligonucleotides (Table 3) using chromosomic 
DNA from the 15981 strain. 
To create the pCN51 plasmid expressing the ∆5’UTR mutant (Table 2), 
oligonucleotides BamHI D5UTR cspA and CspA term EcoRI were 
designed to amplify a cspA mRNA lacking the 5’UTR while preserving the 
RBS (Table 3). pCN51 plasmids harbouring the mutated hairpin loop from 
cspA 5’UTR were constructed by subcloning synthetic DNA fragments 
from plasmids pMA-T_CspA_M5U and pMA-T_CspA_M5UC, previously 
generated by GeneArt (Invitrogen, ThermoFisher Scientific) using BamHI 
and EcoRI sites. Note that any gene cloned into the multiple cloning site of 
the pCN51 plasmid would be expressed as a chimeric operon, in which 
the first gene is cadC, the transcriptional regulatory protein that binds to 
the Pcad promoter (Endo and Silver, 1995; Charpentier et al., 2004).  
Plasmid pGEX-6P-2::cspA, expressing the CspA protein fused to GST, 
was constructed by amplifying a PCR fragment with primers CspA-
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GST_Fv and CspA-GST_Rv (Table 3) and subcloned into the pGEX-6P-2 
vector (GE Healthcare Life Sciences), using BamHI and SalI sites. 
 
 
Staphyloxanthin extraction and quantification 
 
Staphyloxanthin (STX) extraction was performed as previously described 
with slight modifications (Pelz et al., 2005). Preinocula were grown in 
tubes containing 5 ml MH at 37ºC and 200 rpm for 11 h. Bacterial 
concentrations were estimated by measuring their OD600. Normalized 
bacterial aliquots were diluted 1:250 in 250 ml Erlenmeyer flasks 
containing 50 ml of MH. Cultures were incubated at 37ºC and 200 rpm for 
15 h and centrifuged for 10 min at 4,400 g in pre-weighted 50 ml-Falcons. 
Bacterial pellets were washed with 50 ml of PBS and centrifuged again. 
After discarding the supernatants, bacterial pellets were weighted and 
resuspended in a variable volume of ethanol 96% (Merck) proportional to 
their weight. Bacterial suspensions (700 μl) were incubated at 45ºC for 2 h 
and centrifuged for 10 min at 21,000 g. Finally, the concentration of STX 
pigment contained in the supernatants, was determined by measuring 
optical density at 460 nm. The statistical comparison of STX levels means 
from biological triplicates was performed by a two-tailed paired t-test with a 
confidence interval of 95% using Prism software package (GraphPad). 
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Hydrogen peroxidase susceptibility assay 
 
Hydrogen peroxidase (H2O2) assay was performed as previously 
described with slight modifications (Chia-I Liu et al., 2008). Briefly, 
preinocula were grown in tubes containing 5 ml MH at 37ºC and 200 rpm 
for 10 h. Normalized bacterial preinocula were diluted 1:250 into 250 ml 
Erlenmeyer flasks containing 50 ml of MH. Cultures were grown at 37ºC 
and 200 rpm for 15 h. Bacterial density was adjusted to approximately 
5x107 CFU ml-1 and incubated at 37ºC and 200 rpm for 1 h in the 
presence or absence of H2O2 (final concentration of 0.09%). Bacterial 
viability was addressed by plating serial dilutions on TSA plates and 
incubating them at 37ºC ON.  
 
 
Western Blotting 
 
Total protein samples were boiled at 100ºC for 5 min, loaded and run into 
12% SDS-polyacrylamide gels. Resolved proteins were transferred to 
nitrocellulose membranes (Amersham Biosciences) or stained with 
Coomassie brilliant blue R250 (Sigma) for Western Blot and loading 
control respectively. Membranes were treated for at least 1 h at RT with a 
blocking solution (5% skimmed milk powder, 0.1% Tween 20 PBS). After 
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washing several times with 0.1% Tween 20 PBS, membranes were 
incubated for 1.5 h at RT with anti-FLAG antibodies (Sigma) diluted 
1:1000 in the blocking solution. Several washing steps for a period of 45 
min were performed and the flagged proteins were developed using the 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific), 
following the manufacturer instructions. 
 
 
RIP-chip analysis  
 
RNA-Binding Protein Immunoprecipitation-Microarray (RIP-chip) was 
performed as previously described with some modifications (Jain et al., 
2010). Preinocula were grown in 5 ml TSBg at 37ºC and 200 rpm ON. 
Bacterial concentrations were estimated by measuring their OD600. 
Subsequently, bacteria were diluted 1:100 into 500 ml Erlenmeyer flasks 
containing 250 ml of TSBg. Cultures were incubated at 37ºC and 200 rpm 
until mid-exponential phase was reached. Next, bacteria were transferred 
to 50 ml falcon tubes containing 1.4 ml of 37% formaldehyde solution 
(Sigma F8775). The tubes were incubated at RT for 15 min with 
occasional inversion for mixing. Sterile 2.5 M glycine (5 ml) was added to 
each tube to stop the crosslinking reaction and incubated at RT for 5 min. 
Then, falcon tubes were centrifuged at 3,500 g and 4ºC for 6 min. Pellets 
were washed with 50 ml cold Tris-buffered saline (150 mM NaCl, 10 mM 
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Tris-HCl, pH 7.5), centrifuged and frozen at -80ºC ON. Pellets were 
resuspended in 0.5 ml of lysis buffer 1 (10 mM Tris-HCl, pH 8.0, 20% 
sucrose, 50 mM NaCl, 10 mM EDTA) containing protease inhibitors 
(Roche), RNAsin 40 U ml-1 (Promega) and 10 μl of lysostaphin 10 mg ml-1 
(Sigma) and incubated at 37ºC for 15 min. Cell lysis was completed by 
adding 1.5 ml of cold lysis buffer 2 (50 mM HEPES-KOH, pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% 
SDS), containing protease inhibitors and RNAsin. Cell debris was 
removed from the samples by centrifugation at 21,000 g and 4ºC for 15 
min. Supernatants (1.6 ml) were pre-incubated with 100 μl of protein G-
Sepharose beads (Pierce) at 4ºC for 1 h. Prior to use, beads were washed 
4 times with 250 μl of lysis buffer and stored in the same buffer, including 
protease inhibitors and RNAsin. To immunoprecipitate cross-linked RNA 
complexes, the supernatants were retrieved and incubated with G-
Sepharose beads conjugated with anti-Flag antibody (Sigma) (180 μl of G-
sepharose beads and 11 μl of anti-Flag antibody incubated ON) at 4ºC for 
2 h on a rotating wheel. Complexes were pulled down using Spin-X 
columns (CORN 8160) and washed several times. The first wash was 
performed in 1 ml of cold lysis buffer supplemented with 500 mM NaCl. 
The second wash, with 1 ml of cold wash buffer (10 mM Tris-HCl pH 8.0, 
250 mM LiCl, 1 mM EDTA, 0.5% Nonidet P-40, 0.5% sodium 
deoxycholate). Finally, they were washed with 1 ml Tris-EDTA pH 7.5 and 
RNAsin at 4ºC. The beads, contained in the last solution, were then 
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transferred to a 2 ml Eppendorf, centrifuged, and resuspended in 150 μl of 
elution buffer (50 mM Tris-HCl, pH 7.5, 10 mM EDTA, 1% SDS) 
supplemented with RNAsin. For reverse cross-linking, samples were 
incubated at 65ºC for 1 hour and treated with acid phenol and chloroform. 
The RNAs contained in the aqueous phase were precipitated using 5 μl of 
glycogen Ambion (AM 9510), 25 μl 3M sodium acetate and 625 μl of 
ethanol at -80ºC ON. The pellets were retrieved by centrifugation at 
21,000 g and 4ºC for 30 min. RNAs were resuspended in DNase buffer 
including RNAsin and treated with TURBO DNase (Ambion) at 37ºC for 30 
min. After phenol-chloroform extractions RNAs were precipitated as 
indicated above and resuspended in 20 μl of DEPC H2O. 1 μl of each 
RNA sample was loaded into Agilent RNA Nano LabChips (Agilent 
Technologies) to determine their concentration and quality. The rest of the 
RNA sample was used as a template for cDNA synthesis, following the 
recommendations of Affymetrix protocol and hybridized on Affymetrix 
custom S. aureus tiling microarrays, as previously described (Segura et 
al., 2012). CspA-binding signals were normalized with Tiling Array 
Software (TAS) to generate signal intensity files that we then loaded into 
the Integrated Genome Browser (IGB) using the S. aureus NCTC 8325 
genome as a reference (Iandolo et al., 2002; Freese et al., 2016).  
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CspA binding peak calling 
 
The peak calling was performed by two complementary methods. On the 
one hand, peak signals above the background were extracted using IGB 
by applying a threshold value. Prior to establishing the threshold value, the 
distribution of intensity signals from the 363,127 probes contained in the 
tiling microarrays was calculated for each of the RIP-chip samples. The 
CspA3xFLAG, GdpP3xFLAG, and WT RIP-chip samples had background noise 
profiles with a mean signal intensity of 5.5 ± 0.7, 5.4 ± 0.3 and 5.0 ± 0.3 
respectively. Since CspA3xFLAG and GdpP3xFLAG RIP-chips had similar 
signal noise, the background threshold was defined as 5.4 (the mean 
signal intensity of the 3xFLAG-negative control) plus four standard 
deviations. Considering this threshold value, a total of 18,222 probes were 
detected above the background signal in CspA3xFLAG but 2,037 and 1,847 
of them were also present in the negative control samples, WT and 
GdpP3xFLAG, respectively. Most of the signals above this threshold in the 
WT and GdpP3xFLAG RIP-chip samples (95.6% and 92.3%, respectively) 
corresponded to ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs). 
Therefore, these signals were considered non-specific and excluded from 
subsequent analyses. In addition, peaks corresponding to repeated 
regions, which could give false positives, were not considered either 
(Waldminghaus and Skarstad, 2010). On the other hand, CisGenome, an 
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integrated software for processing raw microarray that defines peaks 
thanks to computing false discovery rates (FDR), was used. 
Recommended normalization parameters for Affymetrix tiling microarrays 
were applied (Ji et al., 2011). The peak calling results and normalized RIP-
chip signals are fully available at our RNA map web browser 
(http://rnamaps.unavarra.es/).  
 
 
RNA extraction and Northern blotting 
  
Bacteria were grown as described for total protein extraction (see above). 
Cultures were centrifuged for 3 min at 4,400 g and 4ºC. Pellets were then 
frozen in liquid nitrogen and stored at -80ºC ON. RNA extractions were 
performed as previously described (Toledo-Arana et al., 2009). An 
appropriate amount of RNAs were mixed with formaldehyde loading dye 
(Ambion), denatured for 5 min at 65ºC and run in 1.25 % agarose gels. 
Gels were submerged in an ethidium bromide solution and RNA integrity 
and loading were verified by exposure to UV light. RNAs were then 
transferred to 0.2 μm pore size Nitran N membranes (GE Healthcare Life 
Sciences) by capillarity, using NorthernMax Transfer Buffer (Ambion), for 
1.5 h at RT. The transferred RNAs were crosslinked to the membranes by 
exposing them to UV light inside a UV Stratalinker 1800 (Stratagene). 
Membranes were then placed into hybridization tubes and prehybridized 
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with ULTRAHyb solution (Ambion) for at least 30 min at 40ºC (for 
oligonucleotide probe) inside a rotating oven. After the prehybridization 
step, the corresponding radioactively labelled oligonucleotide was added 
and incubated ON. Membranes were washed three times for 5 min by 
addition of preheated 2X SSC, 0.1% SDS at 40ºC followed by several 
washes with 0,2xSSC, 0,1% SDS at RT until background signal was 
eliminated. Membranes were developed by autoradiography for different 
time periods. 
 
 
Purification of recombinant CspA protein 
 
To produce recombinant CspA protein, E. coli BL21 strain carrying pGEX-
6P-2::cspA plasmid was grown in LB medium supplemented with Amp 100 
μg ml-1 at 37°C and 250 rpm until an OD600 of 0.5 was reached. Isopropyl-
D-thiogalactopyranoside (IPTG) was then added to a final concentration of 
0.4 mM and cell growth resumed for 5 h under the same conditions. Cells 
were collected by centrifugation at 5,000 g for 30 min, resuspended in 
phosphate buffer supplemented with lysozyme (1 mg ml-1; Sigma) and 
incubated for 30 min at RT. Next, bacteria were lysed by sonication and 
centrifuged for 20 min at 16,000 g and 4ºC. The soluble fraction was 
incubated on ice for 30 min in the presence of DNase and RNase (10 μg 
ml-1; Thermo Scientific). The GST-CspA fusion protein was purified from 
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clarified lysates using a GSTrap FF 5-ml column and an AKTAprime plus 
chromatography system (GE Healthcare Life Sciences). For PreScission 
Protease on-column cleavage, 10 U of protease mg-1 of bound GST fusion 
protein was used. To achieve the highest purity, size exclusion 
chromatography was applied with a HiPrep 16/60 Sephacryl S-100 HR 
column (GE Healthcare) equilibrated with 20 mM Tris-HCl, pH 7.4, 
containing 500 mM NaCl, and run with a flow rate of 0.5 ml min-1. 
Fractions containing the protein of interest were pooled and buffer 
exchanged by dialysis against ice cold 10 mM Tris-HCl (pH 8.0), 1 mM 
EDTA, 50 mM potassium chloride, and 10% glycerol using a Slide-A-Lyzer 
Dialysis Cassette (ThermoFisher Scientific) with a molecular mass cut-off 
of 3.5 kDa. Protein purity was determined by SDS-PAGE analysis and 
samples were quantified using the Bio-Rad protein assay (Bio-Rad) and 
stored at -20°C.  
 
 
In vitro transcription 
 
PCR fragments containing the T7 promoter were amplified using the 
oligonucleotides listed in Table 3. Note that Fw primer carried the T7-RNA 
Polymerase binding site at the 5’-end. In vitro transcription was carried out 
using the MEGAscript T7 transcription kit (Ambion) following the 
manufacturer´s recommendations. Transcripts were run in a denaturing 
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6% polyacrylamide gel and visualized with UV-light after staining with 
Ethidium Bromide. Bands were cut and incubated with 500 μl of 
ammonium acetate pH 5.5 2M at 15ºC for 2 h. Next, 500 μl of acid phenol 
pH 4.5 were added to the samples before mixing them ON at 15ºC. After a 
centrifugation for 5 min at 21,000 g and 4ºC, the aqueous phase was 
transferred to a tube containing 500 μl of acid phenol. The aqueous phase 
was again retrieved by centrifugation and washed with 600 μl of 
chloroform. RNA from the aqueous phase was precipitated with 1/10 
volume of 3M sodium acetate pH 4.5 and 3 volumes of 96% ethanol at -
80ºC for at least 1 h.  Samples were then centrifuged at 21,000 g for 30 
min and 4ºC and the resulting pellets washed with 70% ethanol. Pellets 
were air-dried and resuspended in the desired DEPC H2O (Ambion). RNA 
integrity was checked through agarose gel electrophoresis.  
 
 
5’-end labelling of RNA and ssDNA oligonucleotides 
 
Before labelling, RNA and ssDNA oligonucleotides were dephosphorylated 
with FastAP (Thermo Scientific) at 37ºC for 1h. The enzyme was 
inactivated at 75ºC for 5 min. Dephosphorylated nucleic acids were 
incubated with 32P-γ-ATP (Perkin-Elmer) and PNK (Thermo Scientific) for 
30 min at 37ºC. EDTA was added and the enzyme was inactivated for 15 
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min at 75ºC. Labelled nucleic acids were purified with Illustra MicroSpin G-
50 columns (GE Healthcare) and stored at -20ºC until used. 
 
 
Electrophoretic mobility shift assays, EMSAs 
 
Labelled ssDNA were diluted at the appropriate concentration by adding 
DEPC H2O and 5X renaturing buffer (100 mM K-HEPES pH7.5, 50 mM 
MgCl2, 250 mM KCl). Samples were denatured at 90ºC for 1 min, chilled 
on ice 1 min and renatured at 37ºC for 15 min. Labelled samples were 
mixed with RiboLock RNase Inhibitor (Thermo Scientific), 2X reaction 
buffer (20 mM Tris-HCl pH 7.5, 60 mM KCl, 40 mM NH4Cl, 3 mM DTT, 
0,02 mg ml-1 BSA, 10 mM MgCl2) and increasing concentrations of purified 
recombinant CspA protein. The mixture was incubated at 37ºC for 15 min. 
Loading dye (50 % glycerol and bromophenol blue) was added to all 
samples and these were loaded into a non-denaturing 6 or 10% 
polyacrylamide gel (pre-run for 10-20 min) in 0.5X TBE at 110V, 4ºC for 1-
5h. The gel was then dried and developed by autoradiography for different 
time periods. Dissociation constants (Kd) were calculated from signal 
intensities of unbound ssDNA oligonucleotides.   
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In vitro translation assay 
 
In vitro translation assay was performed using the PURExpress® In Vitro 
Protein Synthesis kit (New England Biolabs) following the manufacturer’s 
recommendations. Briefly, 0.06 pmoles of RNA were mixed with 10 μl of 
solution A, 7.5 μl of solution B, 20 U of Ribolock (Thermo) and 2.5 nmoles 
of BSA or CspA accordingly. Samples were incubated for 4 h at 37 ºC and 
then loaded into 12% SDS-polyacrylamide gels for Western blotting as 
described above. 
 
 
FAM-quencher assay 
 
The ssDNA oligonucleotide labelled with the 6-FAM and the Black Hole 
Quencher (BHQ_1) molecules in the 5’ and 3’ extremity, respectively, 
were acquired from Integrated DNA Technologies. As a test control, 1 
pmol of the oligos were mixed with 12.5 μl of 1X CspA storage buffer (10 
mM Tris-HCl (pH 8.0), 1 mM EDTA, 50 mM potassium chloride) and 2.5 μl 
of 10X reaction buffer (100 mM Tris-HCl pH 7.5, 300 mM KCl, 200 mM 
NH4Cl, 15 mM DTT, 50 mM MgCl2) in a final volume of 25 μl. FAM 
fluorescence was then measured at 5 different temperatures (25ºC, 37ºC, 
45ºC, 55ºC and 65ºC) using the Aria Mx Real-Time PCR System (Agilent 
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Technologies). Experiments were performed by diluting 1 pmol of the 
oligos in 10X Reaction buffer and 4U of Ribolock (Thermo) to a final 
volume of 30 μl. Next, 7 nmol of CspA or BSA were added to the mix 
accordingly and incubated at 37ºC for 15 min. Subsequently, 10 μl of 
Proteinase K (20 mgl ml-1) (Sigma) were added and the mix was incubated 
again for 30 min at 37ºC. The samples were then incubated for 5 min at 
65ºC. FAM emission was registered throughout all the incubation steps. 
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Table 1. Strains used in this study 
Strains Relevant characteristic(s) BGR 
IDa 
Source or 
reference 
    
Staphylococcus aureus    
15981 Wild type (WT) strain. MSSA clinical isolate; biofilm 
positive; PNAG-dependent biofilm matrix 
8 (Jaione 
Valle et al., 
2003) 
ΔcspA 15981 strain with deletion of the cspA gene 83 This study 
15981 cspA3xFLAG 15981 strain expressing the 3xFLAG-tagged CspA 
protein from the chromosome 
239 This study 
15981 gdpP3xFLAG 15981 strain expressing the 3xFLAG-tagged GdpP 
protein from the chromosome 
305 This study 
WT pCN51 15981 strain carrying the pCN51 plasmid 105 This study 
ΔcspA pCN51 15981 ΔcspA strain carrying the pCN51 plasmid 107 This study 
ΔcspA pCspA 15981 ΔcspA strain carrying the pCspA plasmid  108 This study 
ΔcspA pCspB 15981 ΔcspA strain carrying the pCspB plasmid  109 This study 
ΔcspA pCspC 15981 ΔcspA strain carrying the pCspC plasmid. 110 This study 
ΔcspA pCspA3xFLAG 15981 ΔcspA strain carrying the pCspA3xFLAG plasmid  268 This study 
ΔcspA pCspB3xFLAG 15981 ΔcspA strain carrying the pCspB3xFLAG plasmid  351 This study 
ΔcspA pCspC3xFLAG 15981 ΔcspA strain carrying the pCspC 3xFLAG plasmid. 652 This study 
ΔcspA  
pCspA3xFLAG∆UTRs 
15981 ΔcspA strain carrying the pCspA3xFLAG∆UTRs 
plasmid  
436 This study 
ΔcspA 
pCspB3xFLAG∆UTRs 
15981 ΔcspA strain carrying the pCspB3xFLAG∆UTRs 
plasmid  
437 This study 
ΔcspA 
pCspC3xFLAG∆UTRs 
15981 ΔcspA strain carrying the pCspC3xFLAG∆UTRs 
plasmid. 
438 This study 
ΔcspA pCspA_orfB3xFLAG 15981 ΔcspA strain carrying the pCspA_orfB3xFLAG 
plasmid 
763 This study 
ΔcspA pCspA_orfC3xFLAG 15981 ΔcspA strain carrying the pCspA_orfC3xFLAG 
plasmid 
761 This study 
ΔcspA pCspA_MLB 15981 ΔcspA strain carrying the pCspA_MLB plasmid 696 This study 
ΔcspA pCspA_MLC 15981 ΔcspA strain carrying the pCspA_MLC plasmid 698 This study 
ΔcspA pCspA_B3xFLAG 15981 ΔcspA strain carrying the pCspA_B3xFLAG 
plasmid 
760 This study 
ΔcspA pCspA_C3xFLAG 15981 ΔcspA strain carrying the pCspA_C3xFLAG 
plasmid 
762 This study 
WT pSigB3x FLAG 15981 strain carrying the pSigB3xFLAG plasmid 656 This study 
WT pCspC3xFLAG 15981 strain carrying the pCspC3xFLAG plasmid. 651 This study 
WT pCspA3xFLAG 15981 strain carrying the pCspAFLAG plasmid  505 This study 
WT pCspA3xFLAG∆5’UTR 15981 strain carrying the pΔ5’CspA3xFLAG plasmid 649 This study 
WT pM5U3xFLAG 15981 strain carrying the pM5U3xFLAG plasmid 746 This study 
WT pM5UC3xFLAG 15981 strain carrying the pM5UC3xFLAG plasmid 748 This study 
ΔcspA pSigB3x FLAG 15981 ΔcspA strain carrying the pSigB3x FLAG plasmid 657 This study 
ΔcspA 
pCspA3xFLAG∆5’UTR 
15981 ΔcspA strain carrying the p∆5’CspA3xFLAG 
plasmid 
650 This study 
ΔcspA pM5U3xFLAG 15981 ΔcspA strain carrying the pM5U3xFLAG plasmid 747 This study 
Continued in the following page 
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Table 1. Continued 
 
ΔcspA pM5UC3xFLAG 15981 ΔcspA strain carrying the pM5UC3xFLAG plasmid 749 This study 
Δrnc 15981 strain with deletion of the rnc gene 409 (Lasa et al., 
2011) 
Δrnc pCspA3xFLAG 15981 Δrnc strain carrying the pCspA3xFLAG plasmid 1036 This study 
Δrnc ΔcspA 15981 strain with deletion of the rnc and cspA genes  989 This study 
Δrnc ΔcspA pCspA3xFLAG 15981 ΔcspA Δrnc strain carrying the pCspAFLAG 
plasmid 
968 This study 
Escherichia coli    
XL1-Blue Strain used for cloning experiments 1 Stratagene 
XL1-Blue pCN40 XL1Blue strain carrying the pCN40 plasmid 18 (Charpentier 
et al., 2004) 
XL1-Blue pCN51 XL1Blue strain carrying the pCN51 plasmid 20 (Charpentier 
et al., 2004) 
BL21pGEX-6P-2::cspA BL21 (DE3) expressing CspA with a GST tail from the 
pGEX-6P plasmid 
631 This study 
a Identification number of the strains stored at the Laboratory of Bacterial Gene Regulation. 
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Table 2. Plasmids used in this study 
 
Plasmids Relevant characteristic(s) Source or 
reference 
   
pMAD E. coli-S. aureus shuttle vector with a thermosensitive origin of 
replication for Gram-positive bacteria. It contains the bgaB 
gene encoding a β-galactosidase under the control of a 
constitutive promoter as reporter of plasmid presence. AmpR, 
ErmR 
(Arnaud et al., 
2004) 
pCN40 E. coli-S. aureus shuttle vector to express genes under the 
control of the PblaZ promoter. Low copy number. AmpR-EmR 
(Charpentier 
et al., 2004) 
pCN51 E. coli-S. aureus shuttle vector to express genes under the 
control of the Pcad inducible promoter. Low copy number. 
AmpR-EmR 
(Charpentier 
et al., 2004) 
pMAD cspA pMAD plasmid containing the allele for deletion of the cspA 
coding region 
This study 
pCspA pCN51 plasmid expressing the CspA protein from the entire 
cspA mRNA molecule 
This study 
pCspB pCN51 plasmid expressing the CspB protein from the entire 
cspA mRNA molecule 
This study 
pCspC pCN51 plasmid expressing the CspC protein from the entire 
cspA mRNA molecule 
This study 
pCspA3xFLAG pCN51 plasmid expressing the 3xFLAG-tagged CspA protein 
from the entire cspA mRNA molecule 
This study 
pCspB3xFLAG pCN51 plasmid expressing the 3xFLAG-tagged CspB protein 
from the entire cspB mRNA molecule 
This study 
pCspC3xFLAG pCN51 plasmid expressing the 3xFLAG-tagged CspC protein 
from the entire cspC mRNA molecule 
This study 
pCspA3xFLAGDUTRs pCN51 plasmid expressing the 3xFLAG-tagged CspA protein 
from a cspA mRNA molecule lacking the UTRs while 
preserving the RBS and transcriptional terminator 
This study 
pCspB3xFLAGDUTRs pCN51 plasmid expressing the 3xFLAG-tagged CspB protein 
from a cspB mRNA molecule lacking the UTRs and containing 
the RBS and transcriptional terminator from cspA 
This study 
pCspC3xFLAGDUTRs pCN51 plasmid expressing the 3xFLAG-tagged CspC protein 
from a cspC mRNA molecule lacking the UTRs and containing 
the RBS and transcriptional terminator from cspA 
This study 
pMA-T_CspA_orfB3xFLAG pMA-T plasmid carrying the synthetic CspA_orfB3xFLAG This study 
pMA-T_CspA_orfC3xFLAG pMA-T plasmid carrying the synthetic CspA_orfC3xFLAG This study 
pCspA_orfB3xFLAG pCN51 plasmid expressing a chimeric cspA mRNA with 
nucleotide substitutions to codify CspB  
This study 
pCspA_orfC3xFLAG pCN51 plasmid expressing a chimeric cspA mRNA with 
nucleotide substitutions to codify CspC 
This study 
pMA-T_MLB pMA-T plasmid carrying the synthetic MLB gene This study 
pMA-T_MLC pMA-T plasmid carrying the synthetic MLC gene This study 
pCspA_MLB pCN51 plasmid expressing a chimeric cspA mRNA with CspB 
RNP1 and RNP2 connecting loop 
This study 
pCspA_MLC pCN51 plasmid expressing a chimeric cspA mRNA with CspC 
RNP1 and RNP2 connecting loop 
This study 
pMA-T_CspAB3xFLAG pMA-T plasmid carrying the synthetic CspA_B3xFLAG gene This study 
pMA-T_CspAC3xFLAG pMA-T plasmid carrying the synthetic CspA_B3xFLAG gene This study 
Continued in the following page 
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Table 2. Continued 
pCspAB3xFLAG pCN51 plasmid expressing a chimeric cspA mRNA with 
nucleotide substitutions to codify the carboxi-half of CspB 
This study 
pCspAC3xFLAG pCN51 plasmid expressing a chimeric cspA mRNA with 
nucleotide substitutions to codify the carboxi-half of CspC 
This study 
pMAD cspA3xFLAG pMAD plasmid containing the allele for insertion of the 3xFLAG 
at the C-terminus of the CspA protein 
This study 
pMAD gdpP3xFLAG pMAD plasmid containing the allele for insertion of the 3xFLAG 
at the C-terminus of the GdpP protein 
This study 
pSigB3xFLAG pCN40 plasmid expressing the 3xFLAG-tagged SigB protein This study 
pΔ5’CspA3xFLAG pCN51 plasmid expressing the 3xFLAG-tagged CspA protein 
from a cspA mRNA lacking the 5’UTR 
This study 
   
pMA-T_CspA_M5U pMA-T plasmid carrying the synthetic cspA_M5U gene This study 
pMA-T_CspA_M5UC pMA-T plasmid carrying the synthetic cspA_M5UC gene This study 
pCspA3xFLAG-M5U pCN51 plasmid expressing the 3xFLAG-tagged CspA protein 
from a cspA mRNA carrying a mutation that substituted the 5U 
motif within the 5’UTR 
This study 
pCspA3xFLAG-M5UC pCN51 plasmid expressing the 3xFLAG-tagged CspA protein 
from a cspA mRNA carrying a mutation that substituted the 5U 
motif and a compensatory one to restore the stem-loop 
structure within the 5’UTR 
This study 
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Table 3. Oligonucleotides used in this study 
Oligonucleotide name Sequence a 
  
Probe for Northern blots assays 
anti_3xFLAG_probe TTTATCGTCGTCATCTTTGTAGTCGATATCATGATCTTTATAATCACCGTCATG
GTCTTTGTAGTC 
Construction of pMAD plasmid for deletion of cspA gene 
CspA_A_BamHI GGATCCTCAAACTTGATTTTCAGAGG 
CspA_B_SalI GTCGACAATCTGAAACCTCCAAGACT 
CspA_C_SalI GTCGACATTCTTAGATTTGAATCATTG 
CspA_D_EcoRI GAATTCGATTTTCTAATTCCATCATCTCTG 
CspA_E TGTCTCATTTTTACCACCTC 
CspA_F CCACACTTTAAACAAGCATC 
Construction of pMAD plasmid for chromosomic 3xFLAG-labeling of the cspA gene  
CspA_3xF_A_EcoRI GAATTCACTACCAATAATTGATTAAATGAATATT 
CspA_3xF_B_NcoI CCATGGTTACTATTTATCGTCGTCATCTTTGTAGTCGATATCATGATCTTTATA
ATCACCGTCATGGTCTTTGTAGTCTAGTTTAACAACGTTTGCAGC 
CspA_3xF_C_NcoI CCATGGTTCTTAGATTTGAATCATTGATTTTAAC 
CspA_3xF_D_BamHI GGATCCGAATTAACAACAAATATAATGTATAAAAC 
Construction of pMAD plasmid for chromosomic 3xFLAG-labeling of the gdpP gene 
GdpP_3xF_A_EcoRI GAATTCTGAATCAACAGTGATGTATGCAG 
GdpP_3xF_B_BamHI GGATCCTTACTATTTATCGTCGTCATCTTTGTAGTCGATATCATGATCTTTATA
ATCACCGTCATGGTCTTTGTAGTCTAATTGTTCTGTAATTGCTTGTTGT 
GdpP_3xF_C_BamHI GGATCCAGTAGGAGTGAAGATGCATGAA 
GdpP_3xF_D_NcoI CCATGGGTACCTTCAACTTCTTTATCTAATTTAACA 
GdpP_3xF_E CTAATCCATTGTTGATATATATGGAACC 
GdpP_3xF_F GCGGCATTTGATTTTGCT 
Construction of plasmid expressing the SigB3xFLAG protein 
EcoRI_sigB_fw GAATTCAAAGAGCAGGTGCGAAATA 
SpeI_sigB_rev ACTAGTTTGATGTGCTGCTTCTTGTA 
SpeI_3xF_TT_pCN51 ACTAGTGACTACAAAGACCATGACGGTGATTATAAAGATCATGATATCGACTA
CAAAGATGACGACGATAAATAAGGCGCGCCTATTCTAAATG 
NarI_3xF_TT_pCN51 AAAGGCGCCTGTCACTTTGC 
Construction of plasmid expressing CspA and its variants 
CspA_+1_BamHI GGATCCAAGCAGATGATTATTCCATATTG 
CspA_ter_EcoRI GAATTCCTATTGCAAACAATGTTGGTGATATAA 
CspA_D5UTR_BamHI GGATCCTCTTGGAGGTTTCAGATTATGAAACAAGGTACAGTTAA 
CspX_D3UTR_KpnI GGTACCAAAAAAAGAGTTCTCAATTTGGTTGAGAAACTCATCGCGTTAAGTAT
TCTATTTATCGTCGTCATCTT 
Construction of plasmid expressing CspB and its variants 
CspB_+1_BamHI GGATCCAAGCTCGTGAATTAAATTGTAGTGTA 
CspB_ter_EcoRI GAATTCATCATCGTGGTATCGTCTCATATT 
3xFcspB_B TTATAATCACCGTCATGGTCTTTGTAGTCAACAGTTTGTACGTTAACTGC 
3xFCspB_C GACTACAAAGACCATGACGGTGATTATAAAGATCATGATATCGACTACAAAG
ATGACGACGATAAATAATCTTACAACATAAAACGACTCATTAT 
CspB_D5UTR_BamHI GGATCCTCTTGGAGGTTTCAGATTATGAAACAAGGTACAGTTAA 
CspX_D3UTR_KpnI GGTACCAAAAAAAGAGTTCTCAATTTGGTTGAGAAACTCATCGCGTTAAGTAT
TCTATTTATCGTCGTCATCTT 
Continued in the following page 
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Table 3. Continued 
Construction of plasmid expressing CspC and its variants 
CspC +1 BamHI GGATCCAATAAAGAGCGTGAAGAAAAATGTG 
3xFcspC_B ACCGTCATGGTCTTTGTAGTCCATTTTAACTACGTTTGCAGCTT 
3xFcspC_C GACTACAAAGACCATGACGGTGATTATAAAGATCATGATATCGACTACAAAG
ATGACGACGATAAATAATTTTAACTTATTCAAACAGT 
CspC ter KpnI GGTACCCCATTATATATTGTTAAATCTCCAAC 
CspC_D5UTR_BamHI GGATCCTCTTGGAGGTTTCAGATTATGAATAACGGTACAGTTAA 
CspX_D3UTR_KpnI GGTACCAAAAAAAGAGTTCTCAATTTGGTTGAGAAACTCATCGCGTTAAGTAT
TCTATTTATCGTCGTCATCTT 
Synthesis of the cspC mRNA 
cspA+1_T7prom TAATACGACTCACTATAGGGAATAAAGAGCGTGAAGAAAAATG 
cspA_term AAAAAATAACGGCTAGTGCTTTT 
Synthesis of the cspA 5’UTR 
cspA+1_T7prom TAATACGACTCACTATAGGGAAGCAGATGATTATTCCATATTG 
rev_cspA_5UTR AATCTGAAACCTCCAAGACTAAAA 
ssDNA oligonucleotide gel shift assays 
f-A1 AAGCAGATGATTATTCCATATTGCAAAGAATATTTGAGTGAAATTTGCATGTA
TTTTTTGTA 
f-A2 TTTTTTGTAATATGCGAATAAGCATATTGAATGAATTTTAGTCTTGGAGGTTTC
AGATTATG 
f-A3 CTTGGAGGTTTCAGATTATGAAACAAGGTACAGTTAAATGGTTTAACGCTGAA
AAAGGAT 
f-A1-DT AAGCAGATGATTATTCCATATTGCAAAGAATATTTGAGTGAAATTTGCATGTA 
f-A2-DT GTAATATGCGAATAAGCATATTGAATGAATTTTAGTCTTGGAGGTTTCAGATT
ATG 
f-C1 AATAAAGAGCGTGAAGAAAAATGTGAGTTATTTATATAGAATATTCTCCTTTTC
ATTTAT 
f-C2 CCTTTTCATTTATGAATTTGTTACAAAATATTTAGTGCAAAAGCACGACGGAG
GTATTCAATATG 
f-C3 CGACGGAGGTATTCAATATGAATAACGGTACAGTTAAATGGTTTAATGCAGA
AAAAGGTT 
f-C4 GAAAAAGGTTTTGGTTTCATCGAAAGAGAAGATGGTAGCGACGTATTCGTAC
ACTTCTCA 
f-C5 ACACTTCTCAGCAATCGCTGAAGATGGATACAAATCATTAGAAGAAGGCCAA
AAAGTTGA 
f-C6 AAAAAGTTGAATTCGACATCGTTGAAGGCGACCGTGGCGAGCAAGCTGCAA
ACGTAGTTAAAA 
f-C7 GTAGTTAAAATGTAATTTTAACTTATTCAAACAGTCCTTACTATAGGGCTGTTT
TTTTAT 
a Restriction enzymes sites, T7 promoter and 3xFLAG sequences included into the oligonucleotides are 
indicated in italic, bold and underlined format, respectively. 
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CHAPTER I: 
 
S. aureus CSPs similarity is not linked to a functional 
redundancy. 
 
As it was explained in the Introduction section, the number of genes 
encoding CSPs is variable in the different bacterial species. Unlike other 
protein families that include several homologs in same genome, such as 
the two-component systems and the GGDEF-domain (containing 
diguanylate cyclases), CSPs have a high protein sequence conservation 
among their members. This degree of similarity has long promoted 
speculations about the existence of redundant functions among CSPs. 
Recent RIP-seq analysis developed in Salmonella revealed that CspC and 
CspE virulence-related RNA targets overlap almost entirely. Although 
single mutations of these CSPs did not pose any significant phenotypic 
changes, a double cspC and cspE gene mutation completely eliminated 
bacterial virulence (Michaux et al., 2017). This phenotype could be 
complemented by overexpressing either one or the other CSP, confirming 
that both CspC and CspE have the same function. However, the other four 
CSPs in Salmonella bound different sets of targets, indicating independent 
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roles for each of them. This was in agreement with the idea that most 
CSPs display a particular function (Xia et al., 2001; Michaux et al., 2017).  
In this chapter, we analysed if S. aureus paralogs CspA, CspB and CspC, 
with a protein identity higher than 70 % (Fig. 1), could play the same role.   
 
 
 
 
 
 
Figure 1. Comparison of S. aureus cold shock protein sequences. Blastp results of 
CspA vs CspB and CspA vs CspC alignments are shown. RNP1 and RNP2 motifs are 
highlighted in orange. 
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CspB and CspC paralogs do not complement CspA function when 
expressed from a heterologous promoter.  
 
As previously described, CspA is required for an efficient production of 
staphyloxanthin (STX) (Katzif et al., 2005). This yellow pigment functions 
as an antioxidant, which is relevant during infection as it offers protection 
against the innate immune response. The levels of STX can be easily 
measured by spectrophotometry after pigment extraction (Chia-I Liu et al., 
2008),(Lan et al., 2010),(George Y Liu et al., 2005). Taking advantage of 
this phenotype, we analysed if CspB or CspC could complement the STX 
production in a mutant strain, lacking the cspA gene. Hence, to control the 
expression of the CSP paralogs, we constructed the pCspA, pCspB and 
pCspC plasmids using pCN51 as a backbone (Charpentier et al., 2004). 
Genes expressed from the pCN51 plasmid rely on the heterologous Pcad-
CadC module, which is inducible by cadmium, for their transcription. (Endo 
and Silver, 1995; Charpentier et al., 2004). The Pcad promoter would 
avoid putative transcriptional regulatory mechanisms that may naturally 
occur to the chromosomal gene copies. 
Each of the csp genes was expressed from the corresponding full-length 
mRNA, including the native 5’ and 3’UTRs, for which transcripts were 
mapped using the transcriptome information from previous works (Lasa et 
Chapter I 	
	84 
al., 2011; Koch et al., 2014). As Figure 2 shows, the three csp genes 
contain long UTR regions.  
 
 
 
Figure 2. mRNAs of S. aureus CSPs contain long UTRs. Transcriptomic maps from a 
previous study showing the mRNA configuration of S. aureus cspA, cspB and cspC 
genes (Lasa et al., 2011). In all cases the 5’ and 3’ UTRs cover a significant percentage 
of the mRNA length.  
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Plasmids were afterwards electroporated into the DcspA strain and STX 
extractions from pellets of bacteria grown in MH, supplemented with 1.5 
mM of CdCl2, performed. The quantification of the pigment production 
revealed that only DcspA carrying pCspA was able to reach the wild type 
(WT) levels. The complemented strains carrying pCspB and pCspC 
showed similar pigment levels to those found in the DcspA strain (Fig. 3). 
This result initially suggested that each of the S. aureus CSPs might have 
different functions.  
 
Specific post-transcriptional regulation drives differential CSP 
expression. 
 
It is well known that protein expression is influenced by transcriptional and 
post-transcriptional regulation. Therefore, the expression of CSPs from the 
same heterologous promoter did not guarantee the same protein levels in 
the complemented DcspA strains. In other words, we could not exclude 
that the cspB and cspC mRNAs were subjected to post-transcriptional 
regulatory mechanisms that could differentially affect their expression. 
Inadequate CSP amounts could lead to failure in complementing the 
phenotype. 
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Figure 3. CspA paralogs (CspB and CspC) do not complement the staphyloxanthin 
(STX) production in a cspA deficient strain. A. Schematic representation of the pCN51 
plasmid constructs harbouring the different csp mRNA sequences that were 
electroporated into the ∆cspA strain. Restriction enzymes used for cloning are indicated. 
B. Quantification of STX production in ∆cspA complemented with the pCspA, pCspB and 
pCspC plasmids. The STX pigment was extracted with ethanol from bacterial pellets after 
growth in MH for 16 hs at 37ºC. The WT and ∆cspA strains harbouring the pCN51 
plasmid were used as positive and negative controls, respectively. Quantification was 
performed by measuring the absorbance of ethanol solutions at 462 nm. The plot shows 
the mean of absorbance from three independent pigment extractions and the standard 
deviation from Student’s t-test, using the WT value as a reference. The asterisk indicates 
the statistical significance of the corresponding mean differences.  
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In order to correlate STX production with CSPs protein levels, we repeated 
the complementation of the DcspA strain using pCN51 plasmids carrying 
3xFLAG-tagged CSPs (Fig. 4A). Quantification of STX levels from these 
tagged strains revealed similar results to the untagged ones (Fig. 4B). On 
the one hand, CspA3xFLAG was able to restore the pigment production, 
indicating that 3xFLAG did not affect the protein function. On the other 
hand, strains complemented with CspB3xFLAG and CspC3xFLAG showed a 
similar amount of pigment to that of DcspA (Fig. 4B). Interestingly, 
Western blot results revealed that CspB3xFLAG and CspC3xFLAG did not 
reach CspA3xFLAG protein levels, despite being expressed from the same 
Pcad-CadC module (Fig. 4C). Although CspC had the closest identity to 
CspA, it was also the least expressed, indicating the presence of different 
post-transcriptional regulatory mechanisms acting on each of the csp 
mRNAs. While this finding proves interesting, the strategy prevents us 
from addressing S. aureus CSPs putative functional redundancy.  
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Figure 4. Differential post-transcriptional regulation of the CSP paralogs avoids 
complementation of the CspA phenotype. A. Schematic representation of the pCN51 
plasmid constructs harbouring tagged CSP mRNAs. 3xFLAG was introduced at the C-
terminus of the CDS. These plasmids were used to transform the ∆cspA strain. B. 
Quantification of STX production in ∆cspA complemented with the pCspA3xFLAG, 
pCspB3xFLAG and pCspC3xFLAG plasmids. The WT and ∆cspA strains harbouring the 
pCN51 plasmid were used as positive and negative controls, respectively. The STX 
extraction was performed, quantified and plotted as indicated in Figure 3. C. Western blot 
showing the expression of the 3xFLAG-tagged CspA, CspB and CspC proteins in the 
∆cspA strain. Total protein extractions were performed at the same time point and 
conditions described in B. Samples were run into 12% polyacrylamide gels and 
transferred to Nitrocellulose membranes. Tagged proteins were developed using 
peroxidase conjugated anti-FLAG antibodies and a bioluminescence kit. Coomassie 
stained gel portions are shown as loading controls. 
  
CSPs specificity 	
	 89 
 
The lack of complementation of a cspA deficient strain with CspB 
and CspC is independent of their protein levels. 
 
In an attempt to avoid the putative post-transcriptional mechanisms 
affecting CspB and CspC protein expression, we decided to genetically 
modify csp mRNAs by eliminating UTRs. It has been previously described 
that both 5’ and 3’UTRs contain post-transcriptional regulatory elements 
that have an impact on the protein levels (Waters and Storz, 2009; Ruiz de 
Los Mozos et al., 2013; Ren et al., 2017). We reasoned that elimination of 
these untranslated regions could help improving CSPs concentration 
inside the cell. Therefore, we constructed a new set of pCN51 plasmids 
expressing 3xFLAG-tagged csp mRNAs that lacked both UTRs while 
presenting the RBS and transcriptional terminator of the cspA mRNA 
(pCspA3xFLAGDUTRs, pCspB3xFLAGDUTRs and pCspC3xFLAGDUTRs). These 
two common elements for all the constructs were included in an attempt to 
avoid differences in translation and termination of transcription (Fig. 5A). 
Surprisingly, elimination of the UTRs produced a significant reduction in 
the production of all CSPs (Fig. 5B). On the one hand, this result 
questioned the hypothesis of the presence of repressive regulatory 
mechanisms affecting the concentration of CspB and CspC through the 
UTRs. On the other hand, it supported the existence of a putative activator 
mechanism that improved CspA expression.  
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Figure 5. Elimination of the UTRs from the csp mRNAs does not increase their 
protein expression. A. Schematic representation of the pCN51 plasmid constructs 
harbouring csp mRNAs lacking the 5’ and 3’UTRs. Only the RBS and TT from cspA 
mRNA were introduced as non-coding elements. These plasmids were used to transform 
the ∆cspA strain. B. Western blot showing the expression of the 3xFLAG-tagged CspA, 
CspB and CspC proteins in ∆cspA. Proteins were extracted, run, transferred and 
developed as described in Figure 4. Coomassie stained gel portions are shown as 
loading controls. 
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Since removing the UTRs from CSPs did not cause the expected effect, 
we decided to make mutations in the cspA the gene for it to codify CspB 
and CspC. This was achieved by performing the fewest nucleotide 
substitutions needed to transform CspA3xFLAG CDS into CspB3xFLAG and 
CspC3xFLAG CDSs, respectively (Table 4 and 5).  
These quimeric mRNAs, which preserved the cspA 5’ and 3’UTRs, were 
synthesized in vitro by GeneArt. Subsequently, we subcloned them into 
pCN51 and the resulting plasmids (pCspA_orfB3xFLAG and 
pCspA_orfC3xFLAG) were used to transform the DcspA strain (Fig. 6A). 
 
Table 4. Codon mutations in the cspA mRNA to express the 
CspB3xFLAG protein 
Position (aa) CspA codon Codon mutation1 Amino acid change 
2 
3 
20 
22 
23 
24 
32 
34 
35 
40 
46 
48 
51 
52 
55 
58 
61 
64 
65 
66 
AAA 
CAA 
GTT 
GGA 
GAA 
AAT 
GCA 
AAC 
CAA 
TCA 
GCT 
GAG 
GTA 
GTT 
GAC 
CCA 
GCA 
GTT 
AAA 
CTA 
AAT 
AAT 
CAA 
AAT 
GGC 
GGT 
GGA 
GCC 
TCA 
ACA 
AAA 
ACG 
ATA 
ACT 
CAA 
GAT 
GTA 
CAA 
ACA 
GTA 
K2N 
Q3N 
V20Q 
G22N 
E23G 
N24G 
A32G 
N34A 
Q35S 
S40T 
A46K 
E48T 
V51I 
V52T 
D55Q 
P58D 
A61V 
V64Q 
K65T 
L66V 
1Nucleotides changes introduced in the corresponding codons are indicated in bold letters 
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Table 5. Codon mutations in the cspA mRNA to express the 
CspC3xFLAG protein 
Position (aa) CspA codon Codon mutation1 Amino acid change 
2 
3 
20 
22 
23 
24 
34 
35 
46 
50 
51 
58 
66 
AAA 
CAA 
GTT 
GGA 
GAA 
AAT 
AAC 
CAA 
GCT 
GAA 
GTA 
CCA 
CTA 
AAT 
AAC 
AGA 
GAT 
GGT 
AGT 
GCT 
GAA 
AAA 
GAT 
ATA 
GAA 
ATG 
K2N 
Q3N 
V20R 
G22D 
E23G 
N24S 
N34A 
Q35E 
A46K 
E50D 
V51I 
P58E 
L66M 
1Nucleotides changes introduced in the corresponding codons are indicated in bold letters 
 
Western blots showed that CspA3xFLAG, CspB3xFLAG and CspC3xFLAG 
proteins were produced at similar rate (Fig. 6B). This result confirmed that 
cspB and cspC mRNAs were subjected to unknown post-transcriptional 
mechanisms and excluded post-translational processes as responsible for 
modifying protein levels. Nevertheless, quantification of the STX levels 
revealed that the production of the yellow pigment could not be restored in 
the DcspA strain by complementation with CspB and CspC, indicating the 
existence of a specific role for each S. aureus CSP (Fig. 6C). 
  
CSPs specificity 	
	 93 
 
 
 
 
 
 
Figure 6. Increased CspB and CspC levels do not complement staphyloxanthin 
(STX) production in a cspA deficient strain. A. Schematic representation of the pCN51 
plasmid constructs harbouring modified cspA mRNAs, which were generated to encode 
CspB or CspC labelled with the 3xFLAG at the C-terminus. These plasmids were 
introduced in the ∆cspA strain. B. Western blot showing the expression of 3xFLAG-
tagged CspA, CspB and CspC proteins in ∆cspA. Proteins were extracted, run, 
transferred and developed as described in Figure 4. C. Quantification of STX production 
in ∆cspA complemented with pCspA3xFLAG, pCspA_orfB3xFLAG and pCspA_orfC3xFLAG 
plasmids. WT and ∆cspA harbouring the pCN51 plasmid were used as positive and 
negative controls, respectively. The STX pigment was extracted, quantified and plotted as 
indicated in Figure 3.  
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The RNP-connecting loop is not responsible for CSP specificity 
 
It is widely accepted that the RNA binding capacity of CSPs resides in the 
RNP1 and RNP2 motifs. These amino acids are highly conserved in most 
organisms, including S. aureus (Fig. 1). However, those that are 
responsible for target specificity remain unknown. Some studies suggest 
that the charge of the protein surface, the different residues surrounding 
RNP1 and RNP2 motifs or the non-conserved amino acidic loop 
connecting RNP1 and RNP2 could drive target specificity (Kenan et al., 
1991; Yamanaka et al., 1998; Phadtare and Inouye, 1999). 
In an effort to understand which region of S. aureus CspA was responsible 
for target specificity, we first considered the connecting loop between 
RNP1 and RNP2. The amino acid differences in this region were relatively 
high (4 out of 6 amino acidic changes) compared to the overall protein 
sequence variation. To test if the functionality of CspA was altered when 
carrying the RNPs-connecting loop sequences of CspB and CspC, we 
performed the following amino acid exchanges: V20Q, G22N, E23G and 
N24G, generating the CspA_MLB protein, and V20R, G22D, E23G and 
N24S, generating the CspA_MLC variant (Fig 7A). After synthetizing such 
CspA chimeras in vitro, we cloned them in pCN51, generating plasmids 
pCspA_MLB and pCspA_MLC, and used them to transform the DcspA 
strain. Surprisingly, both chimeric proteins restored the wild type 
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phenotype, with CspA_MLC showing even higher STX levels than the WT 
strain (Fig. 7B). This result demonstrated that the amino acid variations 
present in the RNPs-connecting loop are not responsible for the in vivo 
CSP specificity but may affect binding affinity in S. aureus.  
 
 
 
 
 
 
Figure 7. The RNPs-connecting loop is not responsible for CspA specificity. A. 
Schematic representation of the pCN51 plasmid constructs harbouring cspA mRNAs, 
which were modified to encode the CspA protein including the RNPs-connecting loop of 
CspB or CspC. These plasmids were used to electroporate the ∆cspA strain. B. 
Quantification of staphyloxanthin (STX) production in the ∆cspA strains complemented 
with pCN51-cspA, _cspA_MLB and _cspA_MLC plasmids. WT and ∆cspA harbouring the 
pCN51 plasmid were used as positive and negative controls, respectively. The STX 
pigment was extracted, quantified and plotted as indicated in Figure 3.  
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CspA target specificity may be encoded in the carboxi-half of the 
protein 
 
The previous results suggested that the target specificity should be 
encoded outside of the RNA binding region. Considering that RNP1 and 
RNP2 motifs included into b2 and b3 strands are located in the first half of 
the protein, we wondered if the second half of the protein could play a role 
recognizing the targets. Thus, we constructed two additional chimeric 
cspA mRNAs expressing a CSP3xFLAG that comprised the N-terminal half 
of CspA (which included the RNP1 and RNP2 motifs) and the C-terminal 
half of CspB or CspC (pCspAB3xFLAG and pCspAC3xFLAG) following the 
codon substitution criteria applied above (Tables 6 and 7) (Fig 8A).  
 
 
Table 6. Codon mutations included into cspA mRNA to express the 
chimeric CspAB3xFLAG protein 
Position (aa) CspA codon Codon mutation1 Amino acid change 
32 
34 
35 
40 
46 
48 
51 
52 
55 
58 
61 
64 
65 
66 
GCA 
AAC 
CAA 
TCA 
GCT 
GAG 
GTA 
GTT 
GAC 
CCA 
GCA 
GTT 
AAA 
CTA 
GGA 
GCC 
TCA 
ACA 
AAA 
ACG 
ATA 
ACT 
CAA 
GAT 
GTA 
CAA 
ACA 
GTA 
A32G 
N34A 
Q35S 
S40T 
A46K 
E48T 
V51I 
V52T 
D55Q 
P58D 
A61V 
V64Q 
K65T 
L66V 
1Nucleotides changes introduced in the corresponding codons are indicated in bold letters 
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Table 7. Codon mutations included into cspA mRNA to express the 
chimeric CspAC3xFLAG protein 
Position (aa) CspA codon Codon mutation1 Amino acid change 
34 
35 
46 
50 
51 
58 
66 
AAC 
CAA 
GCT 
GAA 
GTA 
CCA 
CTA 
GCT 
GAA 
AAA 
GAT 
ATA 
GAA 
ATG 
N34A 
Q35E 
A46K 
E50D 
V51I 
P58E 
L66M 
1Nucleotides changes introduced in the corresponding codons are indicated in bold letters 
 
Although the protein levels of these chimeras were comparable to the 
original CspA3xFLAG protein, the analysis of STX production of the DcspA 
strains harbouring these plasmids revealed that the pigment levels could 
not be restored (Fig. 8B and 8C). This indicated that the few amino acid 
differences in the C-half of the CSPs may be responsible for CSP 
specificity in vivo, at least in S. aureus.  
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Figure 8. CspA carboxi-half amino acids are required to complement 
staphyloxanthin (STX) production in a cspA deficient strain. A. Schematic 
representation of the pCN51 plasmid constructs harbouring cspA mRNAs that were 
modified to encode chimeric CspAB and CspAC proteins labelled with the 3xFLAG at the 
C-terminus of the CDS. These plasmids were introduced in the ∆cspA strain. B. 
Quantification of STX production in the ∆cspA strains complemented with pCspA3xFLAG, 
pCspAB3xFLAG and pCspAC3xFLAG plasmids. The WT and ∆cspA strains harbouring the 
pCN51 plasmid were used as positive and negative controls, respectively. The STX 
pigment was extracted as indicated in Figure 3. C. Western blot showing the expression 
of 3xFLAG-tagged CspA, CspAB and CspAC proteins in the ∆cspA strain. Proteins were 
extracted, run, transferred and developed as described in Figure 4. 
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CHAPTER II: 
 
The regulon of the staphylococcal RNA chaperone CspA. 
 
CspB and CspC inability to restore the STX phenotype in a ∆cspA strain, 
as described in Chapter I, suggested that each of the CSPs has a specific 
function in S. aureus. Since these CSPs are generally accepted as RNA 
binding proteins, one could speculate that S. aureus variants have unique 
targets and, overall, different effects on the biology of the bacteria. In this 
Chapter, we focused on determining the regulon of S. aureus CspA using 
genome-wide approaches.  
 
 
S. aureus CspA is a global modulator of gene expression 
 
In order to evaluate the biological role of CspA in S. aureus, we performed 
comparative label-free LC-MS-based proteomics of the WT and DcspA 
strains. For this purpose, we extracted total protein from both strains at 
mid-exponential phase in biological triplicates. After trypsin treatment, the 
digested peptides were analysed by LC-MS/MS and identified by 
ProteinPilot Software (using the S. aureus NCTC 8325 protein database). 
The abundance of the identified proteins in the WT and DcspA strains was 
Chapter II 	
	104 
determined by Progenesis IQ software, which quantified a total of 1,206 
proteins (a coverage of 43.6% of the S. aureus NCTC 8325 proteome). 
We only considered non-conflicting peptides with a confidence 
identification score higher than 3, an error mass (ppm) lower than 20 and 
an m/z ratio between 450 and 800. Among them, 282 (80 up-regulated 
and 202 down-regulated) proteins were differentially expressed in the 
absence of CspA, with a fold-change ratio higher than 2 and a P-value 
lower than 0.05 (Fig. 9 and Annex I). Up- and down-regulated proteins 
were classified into 21 different functional categories, following the SEED 
database standards (http://pseed.theseed.org/) (Overbeek et al., 2005).  
Proteins related to carbohydrate, nucleotide and protein metabolism, 
virulence and stress response were the most abundant (Fig. 10A). To 
verify if CspA had a bias for modulating expression of proteins belonging 
to a particular biological process, we performed GO terms enrichment 
analysis using the PANTHER Overrepresentation Test tool from the Gene 
Ontology Consortium (Fig. 10B) (http://pantherdb.org) (Mi et al., 2017). 
This analysis revealed that proteins involved in processes such as 
carbohydrate and ribonucleotide biosynthesis (P-value = 8.81e-04 and 
6.40e-05, respectively), small molecule metabolism (P-value = 6.50e-11) 
and oxidative-reduction (P-value = 1.17e-02), among others, were 
enriched in the down-regulated gene group. In contrast, proteins involved 
in S. aureus pathogenesis (P-value = 1.89e-03) and cytolysis (P-value = 
1.41e-02), were enriched in the up-regulated group. The fact that clusters 
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of proteins belonging to specific biological processes were significantly 
affected in ∆cspA suggested that CspA might have a specialized function. 
 
 
 
 
 
 
Figure 9. Volcano plot for differential gene expression determined by label-free 
proteomics in ∆cspA compared to the WT strain. Scattered points represent genes: 
the x-axis reflects the log ratio, log2 fold change, between the ∆cspA and WT strains; 
whereas the y-axis indicates the negative log of the P-value. Red and green dots are the 
proteins that were significantly up- and down-regulated (considering a fold change > 2 
and a P-value <0.05), respectively. Detailed information about these proteins is available 
in Annex I.  
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Figure 10. Functional classification and analysis of proteins affected by cspA 
deletion. A. The plot represents the number of detected up- and down-regulated proteins 
(red and green bars, respectively) that could be classified into different functional SEED 
categories (http://pseed.theseed.org/) (Overbeek et al., 2005). B. Gene Ontology 
Enrichment Analysis performed with the PANTHER Overrepresentation Test tool from the 
Gene Ontology Consortium (http://pantherdb.org) (Mi et al., 2017). P-value (represented 
as negative log) and fold enrichment of overrepresented functional categories (P-value 
<0.05) are plotted. To simplify the plot, redundant categories were eliminated. 
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CspA is required for modulation of stress-associated phenotypes 
 
The previous analysis indicated that CspA is required for the proper 
expression of several biologically relevant genes in S. aureus. Therefore, 
we found it reasonable for some S. aureus phenotypes to be affected. 
There were two evident phenotypic changes that arose upon deletion of 
cspA: an increased bacterial aggregation and, as explained in Chapter I, 
reduced pigmentation. Concerning aggregation, the main 
exopolysaccharide involved in S. aureus biofilm formation is poly-N-acetyl-
glucosamine (PIA-PNAG), whose synthesis depends on the expression of 
the icaADBC operon (Cramton et al., 1999; Maira-Litran et al., 2005). 
Quantification by dot-blot of PIA-PNAG indicated that such increased 
bacterial aggregation (Fig. 11A) could be attributed to a rise in PNAG 
production in ΔcspA (Fig. 11B), which correlated with augmented IcaB 
protein levels (FC = 7.5; P-value 0.0002) (Annex I). The reduced 
pigmentation can be explained by a decrease in the expression of the 
crtOPQMN operon, responsible for STX biosynthesis and controlled by the 
alternative sigma factor SigB (Pelz et al., 2005). In agreement with 
previous results (Katzif et al., 2005), the DcspA strain expressed lower 
levels of SigB (FC = -3.1; P-value 0.0003; Annex I). Reduction of SigB 
also correlated with lower levels of other proteins controlled by SigB, 
including the Asp23 (FC = -7.8, P-value = 0.00007; Annex I and Fig 11C), 
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which, alongside STX production, is typically used as an indicator of SigB 
activity (Kuroda et al., 1995).  
In addition to STX pigment, further proteins involved in oxidative-reduction 
processes, such as superoxide dismutase (FC = -2.0, P-value = 0.001), 
ferritin-like antioxidant (FC = -2.8, P-value = 0.00002) and glutathione 
hydrolase (FC = -2.0, P-value = 0.001), were significantly enriched among 
the down-regulated genes (Fig. 10B). Likewise, regulatory proteins such 
as MgrA, SarZ, and Fur involved in oxidative stress adaptation, as 
previously described, were less abundant in the ΔcspA strain (Annex I) 
(Gaupp et al., 2012). Thus, to verify if the absence of CspA might affect 
oxidative-stress adaptation of S. aureus, the WT and ΔcspA strains were 
grown until late stationary phase and challenged with H2O2 for 1 h. We 
found that the number of viable bacteria recovered from DcspA was 
around one log lower than that from the WT strain, indicating that S. 
aureus CspA improves bacterial survival to oxidative stress (Fig. 11D). All 
the phenotypes associated to DcspA that we analysed were 
complemented by heterologous expression of the cspA gene, confirming 
the role of CspA in modulating their levels (Fig. 11). Altogether, these 
results illustrate the importance of CspA as a key player in ensuring the 
proper expression of important stress-related genes in S. aureus. 
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Figure 11. Phenotypic comparison of the wild type, ∆cspA and ∆cspA pCspA3xFLAG 
strains. A. Bacterial aggregation phenotypes after incubation for 24 h at 250 rpm and 
37ºC in glass tubes containing 5 ml of TSBglu. B. Dot-blot of PIA-PNAG 
exopolysaccharide for each of the strains in the previously mentioned conditions. Serial 
dilutions (1/2) of the samples were spotted onto nitrocellulose membranes and PIA-
PNAG was developed with specific anti-PIA-PNAG antibodies. C. Asp23 levels. Total 
protein extraction was performed at mid-exponential phase after growth at 37ºC and 200 
rpm. The Western blot was developed using peroxidase conjugated anti-FLAG 
antibodies. A Coomassie stained gel portion is shown as loading control (LC). D. 
Hydrogen peroxidase susceptibility assay. Bacterial plate growth from several ten-fold 
serial dilutions after treatment with a fixed concentration of H2O2. Bacteria were grown 
until late stationary phase at 37ºC and 200 rpm, diluted to 5x107 cfu ml-1 and challenged 
with 0.09 % final concentration of H2O2 for 1 h in the same conditions. Non-treated 
bacteria were included as a control.  
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The in vivo targetome map of the S. aureus RNA chaperone CspA 
 
In order to identify which of the regulated proteins found in the proteomic 
analysis were direct targets of CspA in vivo, we performed RIP-chip 
analysis (Jain et al., 2010). Since the three copies of CSPs contained in 
the S. aureus genome are highly similar, the possibility to obtain polyclonal 
antibodies, able to specifically differentiate CspA from CspB and CspC 
proteins, seemed unlikely. Thus, we labelled CspA with a 3xFLAG 
translational fusion (15981 cspA3xFLAG). Prior to introducing the tag, we 
modelled S. aureus CspA structure using Swiss-Model workspace 
(http://swissmodel.expasy.org) (Arnold et al., 2006). Both N- and C- 
terminal ends were exposed on the protein surface and opposite to the 
RNP1 and RNP2 RNA binding domains, seeming equally suitable for the 
introduction of the flag (Newkirk et al., 1994; Schindelin et al., 1994) (Fig. 
12A). We chose to include it at the C-terminus and tested the functionality 
of CspA3xFLAG by verifying that 15981 cspA3xFLAG displayed a similar 
amount of STX compared to the WT strain (Fig. 12B). Western blots 
showed that CspA3xFLAG was expressed at all tested points of the growth 
curve (Fig. 12C).  
In order to purify the RNAs associated to CspA3xFLAG, we included the WT 
strain (lacking the 3xFLAG sequence) and the 15981 GdpP3xFLAG strain 
(carrying a flagged version of GdpP, a protein without RNA-binding 
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domains), as negative controls. We included the latter as an additional 
negative control to exclude unspecific transcripts that might be pulled 
down alongside the 3xFLAG-anti-FLAG-G-sepharose complex. Western 
blots confirmed the presence of the 3xFLAG tagged proteins, CspA3xFLAG 
and GdpP3xFLAG in the purified fractions (Fig. 12D).  
 
 
 
 
Figure 12. Tagging CspA protein does not affect its functionality and allows its co-
immunoprecipitation. A. Putative S. aureus CspA protein structure, predicted by 
SWISS-MODEL (Arnold et al., 2006), using B. subtilis CspB as a template (PDB ID 
2ES2). Residues corresponding to RNA-binding domains RNP1 and RNP2 are showed in 
blue and cyan respectively. B. Quantification of staphyloxanthin (STX) production in the 
WT, ∆cspA and CspA3xFLAG strains. The STX pigment was extracted, quantified and 
plotted as indicated in Figure 3. C. Chromosomal CspA3xFLAG expression profile along the 
growth curve. Protein samples were extracted when bacteria reached OD600nm 0.3 and 
+1, +2, +3 and +4 h later, after growth at 37ºC and 200 rpm. The Western blot was 
developed using peroxidase conjugated anti-FLAG antibodies. A Coomassie stained gel 
portion is shown as loading control (LC). D. CspA3xFLAG and GdpP3xFLAG pull-down control. 
Western blot of the precipitated fractions showing the presence of flagged proteins after 
RIP was performed. The result was developed using peroxidase conjugated anti-FLAG 
antibodies and a bioluminescence kit. 
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We extracted RNAs bound to these purified proteins and identified them 
with the help of S. aureus custom tiling microarray chips, as previously 
described (Segura et al., 2012). To visualize normalized CspA-binding 
signals we used the Integrated Genome Browser (IGB) (Freese et al., 
2016). The majority of the signals were only present in the CspA3xFLAG 
RIP-chip while just a few of them were also found in the negative controls 
(Fig. 13A). This indicated that CspA3xFLAG pull-down was specific. 
Strikingly, the pull down revealed signals in the form of peaks instead of 
full-length transcripts. This was probably due to RNA degradation 
occurring during RIP sample processing. Therefore, the peaks might 
represent RNA regions protected by CspA binding.  
Next, we performed peak calling using two complementary methods, 
Thresholding and CisGenome (see Material and Methods), and identified 
570 and 355 peaks, respectively. The difference in the number of peaks 
detected by both bioinformatics approaches can be explained by their 
distinct data processing procedures. Thresholding method considers all 
peaks above a certain level to be true while CisGenome tends to group 
contiguous peaks, representing them as only one. In this study, we only 
considered those regions that were commonly detected by both methods. 
Figure 13B, shows CspA-binding signals as broadly distributed across the 
whole staphylococcal genome. We integrated this results with the 
transcriptomic data, previously generated (Lasa et al., 2011), and loaded 
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them into a public web server based on Jbrowse (Skinner et al., 2009) 
(http://rnamaps.unavarra.es/). 
To match the identified CspA-binding signals with their corresponding 
transcripts, we manually annotated the boundaries of each of the targeted 
RNAs based on our transcriptomic data (Lasa et al., 2011; Ruiz de Los 
Mozos et al., 2013). We observed that CspA-binding peaks included at 
least 213 transcripts of different RNA nature: monocystronic, polycystronic 
and non-coding transcripts, such as small RNAs or riboswitches (Annex 
II). After defining the summit position for each of the peaks on mRNAs, we 
found that most of the summit peaks (257) mapped onto CDSs and 59 
onto untranslated regions (Fig. 13C). As Figure 13C shows, CspA-binding 
signals were homogeneously distributed along the targeted mRNAs, 
indicating no particular preference for a specific position within them. We 
also wondered if CspA recognised certain RNA sequences within these 
regions. Hence, we looked for a consensus RNA sequence domain using 
MEME suite Version 4.10.1 (Bailey et al., 2009). We run the algorithm with 
the sequences covered by the CspA-binding peaks or with 60-nt 
sequences centred at the summit position. After testing different 
parameters, we did not find any clear RNA motifs that could be considered 
a consensus CspA binding region. Although an RNA binding sequence is 
still missing, these results revealed hundreds of putative RNA targets, 
depicting CspA as a potential global post-transcriptional modulator.  
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Figure 13. Targetome map of the RNA chaperone CspA in S. aureus. A. RIP-on-chip 
genomic maps. IGB plot showing the tiling array signals of the RIP-on-chip assays from 
strains CspA3xFLAG (red), GdpP3xFLAG (blue) and the untagged WT (black) along the 
forward and reverse genomic strands. S. aureus NCTC 8325 strain sequence was used 
as reference genome. These maps can be browsed at http://rnamaps.unavarra.es/. B. 
CspA binding peaks mapped across the S. aureus NCTC 8325 genome. Each dot 
represents the peak intensity signal for a specific genome position. C. Relative summit 
peak positions mapped onto an mRNA model. The length of CDSs encoded by 
transcripts targeted by CspA were normalized to 100 and the summit positions were 
mapped accordingly. The number of relative summit positions mapping onto each 1/20 
fraction of a CDS or outside of it were plotted. 
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CspA binding can positively or negatively modulate the expression 
of its targets at the post-transcriptional level 
 
Integration of the proteomic and the targetome data revealed 52 
transcripts that were directly bound by CspA and had significantly different 
protein levels in DcspA (17 up-regulated and 35 down-regulated) (Annex 
III). Among them, 36 candidates were classified into SEED categories, 
with the stress response group being one of the most represented, 
including: cold shock protein CspC, the alternative RNA polymerase sigma 
factor SigB, serine-protein kinase RsbW and manganese superoxide 
dismutase SOD (Fig. 14 and Annex III). In order to validate the putative 
post-transcriptional effect on CspA targets due to CspA binding, we 
selected SigB and CspC as model examples for down- and up-regulated 
proteins, respectively (Fig. 15A). In addition, we also included CspA since 
the RIP-chip analysis revealed binding signals onto its own mRNA (Fig. 
15A). To exclusively monitor protein expression at the post-transcriptional 
level, we tagged the selected genes with 3xFLAG and placed them under 
the control of heterologous promoters. The resulting plasmids 
(pSigB3xFLAG, pCspC3xFLAG, pCspA3xFLAG) were used to transform the WT 
and DcspA strains and their protein expression analysed by Western blot 
at mid-exponential growth phase.  
Chapter II 	
	116 
 
 
 
 
 
 
 
Figure 14. Targetome map of the RNA chaperone CspA in S. aureus. A. Functional 
classification of differentially expressed CspA targets. The plot represents the number of 
differentially expressed CspA targets that could be classified into different functional 
SEED categories (http://pseed.theseed.org/) (Overbeek et al., 2005). The number of up-
regulated and down regulated targets is shown as red and green bars, respectively. 
Details of the represented genes are included in Annex I and Annex III. 
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As shown in Figure 15B, SigB3xFLAG and CspC3xFLAG expression in the 
DcspA strain was lower and higher, respectively, compared to that in the 
WT strain. This was in agreement with the proteomic data (Annex I; SigB 
FC = -3.1, P-value = 0.0003 and CspC FC = 11.00, P-value 0.001), 
indicating that CspA can modulate both positively and negatively the 
expression of its targets. Like CspC, the expression of CspA3xFLAG was 
higher in the DcspA than in the WT strain, suggesting a possible post-
transcriptional negative loop acting on the cspA mRNA (Fig. 15B). These 
findings proved relevant since the RNA chaperone activity of CSPs is 
expected to contribute to an improvement of translation efficiency (by 
melting RNA secondary structures that impair ribosome movement) and 
not the contrary. 
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Figure 15. Post-transcriptional regulation of selected CspA targets. A. RIP-chip 
maps showing CspA-binding signals on the sigB, cspC and cspA loci. Normalized tiling 
signals of RIP-on-chip experiments for CspA3xFLAG, GdpP3xFLAG and WT are shown 
as red, green and black bars respectively. CDSs appear as blue box arrowsy and mRNAs 
are represented as dashed green arrows. B. Expression of 3xFLAG-tagged SigB, CspC 
and CspA proteins in the WT and ∆cspA strains. Total protein extraction was performed 
at mid-exponential phase after growth at 37ºC and 200 rpm. Samples were run into 12% 
polyacrylamide gels and transferred to Nitrocellulose membranes. Western blots were 
developed using peroxidase conjugated anti-FLAG antibodies and a bioluminescence kit. 
Coomassie stained gel portions are shown as loading controls (LC). 
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CspA represses CspC translation. 
 
Considering that some of CspA direct targets had increased protein levels 
in its absence (Chapter II and Annex III), we concluded that the CspA 
binding had a negative effect on the expression of such targets. This 
proved relevant, since it is commonly expected from CSPs chaperone 
activity to increase translation efficiency (by melting RNA secondary 
structures that impair ribosome movement). For this reason and to gain 
further knowledge on the capacity of CspA to inhibit protein expression at 
the post-transcriptional level, we chose the cspC transcript as a model. 
 
 
CspA protein binds the 5’UTR of the cspC mRNA in vitro  
 
Confirming that CspA effectively bound the cspC mRNA was our first 
priority, for which we decided to perform electrophoretic mobility shift 
assays (EMSAs). Since we needed purified recombinant CspA (rCspA), 
we first generated a plasmid expressing a GST-tagged CspA protein 
under the control of the lacZ promoter (pGEX-6P-2::cspA), which we 
subsequently used to transform E. coli BL21 cells (E. coli BL21 pGEX-6P-
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2::cspA). We then grew E. coli BL21 pGEX-6P-2::cspA strain at 37ºC and 
250 rpm until an OD600 of 0.5 was reached, added 0.4 mM IPTG and 
incubated them for an additional 5 h. Afterwards, we purified the GST-
CspA fusion protein from clarified lysates, using a GSTrap column coupled 
to an AKTAprime plus chromatography system, and collected several 
fractions from the lysate after flowing through the column. We run a small 
portion of them in acrylamide gels. Figure 16 shows a Coomasie stained 
gel with the relative amount of total protein obtained before and after IPTG 
induction, and once treatment with Precision protease was complete (used 
to cleave the GST-CspA fusion protein and release rCspA). An enriched 
band corresponding to GST-CspA indicates an increase in the post-
induction sample compared to the pre-induction sample. In the purified 
fractions, single discrete bands corresponding to rCspA reflect that the 
purification process was successful. 
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Figure 16. Purification of the recombinant CspA protein. A. Coomassie stain of a 
representative acrylamide gel showing the expression of GST-CspA fusion protein after 
before and after IPTG induction. B. Western blot performed with the samples used in A. 
GST-CspA fusion protein was developed using anti-GST antibodies. C. Coomassie stain 
of a representative acrylamide gel showing some of the purified fractions after digestion 
of GST-CspA fusion protein with Prescission protease. D. Western blot performed with 
the samples used in B, showing that the fractions containing the processed CspA lacked 
contamination with GST fragment. GST protein was developed using anti-GST 
antibodies. 
 
  
Chapter III 	
	126 
Having purified rCspA, we performed EMSAs with the whole cspC mRNA, 
which we synthesized in vitro, radioactively labelled the 5’-end with and 
incubated with increasing concentrations of rCspA. As shown in Figure 
17A, rCspA dependent mRNA band shifts are noticeable, indicating that 
rCspA and the cspC mRNA effectively interacted.  
To determine what region of the cspC mRNA was recognized by CspA, we 
designed ssDNA oligonucleotides that covered the entire mRNA molecule. 
The reason for using ssDNA was because CSPs bind ssDNA as efficiently 
as RNA molecules and are more stable than RNA oligonucleotides 
(Phadtare and Inouye, 1999). Each ssDNA oligonucleotide overlapped 
approximately 10-nt with the following one (Fig. 17B). In this manner, we 
avoided missing any possible interactions at the extremes of the 
oligonucleotides. We radioactively labelled ssDNA oligos at the 5’-end and 
incubated with increasing concentrations of rCspA. Then, we run the 
samples in non-denaturing 10% polyacrylamide gels and the results 
showed that CspA bound f-C1 oligonucleotide with the highest affinity 
when compared to than the other six (Fig. 17C). This indicated that CspA 
interacted with the 5’UTR of the cspC mRNA in vitro.  
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Figure 17. CspA binds the cspC mRNA at the 5’UTR in vitro. A. EMSA of CspA-cspC 
mRNA. Band-shifts originated from the combination of 20 fmol of 32P-labeled synthetic 
cspC mRNA and increasing amounts of recombinant CspA (rCspA) (0.25 to 2 nmoles). B. 
Schematic representation of the ssDNA oligonucleotides designed to perform EMSAs 
with the rCspA protein. C. EMSA of f-C1 to f-C7 ssDNA oligonucleotides (20 fmol of 32P-
labelled synthetic oligo fragments) with increasing amounts of rCspA protein. The pmoles 
per reaction used in each lane are indicated. The CspA-oligonucleotide complexes are 
marked with an asterisk. 
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CspA represses CspC protein expression without affecting cspC 
mRNA levels in vivo 
 
To further analyse the suppressor effect of CspA on CspC expression at 
the post-transcriptional level, we carried out Northern blots using RNA 
samples extracted from the WT and DcspA strains carrying the pCN51-
cspC3xFLAG plasmid and grown until mid-exponential phase. We developed 
the transferred RNAs using an antisense oligonucleotide that targeted the 
3xFLAG sequence (as-3xFLAG) as a probe. This probe detected only the 
plasmidic cspC3xFLAG mRNA, which was expressed under the control of the 
heterologous Pcad-cadC module (Charpentier et al., 2004). As shown in 
Figure 18, cspC3xFLAG mRNA levels expressed from pCN51-cspC3xFLAG 
were similar in the WT and DcspA strains, suggesting that CspA binding 
decreased CspC expression post-transcriptionally by impairing translation 
and without affecting cspC mRNA concentration.  
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Figure 18. CspA binding does not affect cspC mRNA levels in vivo. Total RNA 
extraction was performed after growth until mid-exponential phase at 37ºC and 200 rpm. 
RNA samples were run into 1.25% agarose gels and transferred to Nitran membranes. 
Northern blots were developed using a 32P-labelled anti-FLAG oligo probe and 
autoradiography. Ethidium bromide staining of 16S RNA is shown as loading control (LC). 
Protein samples were run into 12% polyacrylamide gels and transferred to Nitrocellulose 
membranes. 
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CspA inhibits CspC translation in vitro 
 
Previous results suggested that CspA bound the 5’UTR region of cspC 
mRNA. Since such binding did not affect mRNA levels, differences on 
CspC levels between the ∆cspA and WT strain, could be explained by a 
direct alteration of CspC translation. To confirm that CspC regulation by 
CspA binding was uncoupled from transcription and mRNA turnover, we 
performed in vitro translation of a synthetic mRNA encoding the 3xFLAG-
tagged CspC protein, in the presence and absence of rCspA. We used 
BSA protein as a negative control. Western blot results revealed that 
CspC3xFLAG could not be efficiently produced in vitro in the presence of 
rCspA (Fig. 19). This result was in agreement with the idea that CspA may 
be acting as a repressor of translation. 
 
 
 
 
Figure 19. CspA inhibits CspC translation in vitro. Western blot of CspC3xFLAG protein 
after in vitro translation of the synthetic cspC3xFLAG mRNA in presence of BSA (lane 2) or 
recombinant CspA proteins (lane 3). Lane 1 shows the result from the in vitro translation 
of the cspC3xFLAG mRNA alone as a positive control. 
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CHAPTER IV: 
 
Insights into the auto-regulation of CspA expression. 
 
In the previous chapter, we showed that CspA could bind the 5’ UTR of 
cspC mRNA and act as direct repressor of CspC translation without 
affecting its mRNA levels. We wondered whether this was a generalized 
mode of action extended to all its negatively-regulated targets. For this 
reason, we decided to deeply analyse the auto-regulation of CspA 
expression (revealed in Chapter II) as an additional example of CspA-
mediated repression.  
 
CspA affects its own mRNA processing and protein expression 
 
To understand how CspA affects its own expression at the post-
transcriptional level, we performed Northern blots and compared the 
expression of the plasmidic cspA3xFLAG mRNA in the WT and DcspA 
strains using a radioactively labelled antisense 3xFLAG oligonucleotide. 
This probe allowed us to specifically detect the cspA3xFLAG mRNA 
expressed from the pCN51-cspA3xFLAG plasmid, which is under the control 
of the heterologous Pcad-cadC module (Charpentier et al., 2004). In 
contrast to what was observed for CspC, Northern blots revealed two 
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cspA3xFLAG mRNA bands in the WT and DcspA strains, indicating the 
presence of a processing site (Fig. 20). Such processed mRNA may be 
due to RNase III activity, as previously described (Lioliou et al., 2012) (Fig. 
20A). In agreement with this idea, the lower band in samples from the Drnc 
and DrncDcspA strains, carrying the pCspA3xFLAG plasmid, was absent 
(Fig. 20B). Interestingly, although the levels of the non-processed mRNA 
were only slightly higher in DcspA compared to the the WT strain, the 
amount of the processed mRNA in the former was significantly elevated 
(Fig. 20C). Lioliou and colleagues suggested that such processed cspA 
mRNA would be more prone to be translated (Lioliou et al., 2012). Our 
observations indicated that CspA might interfere with RNase III processing 
and impair its own translation, which correlated with the detected higher 
CspA3xFLAG protein levels in the DcspA strain (Fig. 20D). Western blots 
also revealed that CspA3xFLAG levels, expressed from the pCspA3xFLAG 
plasmid, were lower in the DrncDcspA double mutant than in the DcspA 
single mutant strain, supporting that RNase III processing is participating 
in CspA auto-regulation (Fig. 20D). However, CspA3xFLAG levels in the 
DrncDcspA double mutant were slightly higher than in the WT and Drnc 
strains, indicating the existence of an additional cooperative RNase III-
independent mechanism contributing to CspA repression (Fig. 20D). 
Altogether, these results suggested that CspA modulated its expression 
by, at least, interfering with RNase III processing of its own mRNA.  
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Figure 20. Processing of the cspA mRNA by RNase III. A. Schematic representation 
of the cspA 5’UTR stem loop adpated from Lioliou and colleagues (Lioliou et al., 2012). 
The RNase III processing site is represented by a bold line and the processed mRNA is 
indicated with an asterisk. B. cspA3xFLAG mRNA levels produced from the pCspA3xFLAG 
plasmid in the WT, ∆cspA, ∆rnc and ∆rnc∆cspA strains. Total RNA extraction was 
performed after growth until mid-exponential phase at 37ºC and 200 rpm. RNA samples 
were run into 1.25% agarose gels and transferred to Nitran membranes. Northern blots 
were developed using a 32P-labelled anti-FLAG oligo probe and autoradiography. 
Ethidium bromide staining of 16S RNAs is shown as loading control (LC). MM, Millenium 
Marker. C. Comparison of non-processed and processed cspA3xFLAG mRNA levels in the 
∆cspA and the WT strain. Bands were quantified by densitometry of Northern blot auto-
radiographies using Fiji (https://fiji.sc/). The mean ratios and standard deviations were 
calculated from four independent experiments. The asterisk indicates the statistical 
significance of the ratio differences (P = 0.0154). D. CspA3xFLAG protein levels from the 
same strains and conditions described in B. Protein samples were run into 12% 
polyacrylamide gels and transferred to Nitrocellulose membranes. Western blots were 
developed using peroxidase conjugated anti-FLAG antibodies and a bioluminescence kit. 
Coomassie stained gel portions are shown as loading controls (LC).  
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The cspA 5’UTR is required for CspA expression and auto-regulation 
 
The hairpin structure targeted by RNase III is located in the 5’UTR of the 
cspA mRNA (Lioliou et al., 2012). To verify whether CspA was acting on 
the 5’UTR, we generated the pCspA3xFLAG∆5’UTR plasmid. This construct 
carried a version of the cspA3xFLAG mRNA that lacked most of the 5’UTR 
while preserving the RBS (up to -18 nt from the start codon). We 
transformed the WT and DcspA strains with pCspA3xFLAG∆5’UTR and then 
addressed their cspA3xFLAG mRNA expression by Northern blot. As 
anticipated, only one mRNA band with a similar intensity was found in both 
strains, indicating that the presence of the 5’UTR RNA was needed for 
RNase III processing (Fig. 21A) (Lioliou et al., 2012). Western blot 
experiments showed that deletion of the 5’UTR drastically decreased 
CspA production in the WT and DcspA strains, nonetheless, the amount of 
protein was comparable between them (Fig. 21B). Altogether, these 
results indicated that mRNA processing is essential for an appropriate 
CspA expression and that the CspA auto-regulatory mechanism requires 
the 5’UTR of the cspA mRNA.  
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Figure 21. CspA expression and auto-regulation require the cspA 5’UTR. A. 
cspA3xFLAG mRNAs generated from pCspA3xFLAG and pCspA3xFLAG-∆5’UTR plasmids in the 
WT and DcspA strains. RNAs were extracted, run, transferred and developed as 
described in Figure 20. Ethidium bromide staining of 16S RNA is shown as a loading 
control (LC). Processed cspA3xFLAG mRNA is indicated with an asterisk. B. CspA3xFLAG 
protein levels from the pCspA3xFLAG and pCspA3xFLAG-∆5’UTR plasmids in the WT and 
DcspA strains. Proteins were extracted, run, transferred and developed as described in 
Figure 20. Exp 1 and Exp 2 indicate two different exposure times. A Coomassie stained 
gel portion is shown as a loading control (LC). 
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CspA might bind a U-rich region located in the right arm of the 5’UTR 
stem-loop 
 
In order to find which region of the cspA 5’UTR was bound by CspA, we 
designed three single-stranded DNA (ssDNA) oligonucleotides of about 
60-nt long that completely covered the 5’UTR and part of the cspA CDS. 
As described in Chapter III, we used ssDNA oligos that overlapped 10 nt 
with each other (Fig. 22A) (Phadtare and Inouye, 1999). Following such 
strategy, f-A1 comprised the stretch of nucleotides from the TSS (-112) to 
position -51, f-A2 from -62 to +3 and f-A3 from -17 to +43 (considering 
position +1 the A of the start codon). After radiolabelling and incubating all 
three ssDNA oligonucleotides with increasing concentrations of purified 
recombinant CspA (rCspA), we run them in non-denaturing 10% 
polyacrylamide gels. Results showed that CspA bound f-A1 and f-A2 with 
dissociation constants (Kd) of approximately 1.5 and 2.8 µM, respectively. 
In contrast, CspA poorly bound f-A3 (Kd > 8.5 µM) (Fig. 22B). To 
demonstrate that CspA binding was specific, we performed competition 
assays using increasing concentrations of cold unlabelled f-A1 and f-A2. 
As expected, these oligonucleotides competed with the labelled ones (Fig. 
22C). Additionally, the f-CDS oligonucleotide (from 148 to 201 of the CspA 
CDS sequence) was included as negative control (Fig. 22D). Altogether, 
these assays showed that CspA bound specifically and more efficiently 
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regions covered by f-A1 and f-A2 than those included by f-A3 and f-CDS. 
This implied that CspA either bound more than one site of the 5’-UTR or 
the 10-nt overlapping region, between f-A1 and f-A2. Coincidentally, such 
overlapping sequence included a thymidine-rich (T-rich) stretch (Fig. 22A). 
Uracil-rich (U-rich) regions of RNAs (or T-rich regions for ssDNA) have 
been previously proposed as potential targets for some CSPs (Phadtare 
and Inouye, 1999; Lopez et al., 2001; Zeeb et al., 2006; Max et al., 2007; 
Sachs et al., 2012; Lee et al., 2013; Benhalevy et al., 2015). Therefore, we 
wondered if the T stretch, common to both oligonucleotides, was involved 
in the band shifts observed in the presence of CspA. For this purpose, we 
repeated the EMSAs using modified f-A1 and f-A2 (f-A1-DT and f-A2-DT) 
that lacked the T-rich sequences from the 3’- and 5’-end, respectively. 
Results showed a remarkable decrease in the affinity of CspA for f-A1-DT 
(Kd > 8.5 µM) and f-A2-DT (Kd ~ 7 µM) compared to that for the original 
ssDNA oligonucleotides (Fig. 22E). This indicated that the T-rich region 
enhanced CspA binding and suggested a putative interaction between 
CspA and the U-rich region of cspA 5’UTR.  
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Figure 22. CspA binds to a T-rich motif in vitro. A. Schematic representation of the 
ssDNA oligonucleotides designed to perform the EMSAs with recombinant CspA (rCspA). 
B. EMSA of f-A1, f-A2 and f-A3 ssDNA oligonucleotides (20 fmol of 32P-labelled synthetic 
oligo fragments) with increasing amounts of rCspA. The pmoles per reaction used in each 
lane are indicated. C. Gel shift competition assay of labelled f-A1 and f-A2 performed in 
the presence of increasing concentrations of unlabelled f-A1 and f-A2 and 25 and 50 
pmoles of rCspA, respectively. D. EMSA of the f-CDS ssDNA oligonucleotide (20 fmol of 
32P-labelled synthetic oligo fragments) with increasing amounts of rCspA. E. EMSA of the 
f-A1-DT and f-A2-DT ssDNA oligonucleotides. These fragments lack the T-rich region 
from the 3’ and 5’ ends of f-A1 and f-A2, respectively. The rCspA-oligonucleotide 
complexes are indicated with an asterisk. 
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CspA melts the stem-loop of the cspA 5’UTR in vitro 
 
The U stretch is located in the right arm of the stem-loop structure 
processed by RNase III (Fig. 20A). Based on this observation, we 
hypothesized that CspA may bind to this region, melt the RNA stem-loop 
and prevent the RNase III processing. To test this hypothesis, we used a 
molecular beacon system, as previously described (Phadtare, Inouye, et 
al., 2002). In our case, it consisted of a 49-mer ssDNA oligonucleotide that 
included the 5’UTR stem-loop (from position -95 to -45 considering the A 
of the start codon as position +1), incorporating a molecule of fluorescein 
(FAM) and the Black Hole Quencher 1 (BHQ_1), which were attached to 
the 5’- and 3’-end of the oligonucleotide, respectively (Fig. 23A). If these 
two molecules fell in close proximity to each other, an efficient quenching 
of the FAM fluorescence would occur. To test the viability of the designed 
molecular beacon system, we measured the fluorescence levels at 
different temperatures. Figure 23B shows basal fluorescence levels at 37 
and 45ºC, indicating that the molecular beacon was properly folded and 
retained a FAM quenched state due to the proximity of BHQ_1. In 
contrast, an appreciable increase of fluorescence levels occurred when 
this structure was incubated at temperatures higher than 55ºC, evidencing 
a melting process in which the FAM was separated from the quencher. 
  
Chapter IV 	
	144 
 
Since the molecular beacon was working as expected, we then incubated 
it with purified BSA, as a negative control, and rCspA for 10 min at 37ºC 
and measured the fluorescence. Addition of rCspA resulted in an increase 
of the beacon fluorescence compared to the BSA treatment, indicating that 
the interaction of rCspA with the stem loop structure eventually led to its 
disruption (Fig. 23C). To test if this effect was due to the presence of 
rCspA, Proteinase K was added to the mixtures and these incubated for 
30 min at 37ºC. After the incubation period, fluorescence decreased as 
Proteinase K degraded rCspA (Fig. 23D). Finally, the mixtures were 
incubated for 10 min at 65ºC to melt the beacon structure. Both mixtures, 
containing rCspA and BSA, presented an increase in the fluorescence 
levels upon temperature shift, confirming that the beacon was still 
functional after the treatments (Fig. 23E). From these results, we learned 
that CspA was able to disrupt the ssDNA stem-loop structure of the cspA 
5’UTR in vitro. The consequence of such disruption in the RNA molecule 
in vivo, would prevent RNase III from cleaving the cspA mRNA. 
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Figure 23. CspA melts the stem loop of the cspA 5’UTR in vitro. A. Schematic 
representation of the molecular beacon design that mimics the stem-loop of the cspA 
5’UTR. The 5’-end and the 3’-end harbour fluorescein (FAM) and the Black Hole 
Quencher 1 (BHQ_1), respectively. The structure would keep FAM close to BHQ_1 
avoiding fluorescence emission. The T-rich motif is indicated in yellow. B. Control test to 
monitor the effectiveness of the molecular beacon design. A temperature increase over 
50ºC for 10 min caused melting of the molecular beacon secondary structure and led to 
fluorescence emission by FAM. C. FAM fluorescence after incubation of the molecular 
beacon with 7 nmoles of recombinant CspA (rCspA) or BSA for 10 min at 37ºC. BSA was 
introduced as a negative control. The presence of rCspA produced a similar effect to 
temperature increase by promoting fluorescence emission. D. FAM fluorescence levels 
after addition of 200 µg of Proteinase K to the previous mixtures and incubation for 30 
min. Proteinase K processed rCspA and BSA, leading to re-naturalization of the beacon 
structure and, as consequence, a reduction in fluorescence emission. E. FAM 
fluorescence after treating the previous mixtures for 10 min at 65ºC. Raise in temperature 
caused an increase of fluorescence due to melting of secondary structures.   
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CspA requires the stem-loop containing the U-rich motif to regulate 
its own expression in vivo  
 
Previous results suggested that CspA might interfere with the cspA 5’UTR 
processing by RNase III. At least, two key elements are necessary for this 
processing to occur: i) a correctly folded stem loop at the 5’UTR, 
generating a double-stranded RNA region, and ii) RNase III being able to 
effectively cleave it (Fig. 20A) (Lioliou et al., 2012). There are several 
hypotheses that might explain the negative effect exerted by CspA on the 
RNase-III processing. CspA could either unfold the stem loop into a single 
stranded RNA or allosterically interfere with RNase III binding. These two 
possibilities would result in inhibition of RNase III activity by direct 
interaction with the cspA mRNA. Another consideration is that CspA could 
indirectly affect RNase III expression. Proteomic analysis revealed that 
RNase III protein levels were reduced in the DcspA strain (-2.1, P-value = 
0.0004) (Annex I). However, this last observation seems in disagreement 
with the increase in RNase III-processing observed for the cspA 5’UTR in 
DcspA (Fig. 20B). Hence, an interference with the processing of the stem 
loop due to direct binding of CspA, as suggested by the in vitro assays, 
seemed the most reliable hypothesis.  
 
CspA auto-regulation 	
	 147 
To evaluate in vivo the role of the stem loop in CspA auto-regulation, we 
constructed the pCspA3xFLAG-M5U plasmid, which carried an exchange of 
nucleotides -59[TTTTT]-54 by nucleotides -59[GACAG]-54, and 
transformed the WT and DcspA strains with it. Such mutation was 
designed to generate a cspA3xFLAG mRNA that, on the one hand, would 
prevent the formation of the hairpin targeted by RNase III and, on the 
other hand, would avoid CspA binding to cspA 5’UTR. As anticipated, 
Northern blots revealed that the mutation of the U-rich motif avoided the 
regular RNase III processing occurring at the cspA 5’UTR (Fig. 24B). In 
this case, the levels of the CspA3xFLAG protein were not remarkably 
affected when DcspA was compared to the WT strain. This result indicated 
that CspA auto-regulation may require the U-rich motif for CspA binding 
and/or the formation of the stem-loop to be digested by RNase III.  
Finally, since the U-rich mutation affected two variables simultaneously 
(CspA binding and RNase III processing of the cspA mRNA), we 
generated a second plasmid, the pCspA3xFLAG-M5UC, which carried an 
additional mutation that substituted nucleotides -87[AAGAA]-83 for -
87[CTGTC]-83. The purpose was to compensate the previous one 
(pCspA3xFLAG-M5U) and restore the RNA hairpin at the 5’UTR. The stem 
loop, lacking the U-rich motif, would still be recognised and processed by 
RNase III. This plasmid was used to transform the WT and DcspA strains. 
Northern blots confirmed that the RNase III dependent mRNA processing 
was restored when cspA was transcribed from pCspA3xFLAG-M5UC (Fig. 
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24C), although to a lower extent than that obtained from the mRNA 
generated from pCspA3xFLAG. This observation could be explained by the 
location of the mutation, at the cleavage site of RNase III, which may 
decrease the processing efficiency of the mRNA (Pertzev, 2006). 
Nonetheless, the levels of CspA3xFLAG protein were not notably different 
between the DcspA and WT strains, indicating that the U-rich region is 
required for CspA repression (Fig. 24). Overall, these observations 
illustrated the existence of a very complex regulatory network where the 
5’UTR stem-loop is crucial in the control of CspA expression. Interestingly, 
this structure is alternatively targeted by two RBPs, RNase III and CspA 
itself. 
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Figure 24. The U-rich motif is required for CspA auto-regulation in vivo. mRNA and 
protein levels of CspA3xFLAG expressed from pCspA3xFLAG (A), pCspA3xFLAG-M5U (B) and 
pCspA3xFLAG-M5UC (C) in the WT and DcspA strains. RNAs and proteins were extracted, 
run, transferred and developed as indicated in Fig. 20. In the Northern blots, the 
processed cspA3xFLAG mRNA, indicated with an asterisk. Ethidium bromide staining of 
16S RNA is shown as loading control (LC). Western blots include Coomassie stained gel 
portions as loading controls (LC). 
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DISCUSSION 
 
Several RBPs with unrelated protein domains have been proposed to act 
as global post-transcriptional modulators of gene expression (Van Assche 
et al., 2015). Up to now, the targetomes of some regulatory RBPs have 
been unveiled (e.g. RNA chaperones Hfq, CsrA, ProQ, CSPs and 
ribonucleases RNase III, RNase E). In all cases, hundreds of RNA targets 
comprising both coding and non-coding RNAs were found, showing that 
RBPs constitute central elements in fine-tuning bacterial biological 
processes (Zhang et al., 2003; Sittka et al., 2008; Lioliou et al., 2012; 
Chao et al., 2012; Dambach et al., 2013; Holmqvist et al., 2016; Smirnov 
et al., 2016; Chao et al., 2017; Michaux et al., 2017). Most of these studies 
have been conducted in Gram-negative bacterial models, leaving Gram-
positives with only a few examples. Throughout this Thesis, different 
functional aspects of the RNA chaperone CspA have been analysed using 
S. aureus, a Gram-positive pathogen of major clinical relevance, as a 
model. Here, we propose a different functionality between S. aureus CspA 
and its paralogs, CspB and CspC. In addition, we suggest that CSPs 
functional specificity may be encoded in the carboxi-half of the protein. We 
also provide the regulon of CspA and insights on the mechanisms by 
which CspA negatively regulates the expression of CspC and itself.  
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S. aureus CSPs are not functionally redundant 
 
Based on their sequence identity, it has been long speculated that CSP 
paralogs present in a genome may share the same biological function. A 
recent report by Michaux and colleagues, demonstrated that CspC and 
CspE RNA targets from Salmonella overlap in a large percentage 
(Michaux et al., 2017). Simultaneous mutation of cspC and cspE genes 
resulted in strong phenotypic changes. However, single-gene deletions did 
not impair the analysed phenotypes indicating redundant functions for 
these two proteins (Michaux et al., 2017). Likewise, both CspC and CspE 
in E. coli are required to resist environmental stresses by stabilizing the 
rpoS transcript at the entry of stationary phase (Shenhar et al., 2012). 
Although these findings show that CSPs may have redundant functions, it 
is important to highlight that Salmonella and E. coli encode six and nine 
CSPs, respectively. Besides, all the remaining CSPs appear to have 
different biological roles (Xia et al., 2001; Michaux et al., 2017). This 
suggests that a few amino acids can dictate CSP target specificity and 
ultimately define particular biological functions for them. Our research 
supports this notion showing that, although S. aureus CSPs display a very 
close sequence identity, CspA function could not be replaced by paralogs 
CspB and CspC in vivo (Fig. 6). Generation of chimeric CSPs indicated 
that the elements responsible for target specificity may be encoded in the 
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carboxi-half region of the protein, comprising in b-strands 4 and 5 and 
excluding the amino acidic loop connecting motifs RNP1 and RNP2 (Fig. 
8). When comparing S. aureus CSP protein sequences, and more 
specifically the carboxi-half we found position 58 to be different for all 
three paralogs. In the case of CspA it was a proline (P58), which seemed 
relevant since it was located in b-strand 4 and, from a three-dimensional 
perspective, in front of RNP1 and RNP2. Moreover, P58 is conserved in 
CspC and CspE of E. coli and in CspB of B. subtilis (BsCspB), which 
shares a 76.9% of identity with S. aureus CspA. For this reason, we 
constructed a plasmid expressing BsCspB to complement the S. aureus 
cspA mutant strain. Unfortunately, STX production could not be restored 
(data not shown), indicating that probably a combination of amino acids is 
what determines CSP functional specificity. We are currently performing 
new chimeras that might help us identifying such amino acids. 
In summary, our results are in agreement with the idea of independent 
regulons for each of S. aureus CSPs. However, identifying the amino 
acids that dictate CspA differential binding as well as CspB and CspC 
RNA targets is a future requirement for understanding CSPs target 
specificity. 
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CspA is a global regulator in S. aureus 
 
The regulon of S. aureus CspA unveiled here includes more than two 
hundred potential direct RNA targets, presenting it as a global post-
transcriptional regulator. The data was loaded into a public web server 
(http://rnamaps.unavarra.es/), which allows any user to quickly look for 
CspA-binding signals on selected genes.  
Restricting the identification of CspA targets to only those appearing in 
both peak-calling methods (thresholding by TAS and CisGenome) may 
somehow have underestimated the number of CspA targets shown in 
Annex II. Besides, the proteomic analysis was only able to detect about 
45% of S. aureus proteins, making it reasonable to argue that CspA 
possibly controls the expression of more proteins than those presented 
here (Annex I). Nevertheless, it is noteworthy that several of the targets 
that we identified, such as the alternative sigma factor B (SigB), the 
DEAD-box RNA helicase, specific ribosomal proteins, superoxide 
dismutase and other stress-associated proteins, have been previously 
related to CSP regulation in other bacteria (Tanaka et al., 2012; Michaux 
et al., 2012). 
We showed that deletion of the cspA gene produced significant changes 
on the protein expression of many genes (Annex I) that could be 
correlated with relevant phenotypic changes. Increased bacterial 
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aggregation, most likely due to an increase in PNAG biosynthesis, and 
impaired resistance to oxidative stress are good examples of this (Fig. 11). 
These observations indicated that CspA is required for S. aureus to adapt 
to different environmental niches. It also supports the idea that CspA may 
recognise targets from specific functional groups, as the GO term 
enrichment analysis revealed (Fig. 10). This made us wonder if such bias 
was also true sequence-wise, by recognizing specific RNA nucleotide 
patterns. However, analysis of CspA binding regions showed that CspA 
had no preference for a particular region among the putative targets. 
Failing to find a consensus sequence for CspA may be explained by the 
fact that cold shock domains bind short nucleotide regions, which have 
been estimated to be around 5-7 nt (Lopez et al., 1999; Sachs et al., 
2012). It could also be speculated that the position of the peaks detected 
by peak-calling may not correspond to the initial binding sites of CspA but 
just be indicative of the region where CspA was placed at the moment of 
the RIP assay. In agreement with this, the position of the binding peak on 
the cspC mRNA did not correlate with the results of the EMSAs (Fig 15A 
and 17C). Additionally, since sRNAs were identified in the RIP-chip 
analysis, we cannot exclude that some of the peaks were indirectly 
originated by pulling down mRNA targets of those sRNAs. Regardless, 
categorization of the differentially expressed targets suggested that CspA 
binds to transcripts that may be functionally related (Fig. 10). Thus, there 
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might be a common pattern (RNA sequence, RNA structure or a 
combination of both) for CspA targets that still needs to be identified.  
Based on previous studies, it is reasonable to expect regulatory elements 
that specifically impair translation efficiency in CspA up-regulated targets 
(Kudla et al., 2009; Pop et al., 2014). Recently, deep sequencing-based 
ribosome profiling analysis have been performed in S. aureus (Davis et al., 
2014; Basu and Yap, 2016). Ribosome-protected footprints (RPFs) placed 
at certain positions can be an indicator of ribosome-stalling sites. In 
contrast, RPFs distributed across a particular transcript implies that the 
mRNA is actively translated. To check if CspA targets contain stalling 
signals, we examined the already available RPF data (Davis et al., 2014; 
Basu and Yap, 2016). Interestingly, we found that several positively 
regulated CspA targets contained RPFs signals, which could represent 
putative ribosome-stalling sites. To gain a deeper insight, we looked for 
the presence of stem-loop structures at the RPF locations using the Mfold 
software (Zuker, 2003). Some of the targets contained predicted 
secondary structures in RPF surroundings (Fig. 25). Given such 
coincidence, one could hypothesize that S. aureus CspA may enhance 
translation by disrupting the mentioned secondary structures, an idea that 
was previously explored in other bacteria like E. coli in cold shock 
conditions (Phadtare and Severinov, 2010).  
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Figure 25. Putative ribosome stalling structures. M-fold predictions of RNA secondary 
structures in CspA directly regulated mRNAs that presented RFPs, as previously 
described (see text for details).  
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Since S. aureus CspA cannot be considered as part of the cold shock 
regulon (it is a non-cold-induced CSP), it would rather act on mRNA 
structures that are formed at the optimal growing temperature. 
Nevertheless, further investigations are required to demonstrate that the 
RNA secondary structures present in CspA targets are able to stall 
ribosomes, impair translation in vivo and susceptible to melting by 
interaction with CspA.  
Considering this idea, ribosome-profiling maps in the DcspA strain would 
prove useful for verifying an enrichment in RPFs in those CspA targets 
whose expression is decreased in its absence. Alternatively, CspA binding 
might impair mRNA degradation by changing the susceptibility to 
ribonucleases and, as a result, increase translation (Bonnin and Bouloc, 
2015). 
 
CspA is able to repress gene expression by different mechanisms  
 
The ability of CspA to reduce the expression of some of its putative targets 
opened the possibility to new regulatory mechanisms other than 
translation enhancement. For this reason, we focused on analysing more 
extensively how CspA binding could repress gene expression.  
In the case of CspC, the post-transcriptional repression did not imply 
variations in the mRNA levels (Fig. 18), indicating that the molecular mode 
of action might be related to the translation process. This was supported 
Discussion 	
	 163 
by in vitro translation experiments, which showed that the cpsC3xFLAG 
mRNA was poorly translated in the presence of CspA. It could be 
speculated that CspA interferes with the translation process by binding the 
5’UTR, as the EMSAs indicated (Fig. 17), and blocks the access to the 
ribosome. However, further experiments are required to demonstrate the 
precise mechanism of regulation. 
Regarding CspA repression, the mode of action seems to have different 
implications than those observed for CspC. Here, we propose an auto-
regulatory mechanism in which a U-rich motif, located in the hairpin of S. 
aureus cspA 5’UTR, seems of importance for CspA to bind its own mRNA 
and regulate its own expression. In principle, the interaction between 
CspA and the cspA mRNA would either disrupt the RNA loop or 
allosterically avoid RNase III binding. The molecular beacon experiment 
suggests that the first possibility is true (Fig. 23). However, since CspA 
targets the RNase III cleavage site, the second possibility cannot be totally 
excluded. Regardless of the precise mechanism of action, the 
consequence would be a lack of processing of the cspA mRNA, favouring 
a less translated form. In contrast, a lack of interaction between CspA and 
the stem loop, would allow RNase III to cleave it and generate a shorter 
cspA mRNA. The resulting processed mRNA would present a more 
efficiently translated conformation (Lioliou et al., 2012). In summary, CspA 
would also be acting as a translation inhibitor for its own mRNA but 
through a different mechanism to the one adopted for regulating CspC.  
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Model of CspA auto-regulation 
 
One could easily imagine the CspA auto-regulagtory mechanism as a way 
to sense the intracellular levels of CspA, in which sufficient concentration 
of the protein would eventually trigger the proposed mechanism (Fig. 26). 
This hypothetical model is in agreement with the results shown in Figure 
24 that demonstrate how the mutations of the cspA 5’UTR, which 
eliminated the U-rich motif but restored the stem-loop, did not significantly 
affect CspA expression. Remarkably, the U stretch is located in the 
denominated proximal-box (PB) of the hairpin, affecting the catalytic 
activity of RNase III (Pertzev, 2006).  
The fact that CspA3xFLAG protein levels in the DrncDcspA double mutant 
were slightly higher than in the WT and Drnc strains indicated that CspA 
might also repress its own expression in the non-processed mRNA (Fig. 
20D). Although further investigation is needed, this might act as an 
additional mechanism to ensure CspA repression. For this reason, the 
presence of other factors in the cspA locus, such as another promoter 
located upstream of the precedent CDS (which generates a bicistronic 
transcript that includes cspA) and an antisense RNA, must also be 
considered (Lioliou et al., 2012; Sahukhal and Elasri, 2014; Uppalapati et 
al., 2017). In this study, we only contemplated the cspA monocytronic 
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transcript as a template for designing plasmid constructs since, according 
to our transcriptomic data (http://rnamaps.unavarra.es/), it was the 
predominant form. While this was sufficient to show a relevant self-
regulatory role for CspA through its 5’UTR, we cannot exclude that CspA 
may also interact with the other transcripts mentioned above. Overall, 
these evidences highlight that a refined regulation is of importance for 
maintaining the proper levels of one of the most abundant staphylococcal 
proteins.   
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Figure 26. Model of the putative CspA auto-regulatory mechanism. Representation 
showing the stem-loop at the 5’UTR of cspA mRNA, which is targeted by RNase III. If 
newly transcribed cspA mRNA encounters low levels of CspA protein, RNase III can 
process its hairpin. The processed cspA mRNA may change its conformation allowing 
CspA translation. In contrast, if the levels of CspA protein are sufficient, it can target the 
U-rich region from the 5’ UTR hairpin and disrupt the secondary structure. As a result, 
RNase III processing is compromised, hindering CspA translation. This model proposes a 
regulatory mechanism in which CspA acts as an antagonist element of the RNase III 
activity by melting the RNA double-stranded structure targeted by it.  
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Could CspA be an antagonist of RNase III activity? 
 
The ability of CspA to interfere with RNase III activity made us wonder if 
the observed antagonist effect of both proteins could be a generalized 
mechanism. Lioliou and colleagues have already mapped the RNAs 
recognised by RNase III in S. aureus (Lioliou et al., 2012). Therefore, we 
correlated the list of targets of both proteins and found that RNase III 
processed up to 80% of the mRNAs bound by CspA. Such a high overlap 
between both datasets suggested a putative antagonist function between 
CspA and RNase III, in which the former would act by disrupting the RNA 
structures targeted by the latter. Although this hypothesis seems plausible 
it deserves further investigation before making it a general assumption. 
 
Regulatory specialization through specific RNA-elements and RBPs  
 
In summary, the differences in both repressive regulatory processes 
supported the idea that post-transcriptional control of gene expression 
depends on the specific regulatory RNA elements located in each mRNA. 
Such elements can be modified by RBPs, like CspA, and consequently 
translation and/or stability of mRNA might change. The presence of 
different RNA regulatory elements could explain why bacteria need 
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several copies of different RBPs (e.g. many bacterial genomes contain 
more than one variant of CSPs, RNA helicases, S1 proteins).  
From a general point of view, some paralogs may have the same 
biological function, however, the fact that most of them recognize different 
RNA targets shows a certain specialization for CSPs in bacteria. 
Discovering that RNA chaperones like S. aureus CspA target RNA 
structures recognized by other RBPs, opens new ways for understanding 
how CSPs modulate protein expression. This suggests that the nature of 
the RNA regulatory elements present in each gene and the way in which 
the different RBPs interact with them are key factors that determine the 
fate of protein expression and, ultimately, safeguard the correct 
development of every organism. 
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CONCLUSIONS 
 
1) S. aureus CSPs share a high percentage of identity. However, despite 
being expressed in comparable amounts, only CspA is able to 
complement staphyloxanthin production in a ∆cspA strain, indicating 
different biological functions for each of them.  
2) Complementation studies of the staphyloxanthin production in a ∆cspA 
strain, using different CSP chimeric proteins, suggests that the amino 
acidic differences in the carboxi-half of the proteins might determine 
the functional specificity of S. aureus CSPs.  
3) S. aureus CSPs expression is differentially regulated at the post-
transcriptional level, possibly through their untranslated regions. 
4) Identification of the CspA regulon portrays this chaperone as a global 
gene expression regulator, mainly of genes related to metabolism, 
virulence and stress response. Therefore, deletion of the cspA gene 
generates evident phenotypic variations such as an increase in 
cellular aggregation and a defect in coping with oxidative stress 
agents.  
5) CspA represses CspC translation upon binding the 5’UTR of the cspC 
mRNA, possibly by masking the RBS and without affecting its mRNA 
levels. 
Conclusions 	
	174 
6) CspA represses its own expression by binding a U-rich motif, located 
in a stem-loop of its 5’UTR. This RNA structure is also targeted and 
cleaved by RNase III in order to improve mRNA translation.  
7) The interaction of CspA with a molecular beacon, which mimics the 
targeted stem-loop, increases fluorescence emission. This indicates 
that CspA is be able to disrupt such double-stranded structure in vitro 
and, possibly, prevent RNase III processing in vivo. 
8) Mutations that eliminate the U-rich motif while preserving the 
secondary structure of the cspA 5’UTR stem-loop, confirm that such 
motif is necessary for CspA auto-regulation in vivo. 
9) The interaction of CspA with a stem-loop, which is also targeted by 
RNase III, suggests a functional antagonism between both RBPs that 
could apply to other RNase III targets. 
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CONCLUSIONES 
1) Las CSPs de S. aureus tienen un alto porcentaje de identidad entre 
ellas. Sin embargo, y a pesar de expresarlas en cantidades similares, 
sólo CspA es capaz de complementar la producción de estafiloxantina 
en una cepa ∆cspA, indicando así una diferencia funcional entre las 
mismas.  
2) Los estudios de complementación de la producción de estafiloxantina 
en una cepa ∆cspA, con distintas quimeras de CSPs, sugieren que las 
diferencias amino acídicas localizadas en la mitad carboxi-terminal de 
la proteína determinan la especificidad funcional de las CSPs de S. 
aureus.   
3) La expresión de las CSPs de S. aureus se encuentra diferencialmente 
regulada a nivel post-transcripcional, probablemente a través de sus 
regiones no traducidas.  
4) La identificación del regulón muestra a CspA como un regulador global 
de la expresión en S. aureus, principalmente de genes relacionados 
con el metabolismo, la virulencia y la respuesta al estrés. Por ello, la 
deleción del gen produce cambios fenotípicos evidentes como un 
aumento en la agregación celular y una disminución en su capacidad 
para hacer frente a agentes oxidantes.  
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5) CspA reprime la traducción de CspC tras unirse a la 5’UTR del mRNA 
de cspC, posiblemente ocultando la zona de unión al ribosoma, sin 
afectar a los niveles de dicho mRNA. 
6) CspA reprime su propia expresión mediante la unión a un motivo rico 
en uridinas (U-rich), localizado en una horquilla de RNA de su propia 
5’UTR. Esta horquilla es diana para el procesamiento del mRNA de 
cspA por RNase III, que es necesario para mejorar su traducción. 
7) La interacción de CspA con una baliza molecular que imita a la 
horquilla de RNA, produce un aumento en la emisión de fluorescencia. 
Esto indica que CspA deshace esta estructura de doble cadena in vitro 
y posiblemente pueda evitar el corte por RNase III in vivo. 
8) Las mutaciones que eliminan el motivo U-rich, pero que preservan la 
estructura de la horquilla presente en la 5’UTR de cspA, confirman que 
dicho motivo es necesario para la auto-regulación de la expresión de 
CspA in vivo.  
9) La interacción de CspA con una estructura de RNA, que también es 
reconocida por RNase III, sugiere un antagonismo funcional entre 
ambas RBPs que podría ser extensible a otras dianas de RNasa III.  
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Annex I. Results of comparative label-free LC-MS-based proteomics. Up- and down-
regulated proteins with a fold change ratio (∆cspA vs WT) higher than 2 and a P-value 
lower than 0.05 are included. Colored rows show proteins encoded by CspA-targeted 
transcripts. Specifically, yellow rows highlight proteins in which the CspA-binding peak 
was nearby or included in the CDS. Orange rows indicate proteins encoded by 
polycistronic transcripts, where the CspA-binding peak was not contained in the CDS. 
The red row emphasizes CspA, which is deleted in the ∆cspA strain. The shown gene IDs 
correspond to S. aureus NCTC 8325. 
 
Gene	ID	 Fold	change	 Anova	(p)	 PATRIC	Description	
SAOUHSC_01255	 Down	 0,027	 Zinc	protease	
SAOUHSC_00615	 Down	 0,005	 5'-nucleotidase	YjjG	(EC	3.1.3.5)	
SAOUHSC_00702	 Down	 0,000	 Hypothetical	protein	(FIG01108024)	
SAOUHSC_00734	 Down	 0,000	 Putative	5'(3')-deoxyribonucleotidase	(EC	3.1.3.-)	
SAOUHSC_00996	 -1210,0	 0,000	 Hypothetical	protein	(FIG01108206)	
SAOUHSC_02409	 -122,0	 0,000	 Arginase	(EC	3.5.3.1)	
SAOUHSC_01403	 -43,9	 0,000	 Cold	shock	protein	CspA	
SAOUHSC_02239	 -32,8	 0,000	 Phage	integrase	
SAOUHSC_02355	 -30,7	 0,008	 Hypothetical	protein	
SAOUHSC_01592	 -24,1	 0,032	 Ferric	uptake	regulation	protein	FUR	
SAOUHSC_02460	 -23,0	 0,000	 oxidoreductase,	aldo/keto	reductase	family	
SAOUHSC_00051	 -22,9	 0,037	 Phosphatidylinositol-specific	phospholipase	C	(EC	4.6.1.13)	
SAOUHSC_01420	 -15,5	 0,002	 Response	regulator	ArlR	
SAOUHSC_00239	 -10,2	 0,015	 Ribokinase	(EC	2.7.1.15)	
SAOUHSC_00890	 -9,8	 0,002	 Hypothetical	protein	(FIG01107890)	
SAOUHSC_00755	 -8,4	 0,018	 FIG01108099:	hypothetical	protein	
SAOUHSC_02651	 -8,2	 0,001	 acetyltransferase,	GNAT	family	
SAOUHSC_02441	 -7,8	 0,000	 Alkaline	shock	protein	23	
SAOUHSC_00552	 -7,7	 0,006	 Glucosamine-6-phosphate	deaminase	(EC	3.5.99.6)	
SAOUHSC_01988	 -7,2	 0,004	 tRNA	(cytidine(34)-2'-O)-methyltransferase	(EC	2.1.1.207)	
SAOUHSC_00475	 -7,1	 0,030	 Peptidyl-tRNA	hydrolase	(EC	3.1.1.29)	
SAOUHSC_02899	 -6,7	 0,001	 Hypothetical	protein	(FIG01108025)	
SAOUHSC_01008	 -6,2	 0,003	 Phosphoribosylaminoimidazole	carboxylase	catalytic	subunit	(EC	4.1.1.21)	
SAOUHSC_02778	 -6,2	 0,001	 Oxidoreductase,	short-chain	dehydrogenase/reductase	family	
SAOUHSC_01012	 -6,2	 0,007	 Phosphoribosylformylglycinamidine	synthase,	glutamine	amidotransferase	subunit	
SAOUHSC_01870	 -5,8	 0,016	 Ribosomal	small	subunit	pseudouridine	synthase	A	(EC	4.2.1.70)	
SAOUHSC_00556	 -5,4	 0,034	 L-Proline/Glycine	betaine	transporter	ProP	
SAOUHSC_01158	 -5,2	 0,000	 Cell	division	initiation	protein	DivIVA	
SAOUHSC_00720	 -5,2	 0,000	 Queuosine	biosynthesis	QueD,	PTPS-I	
SAOUHSC_01248	 -5,1	 0,028	 tRNA	pseudouridine	synthase	B	(EC	4.2.1.70)	
SAOUHSC_01174	 -5,0	 0,034	 Hypothetical	protein	(FIG01107914)	
SAOUHSC_00342	 -4,9	 0,015	 Chromosome	(plasmid)	partitioning	protein	ParB	
SAOUHSC_02150	 -4,8	 0,001	 Thioredoxin	
SAOUHSC_02013	 -4,6	 0,000	 ThiJ/PfpI	family	protein	
SAOUHSC_02403	 -4,4	 0,002	 Mannitol-1-phosphate	5-dehydrogenase	(EC	1.1.1.17)	
SAOUHSC_02542	 -4,4	 0,003	 Molybdopterin	biosynthesis	protein	MoeA	
SAOUHSC_01015	 -4,3	 0,014	 Phosphoribosylformylglycinamidine	cyclo-ligase	(EC	6.3.3.1)	
SAOUHSC_02357	 -4,3	 0,005	 Sua5	subfamily,	required	for	N6-threonylcarbamoyl	adenosine	t(6)A37	modification	in	
tRNA	
SAOUHSC_01593	 -4,2	 0,001	 ADP-ribose	pyrophosphatase	(EC	3.6.1.13)	
SAOUHSC_00553	 -4,1	 0,001	 D-arabino-3-hexulose	6-phosphate	formaldehyde	lyase	
SAOUHSC_01010	 -4,0	 0,005	 Phosphoribosylaminoimidazole-succinocarboxamide	synthase	(EC	6.3.2.6)	
SAOUHSC_02976	 -3,9	 0,034	 Mannose-6-phosphate	isomerase	(EC	5.3.1.8)	
SAOUHSC_02900	 -3,7	 0,000	 Predicted	hydrolase/acyltransferase	
SAOUHSC_01456	 -3,7	 0,009	 Uncharacterized	iron-regulated	membrane	protein;	Iron-uptake	factor	PiuB	
SAOUHSC_02536	 -3,6	 0,030	 Molybdenum	cofactor	biosynthesis	protein	MoaA	
SAOUHSC_01009	 -3,6	 0,008	 Phosphoribosylaminoimidazole	carboxylase	ATPase	subunit	(EC	4.1.1.21)	
SAOUHSC_02860	 -3,5	 0,000	 Hydroxymethylglutaryl-CoA	synthase	(EC	2.3.3.10)	
SAOUHSC_02366	 -3,5	 0,000	 Fructose-bisphosphate	aldolase	class	II	(EC	4.1.2.13)	
SAOUHSC_01139	 -3,4	 0,020	 unknown	conserved	protein	in	B.	subtilis	
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Gene	ID	 Fold	change	 Anova	(p)	 PATRIC	Description	
SAOUHSC_02434	 -3,3	 0,007	 Siderophore	synthetase	superfamily,	group	B	
SAOUHSC_00875	 -3,2	 0,005	 NADH	dehydrogenase	(EC	1.6.99.3)	
SAOUHSC_01198	 -3,2	 0,000	 Malonyl	CoA-acyl	carrier	protein	transacylase	(EC	2.3.1.39)	
SAOUHSC_01597	 -3,2	 0,013	 Pyrroline-5-carboxylate	reductase	(EC	1.5.1.2)	
SAOUHSC_02091	 -3,2	 0,005	 Acyl-CoA	hydrolase	(EC	3.1.2.20)	
SAOUHSC_01621	 -3,1	 0,004	 Transcription	termination	protein	NusB	
SAOUHSC_01250	 -3,1	 0,010	 SSU	ribosomal	protein	S15p	(S13e)	
SAOUHSC_02298	 -3,1	 0,000	 RNA	polymerase	sigma	factor	SigB	
SAOUHSC_00946	 -3,1	 0,004	 Na+/H+	antiporter	
SAOUHSC_02631	 -3,1	 0,001	 TetR	family	regulatory	protein	of	MDR	cluster	
SAOUHSC_00019	 -3,1	 0,012	 Adenylosuccinate	synthetase	(EC	6.3.4.4)	
SAOUHSC_01706	 -3,1	 0,000	 Hypothetical	protein	(FIG01108267)	
SAOUHSC_02961	 -3,0	 0,017	 Transcriptional	regulator,	MarR	family	
SAOUHSC_00554	 -3,0	 0,001	 6-phospho-3-hexuloisomerase	
SAOUHSC_00696	 -3,0	 0,016	 Hypothetical	protein	(FIG01108122)	
SAOUHSC_01452	 -3,0	 0,038	 Alanine	dehydrogenase	(EC	1.4.1.1)	
SAOUHSC_01858	 -3,0	 0,001	 Phenylalanyl-tRNA	synthetase	domain	protein	(Bsu	YtpR)	
SAOUHSC_01786	 -2,9	 0,004	 Translation	initiation	factor	3	
SAOUHSC_00865	 -2,9	 0,001	 Hypothetical	NagD-like	phosphatase	
SAOUHSC_01606	 -2,9	 0,004	 Peptidase	T	(EC	3.4.11.4)	
SAOUHSC_01869	 -2,9	 0,000	 Hypothetical	protein	
SAOUHSC_02774	 -2,9	 0,001	 Hypothetical	protein	(FIG01108532)	
SAOUHSC_02436	 -2,9	 0,018	 Uncharacterized	siderophore	biosynthesis	protein		
SAOUHSC_01323	 -2,9	 0,001	 Hydrolase	(HAD	superfamily)	
SAOUHSC_01199	 -2,9	 0,000	 3-oxoacyl-[acyl-carrier	protein]	reductase	(EC	1.1.1.100)		
SAOUHSC_02381	 -2,8	 0,000	 Iron-binding	ferritin-like	antioxidant	protein	/	Ferroxidase	(EC	1.16.3.1)	
SAOUHSC_02859	 -2,8	 0,000	 Hydroxymethylglutaryl-CoA	reductase	(EC	1.1.1.34)	
SAOUHSC_01092	 -2,8	 0,047	 Phenylalanyl-tRNA	synthetase	alpha	chain	(EC	6.1.1.20)	
SAOUHSC_02581	 -2,8	 0,002	 Hypothetical	protein	similar	to	YrhD	
SAOUHSC_01189	 -2,8	 0,005	 Ribulose-phosphate	3-epimerase	(EC	5.1.3.1)	
SAOUHSC_02276	 -2,8	 0,000	 MutS-related	protein,	family	1	
SAOUHSC_00613	 -2,8	 0,000	 Vitamin	B12	ABC	transporter,	B12-binding	component	BtuF	
SAOUHSC_02527	 -2,8	 0,005	 tRNA-dependent	lipid	II--glycine	ligase	(FmhB)	
SAOUHSC_01818	 -2,7	 0,014	 Alanine	dehydrogenase	(EC	1.4.1.1)	
SAOUHSC_01014	 -2,7	 0,009	 Amidophosphoribosyltransferase	(EC	2.4.2.14)	
SAOUHSC_01018	 -2,7	 0,014	 Phosphoribosylamine--glycine	ligase	(EC	6.3.4.13)	
SAOUHSC_00644	 -2,7	 0,000	 Teichoic	acid	biosynthesis	protein	X	
SAOUHSC_00940	 -2,7	 0,003	 Adenylate	cyclase	
SAOUHSC_01013	 -2,7	 0,022	 Phosphoribosylformylglycinamidine	synthase,	synthetase	subunit	(EC	6.3.5.3)	
SAOUHSC_02335	 -2,7	 0,031	 Hypothetical	protein	
SAOUHSC_02501	 -2,6	 0,004	 LSU	ribosomal	protein	L24p	(L26e)	
SAOUHSC_01166	 -2,6	 0,008	 Aspartate	carbamoyltransferase	(EC	2.1.3.2)	
SAOUHSC_01385	 -2,6	 0,000	 Phosphate	transport	ATP-binding	protein	PstB	(TC	3.A.1.7.1)	
SAOUHSC_02908	 -2,6	 0,000	 Ribulosamine/erythrulosamine	3-kinase	potentially	involved	in	protein	deglycation	
SAOUHSC_00309	 -2,6	 0,002	 Hypothetical	protein	(FIG01108282)	
SAOUHSC_01017	 -2,6	 0,055	 IMP	cyclohydrolase	(EC	3.5.4.10)		
SAOUHSC_01007	 -2,6	 0,034	 Methylenetetrahydrofolate	dehydrogenase	(NADP+)	(EC	1.5.1.5)		
SAOUHSC_02754	 -2,6	 0,003	 YbbL	ABC	transporter	ATP-binding	protein	
SAOUHSC_00454	 -2,6	 0,024	 DNA	polymerase	III	delta	prime	subunit	(EC	2.7.7.7)	
SAOUHSC_01138	 -2,6	 0,000	 Uncharacterized	N-acetyltransferase	BT9727_3663	(EC	2.3.1.-)	
SAOUHSC_01773	 -2,6	 0,010	 Uroporphyrinogen-III	synthase	(EC	4.2.1.75)	
SAOUHSC_01365	 -2,6	 0,006	 Deblocking	aminopeptidase	(EC	3.4.11.-)	
SAOUHSC_00436	 -2,5	 0,014	 Glutamate	synthase	[NADPH]	small	chain	(EC	1.4.1.13)		
SAOUHSC_01802	 -2,5	 0,029	 Citrate	synthase	(si)	(EC	2.3.3.1)	
SAOUHSC_01795	 -2,5	 0,009	 Dephospho-CoA	kinase	(EC	2.7.1.24)	
SAOUHSC_01330	 -2,5	 0,011	 GMP	reductase	(EC	1.7.1.7)	
SAOUHSC_00794	 -2,5	 0,002	 Central	glycolytic	genes	regulator	
SAOUHSC_00017	 -2,5	 0,006	 LSU	ribosomal	protein	L9p	
SAOUHSC_00153	 -2,5	 0,005	 Pyruvate	decarboxylase	(EC	4.1.1.1);	Alpha-keto-acid	decarboxylase	(EC	4.1.1.-)	
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Gene	ID	 Fold	change	 Anova	(p)	 PATRIC	Description	
SAOUHSC_01376	 -2,5	 0,002	 Hypothetical	protein	(FIG01108123)	
SAOUHSC_01987	 -2,5	 0,000	 Hypothetical	protein	(FIG001583),	contains	S4-like	RNA	binding	domain	
SAOUHSC_00574	 -2,5	 0,001	 Phosphate	acetyltransferase	(EC	2.3.1.8)	
SAOUHSC_01961	 -2,5	 0,000	 Ferrochelatase,	protoheme	ferro-lyase	(EC	4.99.1.1)	
SAOUHSC_01702	 -2,5	 0,001	 5'-methylthioadenosine	nucleosidase	(EC	3.2.2.16)		
SAOUHSC_01749	 -2,5	 0,005	 S-adenosylmethionine:tRNA	ribosyltransferase-isomerase	(EC	5.-.-.-)	
SAOUHSC_02566	 -2,5	 0,001	 Transcriptional	regulator	SarR	(Staphylococcal	accessory	regulator	R)	
SAOUHSC_01398	 -2,4	 0,042	 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate	N-acetyltransferase	(EC	2.3.1.89)	
SAOUHSC_01695	 -2,4	 0,002	 Hypothetical	protein	
SAOUHSC_00487	 -2,4	 0,003	 Chaperonin	(heat	shock	protein	33)	
SAOUHSC_01969	 -2,4	 0,007	 Hypothetical	protein	(FIG001583),	contains	S4-like	RNA	binding	domain	
SAOUHSC_02380	 -2,4	 0,004	 Purine	nucleoside	phosphorylase	(EC	2.4.2.1)	
SAOUHSC_00520	 -2,4	 0,010	 LSU	ribosomal	protein	L10p	(P0)	
SAOUHSC_01810	 -2,4	 0,006	 NADP-dependent	malic	enzyme	(EC	1.1.1.40)	
SAOUHSC_02316	 -2,4	 0,002	 Cold-shock	DEAD-box	protein	A	
SAOUHSC_01415	 -2,4	 0,000	 Hypothetical	protein	(FIG01107869)	
SAOUHSC_00024	 -2,4	 0,011	 Zn-dependent	hydrolase	(beta-lactamase	superfamily)	
SAOUHSC_00469	 -2,4	 0,000	 Protein	of	unknown	function	identified	by	role	in	sporulation	(SpoVG)	
SAOUHSC_01156	 -2,4	 0,005	 Hypothetical	protein	(FIG001583),	contains	S4-like	RNA	binding	domain	
SAOUHSC_01016	 -2,4	 0,028	 Phosphoribosylglycinamide	formyltransferase	(EC	2.1.2.2)	
SAOUHSC_01107	 -2,4	 0,003	 Nucleoside	5-triphosphatase	RdgB	(dHAPTP,	dITP,	XTP-specific)	(EC	3.6.1.15)	
SAOUHSC_00893	 -2,4	 0,009	 Putative	NADH-dependent	flavin	oxidoreductase	
SAOUHSC_01886	 -2,4	 0,010	 6,7-dimethyl-8-ribityllumazine	synthase	(EC	2.5.1.78)	
SAOUHSC_00906	 -2,4	 0,006	 Fumarylacetoacetate	hydrolase	family	protein	
SAOUHSC_02544	 -2,3	 0,000	 Molybdenum	cofactor	biosynthesis	protein	MoaB	
SAOUHSC_01214	 -2,3	 0,028	 50S	ribosomal	subunit	maturation	GTPase	RbgA	(B.	subtilis	YlqF)	
SAOUHSC_01614	 -2,3	 0,000	 Dihydrolipoamide	dehydrogenase	of	branched-chain	alpha-keto	acid	dehydrogenase		
SAOUHSC_00336	 -2,3	 0,014	 3-ketoacyl-CoA	thiolase	(EC	2.3.1.16)	@	Acetyl-CoA	acetyltransferase	(EC	2.3.1.9)	
SAOUHSC_01314	 -2,3	 0,008	 Two-component	response	regulator	
SAOUHSC_01771	 -2,3	 0,002	 Glutamate-1-semialdehyde	aminotransferase	(EC	5.4.3.8)	
SAOUHSC_02447	 -2,3	 0,002	 Putative	oxidoreductase	YncB	
SAOUHSC_00879	 -2,3	 0,001	 Cytosol	aminopeptidase	PepA	(EC	3.4.11.1)	
SAOUHSC_02043	 -2,3	 0,029	 Phage	head	protein	[SA	bacteriophages	11,	Mu50B]	/	Phage	major	capsid	protein		
SAOUHSC_00533	 -2,3	 0,000	 chaperone	protein	HchA	
SAOUHSC_02490	 -2,3	 0,001	 Adenylate	kinase	(EC	2.7.4.3)	
SAOUHSC_00920	 -2,3	 0,001	 3-oxoacyl-[acyl-carrier-protein]	synthase,	KASIII	(EC	2.3.1.41)		
SAOUHSC_02512	 -2,3	 0,017	 LSU	ribosomal	protein	L3p	(L3e)	
SAOUHSC_01821	 -2,3	 0,000	 Adenine-specific	methyltransferase	(EC	2.1.1.72)	
SAOUHSC_01977	 -2,3	 0,019	 Hypothetical	protein	
SAOUHSC_02299	 -2,2	 0,000	 Serine-protein	kinase	RsbW	(EC	2.7.11.1)	
SAOUHSC_00834	 -2,2	 0,015	 Thioredoxin	
SAOUHSC_00688	 -2,2	 0,000	 Lysine	decarboxylase	family	
SAOUHSC_00771	 -2,2	 0,021	 Peptide	chain	release	factor	2	
SAOUHSC_00942	 -2,2	 0,001	 GTP	pyrophosphokinase	(EC	2.7.6.5)	
SAOUHSC_00797	 -2,2	 0,000	 Triosephosphate	isomerase	(EC	5.3.1.1)	
SAOUHSC_01201	 -2,2	 0,002	 Acyl	carrier	protein	/	HmrB	protein	involved	in	methicillin	resistance	
SAOUHSC_02553	 -2,2	 0,008	 Inosine-uridine	preferring	nucleoside	hydrolase	(EC	3.2.2.1)	
SAOUHSC_00951	 -2,2	 0,001	 2H	phosphoesterase	superfamily	protein	similar	to	Bsu1186	(yjcG)	
SAOUHSC_03051	 -2,2	 0,004	 rRNA	small	subunit	7-methylguanosine	(m7G)	methyltransferase	GidB	
SAOUHSC_02659	 -2,2	 0,018	 Transcriptional	regulator,	TetR	family	
SAOUHSC_01632	 -2,1	 0,000	 Glycine	dehydrogenase	[decarboxylating]	(glycine	cleavage	system	P2	protein)	(EC	1.4.4.2)		
SAOUHSC_00517	 -2,1	 0,000	 Transcription	antitermination	protein	NusG	
SAOUHSC_01175	 -2,1	 0,018	 Fibronectin/fibrinogen-binding	protein	
SAOUHSC_02445	 -2,1	 0,010	 Bifunctional	protein:	zinc-containing	alcohol	dehydrogenase;	quinone	oxidoreductase		
SAOUHSC_02604	 -2,1	 0,001	 Dehydrogenase	
SAOUHSC_01055	 -2,1	 0,025	 Inositol-1-monophosphatase	(EC	3.1.3.25)	
SAOUHSC_00441	 -2,1	 0,000	 Acetyltransferase	(GNAT)	family	protein	
SAOUHSC_01958	 -2,1	 0,050	 Hypothetical	protein	
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SAOUHSC_02011	 -2,1	 0,023	 Regulatory	protein	RecX	
SAOUHSC_01617	 -2,1	 0,019	 Arginine	pathway	regulatory	protein	ArgR,	repressor	of	arg	regulon	
SAOUHSC_00756	 -2,1	 0,035	 Glycerate	kinase	(EC	2.7.1.31)	
SAOUHSC_01634	 -2,1	 0,014	 Aminomethyltransferase	(glycine	cleavage	system	T	protein)	(EC	2.1.2.10)	
SAOUHSC_01822	 -2,1	 0,006	 Thiol	peroxidase,	Tpx-type	(EC	1.11.1.15)	
SAOUHSC_01203	 -2,1	 0,000	 Ribonuclease	III	(EC	3.1.26.3)	
SAOUHSC_01845	 -2,1	 0,015	 Formate--tetrahydrofolate	ligase	(EC	6.3.4.3)	
SAOUHSC_01983	 -2,1	 0,027	 Fumarate	hydratase	class	II	(EC	4.2.1.2)	
SAOUHSC_01172	 -2,1	 0,007	 Orotate	phosphoribosyltransferase	(EC	2.4.2.10)	
SAOUHSC_02377	 -2,1	 0,008	 Pyrimidine-nucleoside	phosphorylase	(EC	2.4.2.2)	
SAOUHSC_01879	 -2,1	 0,028	 Repressor	of	toxins	Rot	
SAOUHSC_02146	 -2,1	 0,028	 Choloylglycine	hydrolase	(EC	3.5.1.24)	
SAOUHSC_02912	 -2,1	 0,004	 Putative	DNA	binding	3-demethylubiquinone-9	3-methyltransferase	domain	protein	
SAOUHSC_02926	 -2,0	 0,000	 Fructose-bisphosphate	aldolase	class	I	(EC	4.1.2.13)	
SAOUHSC_02801	 -2,0	 0,000	 UTP--glucose-1-phosphate	uridylyltransferase	(EC	2.7.7.9)	
SAOUHSC_01168	 -2,0	 0,021	 Dihydroorotase	(EC	3.5.2.3)	
SAOUHSC_01653	 -2,0	 0,001	 Manganese	superoxide	dismutase	(EC	1.15.1.1);	Superoxide	dismutase	[Fe]	(EC	1.15.1.1)		
SAOUHSC_00894	 -2,0	 0,000	 Acetylornithine	aminotransferase	2	(EC	2.6.1.11)	
SAOUHSC_00244	 -2,0	 0,008	 Hypothetical	protein	(FIG01108649)	
SAOUHSC_01222	 -2,0	 0,023	 DNA	topoisomerase	I	(EC	5.99.1.2)	
SAOUHSC_00796	 -2,0	 0,000	 Phosphoglycerate	kinase	(EC	2.7.2.3)	
SAOUHSC_01839	 -2,0	 0,005	 Tyrosyl-tRNA	synthetase	(EC	6.1.1.1)	
SAOUHSC_01497	 -2,0	 0,000	 L-asparaginase	(EC	3.5.1.1)	
SAOUHSC_01812	 -2,0	 0,001	 3'-to-5'	oligoribonuclease	A,	Bacillus	type	(FIG146085)	
SAOUHSC_01644	 -2,0	 0,001	 Hydroxyacylglutathione	hydrolase	(EC	3.1.2.6)	
SAOUHSC_01501	 -2,0	 0,004	 Elastin	binding	protein	EbpS	
SAOUHSC_01267	 -2,0	 0,005	 2-oxoglutarate	oxidoreductase,	beta	subunit	(EC	1.2.7.3)	
SAOUHSC_01807	 -2,0	 0,000	 6-phosphofructokinase	(EC	2.7.1.11)	
SAOUHSC_00712	 -2,0	 0,002	 oxidoreductase	of	aldo/keto	reductase	family,	subgroup	1	
SAOUHSC_00480	 -2,0	 0,001	 Nucleoside	triphosphate	pyrophosphohydrolase	MazG	(EC	3.6.1.8)	
SAOUHSC_01038	 -2,0	 0,002	 Peptide	deformylase	(EC	3.5.1.88)	
SAOUHSC_01259	 -2,0	 0,018	 Hypothetical	protein	(FIG01108279)	
SAOUHSC_02812	 -2,0	 0,001	 Hypothetical	protein	(FIG01108416)	
SAOUHSC_01190	 -2,0	 0,002	 Thiamin	pyrophosphokinase	(EC	2.7.6.2)	
SAOUHSC_00462	 -2,0	 0,003	 Putative	deoxyribonuclease	YcfH	
SAOUHSC_01815	 -2,0	 0,002	 metal-dependent	hydrolase	(FIG146085)	
SAOUHSC_01121	 2,0	 0,027	 Alpha-hemolysin	precursor	
SAOUHSC_00135	 2,0	 0,002	 FIG01108032:	hypothetical	protein	
SAOUHSC_01919	 2,0	 0,023	 Hypothetical	protein	(FIG001583),	contains	S4-like	RNA	binding	domain	
SAOUHSC_02243	 2,0	 0,005	 Leukocidin	LukS-PV	
SAOUHSC_00608	 2,0	 0,006	 Alcohol	dehydrogenase	(EC	1.1.1.1)	
SAOUHSC_02629	 2,0	 0,051	 Membrane	component	of	multidrug	resistance	system	
SAOUHSC_00535	 2,0	 0,017	 L-threonine	3-dehydrogenase	(EC	1.1.1.103)	
SAOUHSC_01366	 2,1	 0,004	 Anthranilate	synthase,	aminase	component	(EC	4.1.3.27)	
SAOUHSC_00483	 2,1	 0,008	 S1	RNA	binding	domain	protein	
SAOUHSC_02442	 2,1	 0,024	 Hypothetical	protein	
SAOUHSC_02323	 2,1	 0,006	 Cardiolipin	synthetase	(EC	2.7.8.-)	
SAOUHSC_00258	 2,1	 0,008	 Putative	secretion	accessory	protein	EsaA/YueB	
SAOUHSC_02026	 2,2	 0,000	 Hypothetical	protein,	phi-ETA	orf58	homolog		
SAOUHSC_00691	 2,2	 0,018	 Undecaprenyl-diphosphatase	(EC	3.6.1.27)	
SAOUHSC_01455	 2,2	 0,003	 Uncharacterized	protein	similar	to	YpbR	
SAOUHSC_02756	 2,2	 0,016	 Hypothetical	protein	(FIG01108728)	
SAOUHSC_01342a	 2,3	 0,005	 Large-conductance	mechanosensitive	channel	
SAOUHSC_02580	 2,3	 0,042	 N-acetylmuramoyl-L-alanine	amidase	(EC	3.5.1.28)	/	Endo-beta-N-acetylglucosaminidase	
SAOUHSC_02611	 2,4	 0,008	 Hypothetical	protein	(FIG01108370)	
SAOUHSC_01809	 2,4	 0,005	 Acetyl-coenzyme	A	carboxyl	transferase	beta	chain	(EC	6.4.1.2)	
SAOUHSC_00808	 2,4	 0,001	 Hypothetical	SAV0808	homolog,	near	pathogenicity	islands	SaPI	att-site	
SAOUHSC_00481	 2,4	 0,018	 Ribosome-associated	heat	shock	protein	(S4	paralog)	
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SAOUHSC_00660	 2,4	 0,016	 Hypothetical	protein	(FIG01108275)	
SAOUHSC_02463	 2,5	 0,054	 Hyaluronate	lyase	precursor	(EC	4.2.2.1)	
SAOUHSC_02407	 2,5	 0,006	 Hypothetical	protein	similar	to	YbbP,	contains	nucleotide-binding	domain		
SAOUHSC_00429	 2,6	 0,001	 Hypothetical	protein	(FIG01107849)	
SAOUHSC_02698	 2,6	 0,020	 L-Cystine	ABC	transporter,	permease	protein	TcyB	
SAOUHSC_01002	 2,6	 0,006	 quinol	oxidase	polypeptide	II	QoxA	(EC:1.9.3.-)	
SAOUHSC_01680	 2,6	 0,020	 Ribosomal	RNA	small	subunit	methyltransferase	E	(EC	2.1.1.-)	
SAOUHSC_01796	 2,6	 0,022	 Formamidopyrimidine-DNA	glycosylase	(EC	3.2.2.23)	
SAOUHSC_01110	 2,7	 0,003	 Hypothetical	protein,	similarity	with	fibrinogen-binding	protein	Efb	
SAOUHSC_02571	 2,7	 0,013	 Secretory	antigen	precursor	SsaA	
SAOUHSC_00249	 2,7	 0,015	 ABC	transporter	ATP-binding	protein	
SAOUHSC_01633	 2,7	 0,002	 Glycine	dehydrogenase	[decarboxylating]	(glycine	cleavage	system	P1	protein)	(EC	1.4.4.2)		
SAOUHSC_01338	 2,7	 0,008	 alternate	gene	name:	yoxG	
SAOUHSC_01462	 2,7	 0,009	 Cell	division	protein	GpsB	
SAOUHSC_01838	 2,7	 0,001	 Serine	protease,	DegP/HtrA,	do-like	(EC	3.4.21.-)	
SAOUHSC_00069	 2,8	 0,038	 Protein	A,	von	Willebrand	factor	binding	protein	Spa	
SAOUHSC_02028	 2,8	 0,002	 Hypothetical	protein	(FIG01108548)	
SAOUHSC_02127	 2,8	 0,000	 Staphopain	A	precursor	(EC	3.4.22.48)	
SAOUHSC_01241	 2,9	 0,004	 DNA	polymerase	III	polC-type	(EC	2.7.7.7)	
SAOUHSC_00264	 2,9	 0,001	 EsaC	protein	within	ESAT-6	gene	cluster	
SAOUHSC_00256	 2,9	 0,002	 Secretory	antigen	precursor	SsaA	
SAOUHSC_00427	 2,9	 0,002	 Autolysin	precursor	
SAOUHSC_02706	 3,0	 0,000	 IgG-binding	protein	SBI	
SAOUHSC_00728	 3,0	 0,000	 Lipoteichoic	acid	synthase	LtaS	Type	Ib	
SAOUHSC_02839	 3,1	 0,007	 L-serine	dehydratase,	alpha	subunit	(EC	4.3.1.17)	
SAOUHSC_01183	 3,2	 0,000	 Methionyl-tRNA	formyltransferase	(EC	2.1.2.9)	
SAOUHSC_02816	 3,3	 0,014	 Alkaline	phosphatase	like	protein	
SAOUHSC_00648	 3,3	 0,013	 nucleoside	transport	protein	
SAOUHSC_01418	 3,3	 0,027	 2-oxoglutarate	dehydrogenase	E1	component	(EC	1.2.4.2)	
SAOUHSC_01714	 3,3	 0,019	 Transcription	elongation	factor	GreA	
SAOUHSC_01356	 3,4	 0,026	 Transcription	antiterminator	
SAOUHSC_02029	 3,5	 0,042	 Putative	major	teichoic	acid	biosynthesis	protein	C	
SAOUHSC_02680	 3,6	 0,002	 Respiratory	nitrate	reductase	beta	chain	(EC	1.7.99.4)	
SAOUHSC_01827	 3,8	 0,004	 Septation	ring	formation	regulator	EzrA	
SAOUHSC_00300	 3,9	 0,000	 Triacylglycerol	lipase	(EC	3.1.1.3)	
SAOUHSC_02541	 4,0	 0,000	 Molybdopterin-guanine	dinucleotide	biosynthesis	protein	MobB	
SAOUHSC_02099	 4,0	 0,002	 Sensor	histidine	kinase	VraS	
SAOUHSC_02241	 4,0	 0,001	 Leukocidin	LukF-PV	
SAOUHSC_02972	 4,1	 0,001	 immunodominant	antigen	B	
SAOUHSC_02971	 4,1	 0,003	 Zinc	metalloproteinase	precursor	(EC	3.4.24.29)	/	aureolysin	
SAOUHSC_00421	 4,2	 0,001	 Cystathionine	beta-synthase	(EC	4.2.1.22)	
SAOUHSC_01114	 4,2	 0,002	 Extracellular	fibrinogen-binding	protein	Efb	
SAOUHSC_00562	 4,3	 0,000	 Hydroxymethylpyrimidine	phosphate	kinase	ThiD	(EC	2.7.4.7)	
SAOUHSC_02855	 4,3	 0,028	 Secretory	antigen	SsaA	
SAOUHSC_01964	 4,6	 0,001	 Uncharacterized	protein,	homolog	of	B.subtilis	yhgC	
SAOUHSC_02240	 4,6	 0,038	 Beta-hemolysin	
SAOUHSC_01039	 4,7	 0,003	 Hypothetical	protein	(FIG01108153)	
SAOUHSC_01759	 5,2	 0,006	 Rod	shape-determining	protein	MreC	
SAOUHSC_00897	 5,6	 0,001	 Glycerophosphoryl	diester	phosphodiesterase,	periplasmic	(EC	3.1.4.46)	
SAOUHSC_00994	 5,8	 0,001	 N-acetylmuramoyl-L-alanine	amidase	(EC	3.5.1.28)/	endo-beta-N-acetylglucosaminidase		
SAOUHSC_02883	 6,2	 0,012	 Secretory	antigen	precursor	SsaA	
SAOUHSC_00803	 6,3	 0,001	 3'-to-5'	exoribonuclease	RNase	R	
SAOUHSC_02064	 6,4	 0,002	 Phage	protein	
SAOUHSC_03004	 7,5	 0,000	 Polysaccharide	intercellular	adhesin	(PIA)	biosynthesis	deacetylase	IcaB	
SAOUHSC_01108	 7,8	 0,002	 phosphoesterase	
SAOUHSC_00819	 11,0	 0,001	 Cold	shock	protein	CspC	
SAOUHSC_00818	 13,3	 0,000	 Phage-encoded	chromosome	degrading	nuclease	YokF	
SAOUHSC_02710	 218,0	 0,000	 Gamma-hemolysin	component	B	
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intensity signals (Summit_value) for the CspA-binding peaks are indicated. Boundaries, length and 
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corresponding peak is provided. 
Summit 
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Summit 
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Peak 
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Transcript Features in 
Transcript 
Feature 
closer to 
peak 
Gene 
Name Description Start End Length 
12640 1084,8 + 12473 14185 1712 T_box 
serS 
00009 serS Seryl-tRNA synthetase (EC 6.1.1.11) 
115267 650,8 - 115195 115606 411 ncRNA ncRNA  non-coding RNA 
140838 150,5 + 140777 141609 832 00135 00135 00135 FIG01108032: hypothetical protein 
157659 1121,2 - 157136 157723 587 00146 00146 00146 FIG01107837: hypothetical protein, integral 
membrane protein 
168271 121,5 - 166616 169004 2388 rsaK 
pstG 
00155 ptsG PTS system glucose-specific protein (EC 2.7.1.69) 
180213 585,0 - 180178 182034 1856 00167 00167 00167 Putative glutathione transporter, ATP-binding 
component 
228464 3037,0 + 228171 229390 1219 00206 00206 00206 L-lactate dehydrogenase (EC 1.1.1.27) 
254742 145,0 + 254103 255353 1250 00232 
00233 
00233 00233 murein hydrolase export regulator, antiholin-like 
protein LrgB 
275952 782,0 + 275857 276274 417 esxA 00257 esxA ESAT-6/Esx family secreted protein EsxA/YukE 
297001 298,0 - 296288 297197 909 00281 00281 00281 formate/nitrite transporter family protein 
298485 245,0 - 297358 298802 1444 brnQ 00282 brnQ Branched-chain amino acid transport system carrier 
protein 
303028 178,8 + 302323 303501 1178 00290 00290 00290 Perfringolysin O regulator protein PfoR 
341871 250,2 - 341658 343238 1580 00330 
00329 
00328 
00328 00328 hypothetical protein, MttB family protein 
345742 234,0 + 343403 345957 2554 00331 
00332 
00333 
00334 
00334 00334 conserved hypothetical protein 
359994 171,0 + 357853 360175 2322 ychF 00346 ychF GTP-binding and nucleic acid-binding protein YchF 
360638 880,3 + 360547 361788 1241 rpsF 
00349 
rpsR 
00348 rpsF ribosomal protein S6 
361184 265,2 + 360547 361788 1241 rpsF 
00349 
rpsR 
00349 00349 Single-stranded DNA-binding protein 
361492 289,0 + 360547 361788 1241 rpsF 
00349 
rpsR 
00350 rpsR ribosomal protein S18, zinc-independent 
361947 818,8 - 361903 363339 1436 00352 
00351 
ncRNA 
00351 00351 conserved hypothetical protein 
366784 821,0 + 366659 366997 338 00358 00358 00358 transglycosylase-associated protein 
410219 191,5 - 410048 410578 530 00409 00409 00409 conserved domain protein 
421020 205,2 + 420781 422212 1431 00420 00420 00420 Sodium-dependent transporter 
422504 215,0 + 422300 424497 2197 00421 
00422 
00421 00421 Cystathionine beta-synthase (EC 4.2.1.22) 
424310 219,0 + 422300 424497 2197 00421 
00422 
00422 00422 Cystathionine gamma-lyase (EC 4.4.1.1) 
428370 346,5 + 427450 428795 1345 00427 00427 00427 Autolysin precursor, N-acetylmuramoyl-L-alanine 
amidase 
430491 223,5 - 430189 432177 1988 00433 
00431 
00431 00431 putative membrane protein 
447886 231,8 + 446995 448042 1047 00444 
recR 
00445 recR Recombination protein RecR 
456790 408,5 + 456596 459427 2831 00452 
00454 
00455 
00456 
00452 00452 conserved hypothetical protein 
466436 358,5 + 466181 466560 379 00465 00465 00465 Veg protein 
468508 134,0 + 468334 469319 985 00468 
00469 
00468 00468 putative endoribonuclease L-PSP 
472148 245,8 + 472089 472924 835 00474 00474 00474 LSU ribosomal protein L25p 
487548 451,0 + 486656 487761 1105 00488 00488 cysK Cysteine synthase (EC 2.5.1.47) 
502087 303,0 - 501724 503037 1313 00501 00501 00501 Nucleoside permease NupC 
512916 530,5 + 512707 512995 288 Ribosw 
cysS 
00510 
(Ribosw) 
cysE Serine acetyltransferase (EC 2.3.1.30) 
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518782 508,0 + 518560 520029 1469 rplK 
rplA 
00518 rplK LSU ribosomal protein L11p (L12e) 
519958 754,0 + 518560 520029 1469 rplK 
rplA 
00519 rplA LSU ribosomal protein L1p (L10Ae) 
520252 324,0 + 520063 521268 1205 Ribosw 
rplJ 
rplL 
00520 00520 LSU ribosomal protein L10p (P0) 
521022 189,2 + 520063 521268 1205 Ribosw 
rplJ 
rplL 
00521 rplL LSU ribosomal protein L7/L12 (P1/P2) 
534196 1185,5 + 529574 534583 5009 00526 
rpsL 
rpsG 
fusA 
tuf 
00530 tuf Translation elongation factor Tu 
538088 156,0 + 537555 538526 971 00533 00533 00533 chaperone protein HchA 
564506 226,0 + 563992 565609 1617 00556 00556 00556 L-Proline/Glycine betaine transporter ProP 
565857 2186,0 - 565565 565902 337 ncRNA ncRNA NA non-coding RNA 
569301 4094,0 - 569178 569598 420 00561 00561 00561 conserved domain protein 
572808 581,5 + 572730 574290 1560 00569 00569 00569 cationic amino acid transporter 
575902 291,5 + 575845 576120 275 rsaA RsaA RsaA non-coding RNA 
609908 185,0 + 609295 610142 847 00618 00618 00618 FIG01108193: hypothetical protein 
623747 367,5 - 623345 624458 1113 RsaC RsaC RsaC non-coding RNA 
626127 570,0 - 623345 627121 3776 00637 
00636 
00635 
rsaC 
00636 00636 iron (chelated) ABC transporter permease 
626981 544,5 - 623345 627121 3776 00637 
00636 
00635 
rsaC 
00637 00637 Manganese ABC transporter, ATP-binding protein 
SitB 
631650 200,0 + 630622 631749 1127 00642 00642 00642 Teichoic acid translocation permease protein TagG 
646630 518,3 + 646310 646921 611 00659 00659 00659 conserved hypothetical protein 
647344 273,5 + 647276 648470 1194 00660 00660 00660 branched-chain amino acid transport system II carrier 
protein 
658082 231,0 + 657120 659012 1892 00669 
00670 
00670 00670 phosphate transporter 
659615 232,0 - 659463 660418 955 00671 00671 00671 conserved hypothetical protein 
669716 312,0 + 666322 669952 3630 00678 
00679 
00680 
00681 
00682 
00682 00682 conserved hypothetical protein 
675169 171,0 - 674752 675735 983 00691 00691 00691 Undecaprenyl-diphosphatase (EC 3.6.1.27) 
679789 288,0 - 679202 680075 873 00694 00694 mgrA Transcriptional regulator MgrA 
693390 777,0 + 690231 694053 3822 00706 
00707 
00708 
00708 00708 fructose specific permease PTS system, fructose-
specific (EC 2.7.1.69) 
702651 245,3 - 702383 703056 673 00718 00718 00718 putative membrane protein 
745372 412,0 + 744206 745564 1358 00762 00762 00762 probable undecaprenyl-phosphate N-
acetylglucosaminyl 1-phosphatetransferase 
774338 9787,5 + 774294 774417 123 RsaH RsaH RsaH non-coding RNA 
778230 292,5 + 776018 778299 2281 00794 
00795 
00795 gap NAD-dependent glyceraldehyde-3-phosphate 
dehydrogenase (EC 1.2.1.12) 
784334 773,3 + 784200 784489 289 00801 00801 secG preprotein translocase, SecG subunit 
801204 850,2 + 800965 801321 356 00819 00819 cspC Cold shock protein CspC 
803311 214,0 - 803125 803693 568 00824 
00823 
00823 00823 conserved hypothetical protein 
803983 684,5 - 803896 804470 574 00826 
(Overlappin
g 3') 
00826 00826 conserved hypothetical protein 
816212 180,3 + 815991 816314 323 00845 00845 00845 conserved hypothetical protein 
816821 277,5 - 816348 817371 1023 00846 00846 00846 integral membrane protein 
838675 121,5 - 838365 838917 552 00873 00873 00873 conserved hypothetical protein, nitrogen-fixing NifU, 
C-terminal 
842966 240,0 + 841625 843093 1468 00878 00878 00878 NADH dehydrogenase (EC 1.6.99.3) 
876538 146,7 + 875640 876621 981 00906 00906 00906 Fumarylacetoacetate hydrolase family protein 
880122 484,5 + 879738 880230 492 00910 00910 00910 N-6 Adenine-specific DNA methylase YitW 
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890755 589,5 - 890591 890881 290 00919 00919 00919 conserved hypothetical protein 
893282 309,5 + 891111 893391 2280 00920 
00921 
00921 00921 3-oxoacyl-[acyl-carrier-protein] synthase, KASII (EC 
2.3.1.41) 
907170 229,0 + 906625 907303 678 00934 00934 spxA regulatory protein spxA 
908304 303,0 + 907421 908372 951 00935 00935 00935 Negative regulator of genetic competence MecA 
920722 184,0 + 919955 920853 898 00947 00947 00947 Enoyl-[acyl-carrier-protein] reductase [NADH] (EC 
1.3.1.9) 
925370 139,0 + 925061 925674 613 00951 00951 00951 2H phosphoesterase superfamily protein Bsu1186 
(yjcG) 
932706 199,0 + 931872 932923 1051 yybP 
ykoY 
00957 
00957 00957 conserved hypothetical protein, toxic anion resistance 
protein, integral membrane protein TerC 
941204 511,5 + 941116 942032 916 00964 
00965 
00964 00964 FIG01108367: hypothetical protein 
942170 178,3 + 941116 942032 916 00964 
00965 
00965 00965 hypothetical protein 
949051 249,2 - 948687 949167 480 00975 00975 00975 hypothetical protein 
952005 182,0 - 951760 952777 1017 00980 00980 menA 1,4-dihydroxy-2-naphthoate octaprenyltransferase 
(EC 2.5.1.74) 
957192 151,5 + 956703 957611 908 00985 00985 menB Naphthoate synthase (EC 4.1.3.36) 
972599 786,0 - 972359 976602 4243 01002 
01001 
01000 
00999 
00999 qoxD cytochrome aa3 quinol oxidase, subunit IV 
973369 689,5 - 972359 976602 4243 01002 
01001 
01000 
00999 
01000 qoxC cytochrome aa3 quinol oxidase, subunit III 
974125 295,5 - 972359 976602 4243 01002 
01001 
01000 
00999 
01001 qoxB quinol oxidase polypeptide I QoxB (EC:1.9.3.-) 
976589 157,7 - 972359 976602 4243 01002 
01001 
01000 
00999 
01002 01002 quinol oxidase polypeptide II QoxA (EC:1.9.3.-) 
977387 316,5 - 977080 977534 454 01005 01005 01005 chitinase-related protein 
995762 624,0 + 994363 995892 1529 01025 01025 01025 FIG01107839: hypothetical protein 
999346 198,0 + 997401 1000188 2787 01027 
01028 
01029 
01029 ptsI Phosphoenolpyruvate-protein phosphotransferase of 
PTS system (EC 2.7.3.9) 
1033401 202,5 - 1032357 1033672 1315 01065 01065 01065 heme A synthase 
1034234 203,0 + 1033726 1035261 1535 01066 
01067 
01066 cyoE protoheme IX farnesyltransferase 
1034864 591,3 + 1033726 1035261 1535 01066 
01067 
01067 01067 hypothetical protein 
1041276 296,3 + 1041239 1042135 896 01077 
01078 
01077 01077 conserved hypothetical protein 
1042046 1897,7 + 1041239 1042135 896 01077 
01078 
01078 rpmF ribosomal protein L32 
1062024 295,5 + 1061895 1062299 404 01100 01100 trx Thioredoxin 
1093874 236,0 + 1092078 1093963 1885 01142 
01143 
01144 
01144 01144 Cell division protein FtsL 
1106992 299,8 + 1106948 1109980 3032 T-box 
01159 
01159_T-
box 
ileS Isoleucyl-tRNA synthetase (EC 6.1.1.5) 
1114006 292,0 + 1113379 1123855 10476 01164 
01165 
pyrB 
pyrA 
01168 
01169 
carB 
pyrF 
pyrE 
01173 
01164 01164 Uracil phosphoribosyltransferase (EC 2.4.2.9) / 
Pyrimidine operon regulatory protein PyrR 
1127628 178,0 + 1126795 1127787 992 01176 
01177 
01177 rpoZ DNA-directed RNA polymerase, omega subunit 
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1133193 460,5 - 1133021 1133386 365 01181 01181 01181 hypothetical protein 
1143133 1187,0 - 1142888 1143211 323 01191 01191 rpmB ribosomal protein L28 
1151008 170,0 + 1148068 1151823 3755 01196 
01197 
01198 
01199 
01201 
01199 fabG 3-oxoacyl-[acyl-carrier protein] reductase (EC 
1.1.1.100) 
1151624 674,0 + 1151508 1151823 315 01201 01201 acpP Acyl carrier protein / HmrB protein involved in 
methicillin resistance 
1161522 1499,5 + 1161457 1161988 531 01211 01211 rplS LSU ribosomal protein L19p 
1185672 309,0 + 1184400 1186087 1687 01237 
01238 
01238 cdsA Phosphatidate cytidylyltransferase (EC 2.7.7.41) 
1201408 457,0 + 1201340 1201774 434 01250 01250 rpsO SSU ribosomal protein S15p (S13e) 
1219132 377,0 + 1217544 1219217 1673 01263 01263 01263 FIG002344: Hydrolase (HAD superfamily) 
1269469 288,0 - 1268315 1269849 1534 01326 01326 01326 Lysine-specific permease 
1271618 371,0 + 1269992 1271856 1864 01327 
01328 
01328 rpmG ribosomal protein L33 
1278814 177,2 + 1278729 1279112 383 01338 01338 01338 alternate gene name: yoxG 
1279346 253,8 + 1279199 1279766 567 01340 01340 01340 hypothetical protein 
1285562 334,0 + 1284536 1286345 1809 01346 01346 01346 Glycine betaine transporter OpuD 
1291183 311,0 - 1290679 1291296 617 01349 01349 01349 FIG01108262: hypothetical protein 
1291953 410,0 - 1291334 1292026 692 01350 01350 01350 Acyl-phosphate:glycerol-3-phosphate O-
acyltransferase PlsY 
1300864 537,0 + 1298789 1301066 2277 01356 
01357 
01358 
01358 01358 hypothetical protein 
1310048 233,0 + 1309993 1316880 6887 T_box05 
T_box06 
01366 
01367 
01368 
01369 
01370 
01371 
01372 
01366_T-
box 
01366 Anthranilate synthase, aminase component (EC 
4.1.3.27) 
1345965 2415,0 - 1345800 1346231 431 01403 01403 cspA Cold shock protein CspA 
1351005 255,8 - 1349764 1351237 1473 01411 01411 brnQ branched-chain amino acid transport system II carrier 
protein 
1375176 258,5 + 1374326 1375556 1230 01440 01440 01440 hypothetical protein 
1423294 141,0 + 1420791 1423796 3005 01466 
01467 
01467 01467 Multimodular transpeptidase-transglycosylase (EC 
2.4.1.129) (EC 3.4.-.-) / Penicillin-binding protein 
1A/1B (PBP1) 
1434991 1487,2 - 1434764 1435559 795 01477 01477 01477 probable Zn-dependent protease 
1445659 2315,0 - 1445568 1445924 356 01490 01490 01490 DNA-binding protein HU-beta 
1458441 177,0 - 1457987 1458849 862 RFN 
01505 
01505 01505 riboflavin transporter 
1513489 243,0 - 1511665 1514226 2561 01586 
01585 
01586 SrrA DNA-binding response regulator SrrA 
1551478 158,0 + 1551210 1551873 663 01630 01630 01630 Rhodanese-like domain protein 
1556007 962,0 - 1551836 1555930 4094 gcvT_Ribos
w 
01634 
01633 
01632 
01634_g
cvT 
gcvT Aminomethyltransferase (glycine cleavage system T 
protein) (EC 2.1.2.10) 
1567319 292,0 - 1567094 1567840 746 01653 01653 01653 Manganese superoxide dismutase (EC 1.15.1.1); 
Superoxide dismutase [Fe] (EC 1.15.1.1) 
1579352 240,8 + 1579250 1580952 1702 RsaOD 
01666 
01666_R
saOD 
glyS Glycyl-tRNA synthetase (EC 6.1.1.14) 
1587563 313,3 - 1585128 1587617 2489 01677 
01676 
01675 
01677 01677 hypothetical protein 
1587871 382,5 - 1587726 1588060 334 01678 01678 rpsU SSU ribosomal protein S21p 
1600254 124,0 + 1599925 1600400 475 01689 01689 rpsT SSU ribosomal protein S20p 
1624201 233,8 - 1624100 1625228 1128 01721 
01720 
01719 
01719 01719 hypothetical protein 
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1628121 328,5 - 1624100 1628201 4101 T_box07 
01722 
01721 
01720 
01719 
01722_T
box 
01722 Alanyl-tRNA synthetase (EC 6.1.1.7) 
1638061 227,0 - 1637960 1638876 916 01735 01735 01735 HesA/MoeB/ThiF family protein related to EC-YgdL 
1642639 252,5 - 1639007 1642772 3765 Ribosw 
01738 
01737 
01738 hisS Histidyl-tRNA synthetase (EC 6.1.1.21) 
1639181 4957,5 - 1639007 1639237 230 ncRNA ncRNA NA non-coding RNA 
1652607 312,8 - 1652284 1653522 1238 01748 
01747 
01747 yajC Preprotein translocase subunit YajC (TC 3.A.5.1.1) 
1658613 1211,0 - 1658526 1659659 1133 01757 
01756 
01755 
01755 rpmA LSU ribosomal protein L27p 
1659551 182,0 - 1658526 1659659 1133 01757 
01756 
01755 
01757 rplU LSU ribosomal protein L21p 
1662232 660,8 + 1662033 1662338 305 01761a 01761a 01762a hypothetical protein 
1662449 283,0 - 1662293 1662691 398 01762 01762 01762 conserved hypothetical protein 
1668581 470,5 - 1664327 1668656 4329 Ribosw 
01767 
01766 
01767_Ri
bosw 
valS Valyl-tRNA synthetase (EC 6.1.1.9) 
1670807 139,5 - 1670716 1676942 6226 01776 
01775 
01774 
01773 
01772 
01771 
01771 hemL Glutamate-1-semialdehyde aminotransferase (EC 
5.4.3.8) 
1682567 231,0 - 1682409 1683776 1367 01786 
01785 
01784 
01784 rplT LSU ribosomal protein L20p 
1687915 330,0 - 1685424 1688075 2651 T_box08 
01788 
01788_T-
box 
thrS Threonyl-tRNA synthetase (EC 6.1.1.3) 
1705646 457,5 + 1704258 1705724 1466 01803 01803 01803 amino acid permease-associated region 
1708551 154,5 - 1707914 1710747 2833 01807 
01806 
01806 pyk Pyruvate kinase (EC 2.7.1.40) 
1721809 127,3 - 1721229 1722034 805 01815 01815 01815 FIG002379: metal-dependent hydrolase 
1734430 345,0 + 1733840 1735221 1381 01828 
01829 
01829 rpsD SSU ribosomal protein S4p (S9e) 
1746155 481,0 - 1744592 1746232 1640 T_box09 
01839 
01839_T-
box 
tyrS Tyrosyl-tRNA synthetase (EC 6.1.1.1) 
1773427 156,3 - 1771835 1773590 1755 Ribosw 
01866 
01865 
01866_Ri
bosw 
01866 amino acid permease-associated region 
1776311 616,0 - 1776218 1777536 1318 01869 01869 01869 conserved hypothetical protein 
1791389 378,5 - 1788410 1791460 3050 T_box10 
01875 
01874 
01875_T-
box 
leuS Leucyl-tRNA synthetase (EC 6.1.1.4) 
1806901 203,0 - 1806697 1807686 989 01895 01895 01895 Autolysin (EC 3.5.1.28) 
1857847 256,5 - 1857709 1857931 222 01953 01953 01953 conserved domain protein 
1870496 257,5 + 1870084 1870736 652 01964 01964 01964 Signal transduction protein TRAP 
1873744 218,5 + 1873288 1873872 584 01969 01969 01969 conserved hypothetical protein 
1971100 210,0 + 1970578 1971509 931 02095 
02096 
02096 02096 FIG010063: hypothetical protein 
2018791 233,5 - 2018612 2019226 614 02145 02145 02145 FIG01108203: hypothetical protein 
2027009 438,5 - 2026887 2027175 288 02156 02156 02156 conserved domain protein 
2131967 242,5 - 2131841 2133553 1712 02300 
02299 
02298 
02298 sigB RNA polymerase sigma factor SigB 
2154052 228,0 + 2152935 2154323 1388 02319 02319 02319 cell cycle protein 
2154549 450,0 - 2154256 2154595 339 02320 02320 02320 conserved hypothetical protein 
2158385 419,3 - 2158271 2159248 977 02327 02327 02327 Inner membrane protein translocase component 
YidC, short form OxaI-like 
Continued in the following page 	 	
Annex II 	
	222 
Annex II. Continued. 
Summit 
position 
Summit 
value 
Peak 
strand 
Transcript Features in 
Transcript 
Feature 
closer to 
peak 
Gene 
Name Description Start End Length 
2167471 256,0 - 2167394 2178187 10793 02355 
02354 
02353 
02352 
02351 
02350 
02349 
02347 
02346 
02345 
02343 
02341 
02340 
02340 atpC ATP synthase epsilon chain (EC 3.6.3.14) 
2182857 732,0 - 2182547 2182920 373 02361 02361 rpmE LSU ribosomal protein L31p @ LSU ribosomal protein 
L31p, zinc-independent 
2188779 475,0 - 2188266 2189248 982 02366 02366 fba Fructose-bisphosphate aldolase class II (EC 4.1.2.13) 
2190123 304,5 - 2190001 2193569 3568 02370 
02369 
02368 
02368 pyrG CTP synthase (EC 6.3.4.2) 
2194274 167,0 + 2193898 2194786 888 02371 02371 coaA Pantothenate kinase type II, eukaryotic (EC 2.7.1.33) 
2199251 268,3 - 2199172 2202081 2909 02379 
02378 
02377 
02376 
02376 02376 conserved hypothetical protein 
2206601 129,5 - 2206422 2207872 1450 02386 
02385 
02384 
02384 02384 conserved domain protein 
2250197 269,0 - 2249857 2252359 2502 02424 
02424 
02422 
02422 02422 conserved domain protein 
2271239 136,0 - 2270541 2272915 2374 02448 
02447 
02447 02447 Putative oxidoreductase YncB 
2299379 492,0 - 2299275 2300374 1099 02478 
02477 
02477 rpsI SSU ribosomal protein S9p (S16e) 
2304125 159,5 - 2304011 2318343 14332 rpsJ, rplC, 
rplD, rplW, 
rplB, rplV 
rpsC, rplP, 
rpmC, rpsQ, 
rplN, rplX, 
rplE, rpsN, 
rpsH, rplF, 
rplR, rpsE, 
rpmD, rplO, 
secY, adk, 
infA, rpmJ, 
rpsM, rpsK, 
rpoA,rplQ 
02484 rplQ LSU ribosomal protein L17p 
2315381 199,5 - 2304011 2318343 14332 Same than 
previous 
02509 rplB LSU ribosomal protein L2p (L8e) 
2318636 346,2 + 2318477 2319077 600 02515 02515 02515 conserved hypothetical protein 
2320071 553,0 - 2319029 2320438 1409 02516 02516 02516 Hypoxanthine/guanine permease PbuG 
2324096 214,5 + 2323860 2325155 1295 02520 02520 02520 glucose uptake protein GlcU 
2326588 174,5 + 2326200 2327141 941 02523 
02524 
02524 02524 conserved hypothetical protein 
2362540 742,5 + 2361899 2362857 958 02571 02571 02571 Secretory antigen precursor SsaA2 
2366964 311,5 + 2366634 2367315 681 02576 02576 02576 N-acetylmuramoyl-L-alanine amidase aaa 
2378955 1178,5 - 2378886 2379728 842 02587 02587 02587 conserved hypothetical protein, abortive infection 
protein 
2383085 214,0 - 2381516 2383267 1751 02590 02590 02590 Histidine transport protein (permease) 
2391597 527,0 - 2389457 2391678 2221 S_box04 
02601 
02600 
02601_S-
box 
02601 Na+/H+ antiporter family protein 
2416454 117,3 + 2415846 2416787 941 02628 02628 02628 FIG01108339: hypothetical protein 
2433177 322,5 - 2432948 2434729 1781 02648 02648 02648 L-lactate permease 
2441241 384,5 - 2441078 2441621 543 02656 02656 02656 conserved hypothetical protein 
2452077 259,2 - 2451990 2453353 1363 02667 02667 02667 proton/sodium-glutamate symport protein 
2454702 313,7 + 2454255 2455435 1180 02669 
02670 
02669 sarZ Transcriptional regulator SarZ (Staphylococcal 
accessory regulator Z) 
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2455787 160,3 - 2455390 2456770 1380 02671 02671 02671 nitrite extrusion protein 
2473595 328,0 - 2473309 2474239 930 02687 02687 02687 formate/nitrite transporter family protein 
2480623 219,0 - 2480484 2482798 2314 02699 
02698 
02697 
02697 02697 Molybdenum transport ATP-binding protein ModC 
(TC 3.A.1.8.1) 
2506292 250,5 + 2505521 2506818 1297 02725 02725 02725 Bicyclomycin resistance protein TcaB 
2519207 292,0 - 2517734 2520481 2747 02740 
02739 
02740 02740 putative transporter 
2555978 152,0 + 2555360 2556400 1040 02779 02779 02779 FIG01107931: hypothetical protein 
2555831 8117,0 - 2555765 2556195 430 02781 02781 02781 conserved hypothetical protein 
2595500 326,5 + 2595214 2596028 814 02816 02816 02816 Alkaline phosphatase like protein 
2627518 1424,2 + 2627373 2627682 309 ncRNA ncRNA NA non-coding RNA 
2628162 109,5 + 2627974 2628492 518 02855 02855 02855 Secretory antigen SsaA 
2633349 200,5 - 2632758 2633443 685 02861 02861 ogt methylated-DNA--protein-cysteine methyltransferase 
2661335 499,0 - 2660606 2661491 885 02887 02887 isaA Immunodominant staphylococcal antigen A precursor 
2679416 169,0 + 2679205 2679765 560 02912 02912 02912 PhnB protein; putative DNA binding 3-
demethylubiquinone-9 3-methyltransferase domain 
protein 
2721199 858,5 - 2721111 2721871 760 02961 02961 02961 Transcriptional regulator, MarR family 
2738986 213,0 + 2738054 2741067 3013 02975 
02976 
02976 manA Mannose-6-phosphate isomerase (EC 5.3.1.8) 
2774161 417,0 - 2774060 2775082 1022 03001 03001 icaR biofilm operon icaADBC negative transcriptional 
regulator, IcaR 
2778522 267,5 + 2775142 2778667 3525 03002 
03003 
03004 
03005 
03005 icaC Polysaccharide intercellular adhesin (PIA) 
biosynthesis protein IcaC 
2805976 194,3 + 2804232 2806165 1933 03032 
03033 
03033 03033 high-affinity nickel-transport protein NixA 
2807201 352,5 - 2807132 2807764 632 03035 03035 03035 putative membrane protein 
2813074 1024,0 + 2812935 2813326 391 03045 03045 cspB Cold shock protein CspB 
2821047 1635,5 - 2820979 2821291 312 03055 03055 rpmH ribosomal protein L34 
 

Annex III 	
	 225 
 
Annex III: Table summarizing the list of putative mRNAs targeted by CspA for which the protein levels 
were found significantly affected in the ∆cspA mutant strain. 
Start End Length Strand Summit pos. Gene ID 
Fold 
change 
Anova 
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140777 141609 832 + 140838 SAOUHSC_00135 2,0 0,002 FIG01108032: hypothetical protein 
422300 424497 2197 + 422504 SAOUHSC_00421 4,2 0,001 Cystathionine beta-synthase (EC 4.2.1.22) 
427450 428795 1345 + 428370 SAOUHSC_00427 2,9 0,002 Autolysin precursor 
456596 459427 2831 + 456790 SAOUHSC_00454 -2,6 0,024 DNA polymerase III delta prime subunit  
468334 469319 985 + 468508 SAOUHSC_00469 -2,4 0,000 Putative role in sporulation (SpoVG) 
520063 521268 1205 + 520252 SAOUHSC_00520 -2,4 0,010 LSU ribosomal protein L10p (P0) 
537555 538526 971 + 538088 SAOUHSC_00533 -2,3 0,000 chaperone protein HchA 
563992 565609 1617 + 564506 SAOUHSC_00556 -5,4 0,034 L-Proline/Glycine betaine transporter ProP 
647276 648470 1194 + 647344 SAOUHSC_00660 2,4 0,016 Hypothetical protein (FIG01108275) 
674752 675735 983 - 675169 SAOUHSC_00691 2,2 0,018 Undecaprenyl-diphosphatase (EC 3.6.1.27) 
776018 778299 2281 + 778230 SAOUHSC_00794 -2,5 0,002 Central glycolytic genes regulator 
800965 801321 356 + 801204 SAOUHSC_00819 11,0 0,001 Cold shock protein CspC 
875640 876621 981 + 876538 SAOUHSC_00906 -2,4 0,006 Fumarylacetoacetate hydrolase family protein 
891111 893391 2280 + 893282 SAOUHSC_00920 -2,3 0,001 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII 
925061 925674 613 + 925370 SAOUHSC_00951 -2,2 0,001 2H phosphoesterase superfamily protein  
972359 976602 4243 - 976589 SAOUHSC_01002 2,6 0,006 quinol oxidase polypeptide II QoxA (EC:1.9.3.-) 
1113379 1123855 10476 + 1114006 SAOUHSC_01166 -2,6 0,008 Aspartate carbamoyltransferase (EC 2.1.3.2) 
1113379 1123855 10476 + 1114006 SAOUHSC_01172 -2,1 0,007 Orotate phosphoribosyltransferase (EC 2.4.2.10) 
1113379 1123855 10476 + 1114006 SAOUHSC_01168 -2,0 0,021 Dihydroorotase (EC 3.5.2.3) 
1148068 1151823 3755 + 1151008 SAOUHSC_01198 -3,2 0,000 Malonyl CoA-acyl carrier protein transacylase  
1148068 1151823 3755 + 1151008 SAOUHSC_01199 -2,9 0,000 3-oxoacyl-[acyl-carrier protein] reductase  
1151508 1151823 315 + 1151624 SAOUHSC_01201 -2,2 0,002 Acyl carrier protein  
1201340 1201774 434 + 1201408 SAOUHSC_01250 -3,1 0,010 SSU ribosomal protein S15p (S13e) 
1278729 1279112 383 + 1278814 SAOUHSC_01338 2,7 0,008 alternate gene name: yoxG 
1298789 1301066 2277 + 1300864 SAOUHSC_01356 3,4 0,026 Transcription antiterminator 
1309993 1316880 6887 + 1310048 SAOUHSC_01366 2,1 0,004 Anthranilate synthase, aminase component  
1345800 1346231 431 - 1345965 SAOUHSC_01403 -43,9 0,000 Cold shock protein CspA 
1551836 1555930 4094 - 1556007 SAOUHSC_01632 -2,1 0,000 Glycine cleavage system P-protein 
1551836 1555930 4094 - 1556007 SAOUHSC_01634 -2,1 0,014 Aminomethyltransferase  
1551836 1555930 4094 - 1556007 SAOUHSC_01633 2,7 0,002 Glycine cleavage system P-protein 
1567094 1567840 746 - 1567319 SAOUHSC_01653 -2,0 0,001 Manganese superoxide dismutase (EC 1.15.1.1); 
1670716 1676942 6226 - 1670807 SAOUHSC_01773 -2,6 0,010 Uroporphyrinogen-III synthase (EC 4.2.1.75) 
1670716 1676942 6226 - 1670807 SAOUHSC_01771 -2,3 0,002 Glutamate-1-semialdehyde aminotransferase 
1682409 1683776 1367 - 1682567 SAOUHSC_01786 -2,9 0,004 Translation initiation factor 3 
1707914 1710747 2833 - 1708551 SAOUHSC_01807 -2,0 0,000 6-phosphofructokinase (EC 2.7.1.11) 
1721229 1722034 805 - 1721809 SAOUHSC_01815 -2,0 0,002 metal-dependent hydrolase (FIG146085) 
1744592 1746232 1640 - 1746155 SAOUHSC_01839 -2,0 0,005 Tyrosyl-tRNA synthetase (EC 6.1.1.1) 
1776218 1777536 1318 - 1776311 SAOUHSC_01869 -2,9 0,000 Hypothetical protein 
1870084 1870736 652 + 1870496 SAOUHSC_01964 4,6 0,001 Homolog of B. subtilis yhgC 
1873288 1873872 584 + 1873744 SAOUHSC_01969 -2,4 0,007 Hypothetical protein, S4-like RNA binding domain 
2131841 2133553 1712 - 2131967 SAOUHSC_02298 -3,1 0,000 RNA polymerase sigma factor SigB 
2131841 2133553 1712 - 2131967 SAOUHSC_02299 -2,2 0,000 Serine-protein kinase RsbW (EC 2.7.11.1) 
2188266 2189248 982 - 2188779 SAOUHSC_02366 -3,5 0,000 Fructose-bisphosphate aldolase class II  
2199172 2202081 2909 - 2199251 SAOUHSC_02377 -2,1 0,008 Pyrimidine-nucleoside phosphorylase (EC 2.4.2.2) 
2270541 2272915 2374 - 2271239 SAOUHSC_02447 -2,3 0,002 Putative oxidoreductase YncB 
2361899 2362857 958 + 2362540 SAOUHSC_02571 2,7 0,013 Secretory antigen precursor SsaA 
2480484 2482798 2314 - 2480623 SAOUHSC_02698 2,6 0,020 L-Cystine ABC transporter, permease protein TcyB 
2595214 2596028 814 + 2595500 SAOUHSC_02816 3,3 0,014 Alkaline phosphatase like protein 
2627974 2628492 518 + 2628162 SAOUHSC_02855 4,3 0,028 Secretory antigen SsaA 
2679205 2679765 560 + 2679416 SAOUHSC_02912 -2,1 0,004 PhnB protein 
2721111 2721871 760 - 2721199 SAOUHSC_02961 -3,0 0,017 Transcriptional regulator, MarR family 
2775142 2778667 3525 + 2778522 SAOUHSC_03004 7,5 0,000 Polysaccharide intercellular adhesin (icaB) 
 
 	
